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ABSTRACT
CIRCADIAN DISRUPTION IN WOMEN WITH BREAST CANCER
Eric Dedert
October 22, 2007
Cancer patients show circadian disruption that increases as disease progresses.
Disrupted endocrine and activity rhythms predict early metastatic cancer mortality.
Effects of psychological versus biological factors on rhythms are unknown, as are
potential links between endocrine and sleep disruption, and relevance of disruption in
early stage cancer. This study sought to examine the associations of cancer-related
intrusions and avoidant coping with circadian cortisol rhythms, assessed with saliva
samples, and rest/activity rhythms, assessed with actigraphy. Participants were women
who had been recently diagnosed with breast cancer, meaning participants provided data
at similar points in the course of diagnosis and treatment of cancer.
Between diagnosis and surgical treatment, 45 women with breast cancer
completed four days of data collection including daily reports on intrusions (IES intrusion
scale) and avoidant coping (Brief COPE avoidant coping subscales), 12 saliva samples
(waking, +30 minutes, 16:00 hours, bedtime), and actigraphy recordings. Mean intrusion
and avoidant coping scores were calculated. Cortisol EIA assay results were examined
for outliers and log-transformed prior to calculation of the diurnal slope. Actigraphy
yielded the activity rhythm (autocorrelation coefficient), activity while in bed and out of
bed (dichotomy index), and sleep variables. This study was unique in its opportunity to
v

explore circadian disruption through collection of multiple measures of circadian
rhythmicity and daily reports of breast cancer-related intrusions and avoidant coping while
patients adjusted to diagnosis and anticipated treatment.
Hierarchal regression analyses adjusted for relevant demographic and medical
variables. Intrusions and avoidant coping were independently related to activity rhythm
disruption (R2 change = .146 and .098, p = .008 and .034, respectively). Avoidant coping
was associated with higher activity while in bed (R2 change = .168, p = .006). Circadian
rhythm measures, diurnal cortisol slope and autocorrelation, were significantly associated
in the predicted direction (r = -.613, p < .001). Higher autocorrelation was related to
higher waking, and lower bedtime cortisol (r = -.459, p = .003). Breast cancer-related
intrusions and avoidant coping may influence circadian rest/activity with possible
implications for clinical intervention.
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INTRODUCTION
Breast cancer currently has the highest incidence of any cancer experienced by
women. Estimates indicate approximately 213,000 women will be diagnosed with breast
cancer in the United States in 2006 (National Cancer Institute [NCI], 2005). Breast
cancer accounts for an estimated 30.7% of all newly diagnosed cancers in women in the
United States (NCI, 2005). Breast cancer also accounts for 15.7% of cancer-related death
in American women, trailing only lung cancer (NCI, 2005). While breast cancer mortality
rates have declined in the United States in recent years, incidence rates have remained
stable, and breast cancer is expected to continue to afflict many women. An estimated
12.67% of women born in the United States today are expected to develop breast cancer
at some point, with an estimated 2.96% dying of breast cancer (NCI, 2006). An estimated
$8.1 billion are spent annually on treatment of domestic breast cancer (NCI, 2005).

Breast Cancer Staging
At the time they are informed of a diagnosis of breast cancer, women may also
receive information about their disease stage, a grouping of patients by the extent of
tumor spread. Cancer that originates in the breast, as opposed to spreading from another
part of the body, is referred to as primary breast cancer. Primary breast cancer can be
staged between 0 and IV according to the staging system developed by the American
Joint Committee on Cancer (2006). According to this system, staging is determined by
the size of the tumor and involvement of lymph nodes in metastasis, the spread of cancer
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from its primary site. Cancer that has spread from its primary site and invaded other sites
in the body is termed metastatic.

Treatments
Women diagnosed with early stage breast cancer, typically less than stage III, are
often given surgical treatment options that include total mastectomy, a removal of the
entire breast, or partial mastectomy, removal of the cancerous portion of the breast as
well as some of the healthy tissue around it. These surgeries are often accompanied by
breast reconstruction surgery. Patients are also often given the option of breastconserving surgery, called a lumpectomy, which removes the cancer and a minimal
amount of tissue surrounding it, but leaves most of the breast intact. Existing research
suggests that when breast-conserving surgery is paired with radiation that kills cancer
cells, survival is similar to that of women receiving a mastectomy (NCI, 2004). In
addition, a six-year follow-up study found no differences in psychological adjustment
between women undergoing breast-conserving surgery and those receiving mastectomy
(Omne-Ponten, Holmberg, & Sjoden,1994). Mastectomy is still chosen by some women
to avoid undergoing radiation or reduce the chance of recurrence in the same breast
(Molenaar, et al., 2001). Of women diagnosed with early stage breast cancer, an
estimated 41% receive mastectomy, 37% receive breast-conserving surgery paired with
radiation, and 19% receive breast-conserving surgery without radiation (National Institute
of Health [NIH], 2005)
For patients whose primary breast cancer has spread to their lymph nodes,
chemotherapy is generally recommended. Chemotherapy uses drugs to target and kill
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rapidly-growing tumor cells. Chemotherapy drugs are taken orally, injected
intravenously, or placed near the cancer site. An estimated 69% of patients with cancer
metastasis to lymph nodes receive chemotherapy (NIH, 2005).
Some hormones, particularly estrogen and progesterone, are capable of
stimulating the multiplication of cancer cells. Consequently, hormone therapies (e.g.
tamoxifen, aromatase inhibitors) aim to block the activity of hormones that stimulate
cancer cells. Hormone therapy offers potential benefits only for tumors with estrogen or
progesterone receptors.

Symptoms Associated with Diagnosis
The course of breast cancer is frequently marked by manifestations of
psychological distress including depression, anxiety, disrupted social and sexual
functioning, self-image changes, fears of recurrence (Northouse, Templin, Mood, &
Oberst, 1998; Rowland & Massie, 1998; Yurke, Farrar, & Anderson, 2000), as well as
pain, hot flashes, weight gain, and vaginal discharge and dryness (Avis, Crawford, &
Manuel, 2005). Quality of life studies support the notion that the period immediately
following diagnosis, and including treatment, is the most troublesome for patients with
breast cancer (Knobf, 2007). A recent review reported as much as 30% of patients
develop an anxiety or depressive disorder within the first year after diagnosis (Edwards,
Hailey, & Maxwell, 2004). Additionally, patients report more distress during the pretreatment period than during the post-treatment period (Culver, Arena, Antoni, & Carver,
2002; Northouse, 1989). Patients also report elevated symptom distress related to
insomnia, loss of concentration, and fatigue during the pre-treatment period (Cimprich,
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1999). In candidates for surgical treatment, part of this distress could be due to the
decision between mastectomy and breast-conserving surgery. Patients are generally
interested in participating in this decision (Degner et al., 1997), but the acquisition of
complex information and weighing of risks and benefits, in addition to adjusting to the
diagnosis itself, is taxing for many patients. While distress is primarily evident prior to
treatment, significant long-term distress has been noted in 18% of patients in a study of
patients 20 years after diagnosis (Kornblith et al., 2003). In addition to the burden of
distress experienced pre-treatment, this distress has been associated with post-treatment
pain, nausea, fatigue, and discomfort in at least one sample of patients with breast cancer
(Montgomery, & Bovbjerg, 2004).

Distress, Psychiatric Morbidity, and Quality of Life
While many studies have documented the difficulty of psychological adjustment
to breast cancer, the prevalence of these difficulties are unclear due to inconsistent
findings. For example, prevalence reports regarding depression in women with breast
cancer have ranged from 1.5% to 50% (Rowland & Massie, 1998). Disparities in reports
of psychological disorders in these patients have numerous explanations. Because a
number of instruments for measuring depressive symptoms are available, depression
research can be used as an example of the effect of methodology on estimates of
prevalence rates in patients with breast cancer. The Diagnostic and Statistical Manual of
Mental Disorders – Fourth Edition (APA, 1994) specifies criteria for a Depressive
Episode that have substantial overlap with the consequences of illness and medical
treatments such as chemotherapy. Anhedonia, decreased appetite, sleep disturbance,
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reduced psychomotor activity, and fatigue might all be secondary to cancer and its
treatment, confounding even a skilled assessment.
Differences between studies in the methods of addressing this issue likely account
for some of the variance in reports of depressive symptomatology (Trask, 2004). For
example, some studies have measured and used all symptoms of depression regardless of
whether they are caused by a general medical condition (Rifkin et al., 1985). This
approach maximizes sensitivity for detecting symptoms of depression but decreases
specificity. A likely result is that depression estimates using this method are inflated.
Conversely, fatigue and appetite/weight changes, two symptoms often confounded with
medical conditions, have been eliminated from assessments of depression in samples of
patients with a medical condition (Bukberg, Penman, & Holland, 1984). This method
maximizes specificity at the expense of sensitivity and likely underestimates symptoms
of depression. Alternatively, a symptom of depression has sometimes been counted only
if it is clearly not attributable to a general medical condition as determined by the
interviewer or investigator (Rodin, Craven, & Littlefield, 1991). To the extent that the
etiology can be determined, this method is useful, but determinations regarding symptom
etiology can be challenging, even for skilled interviewers (Trask, 2004). Some
researchers have addressed this issue by distinguishing between somatically and
cognitively focused symptoms such as helplessness, hopelessness, indecisiveness, or
pessimism (Endicott, 1984). This method matches the assessment to the specific medical
population, but there is no consensus regarding which symptoms are most appropriate to
use (Trask, 2004) and how well the resulting depression estimates compare to estimates
using formal criteria for a depressive disorder.
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Confusion regarding symptom etiology is not the only potential confound
contributing to variability in estimates of psychiatric morbidity in patients with breast
cancer. Studies use both interview and written self-report measures to assess
psychological disorders and symptomatology. While a diagnostic interview is preferable
for establishing the presence of a psychological disorder, self-report questionnaires are
frequently more feasible. Studies using a self-report questionnaire sometimes employ a
cutoff score to indicate which patients are likely suffering from clinically significant
depression, but these measures tend to yield a high number of false positive diagnoses
(Lynch, 1995).
Variability in the assessment of psychological disorders can also be derived from
differences in who assesses the patient. Routine screening for depression often does not
exist, and research suggests a minority of patients are likely to report symptoms of
depression to nonpsychiatric hospital staff (Koller et al., 1996; Passik et al., 1998). As a
result, archival studies of depressive symptoms may underestimate the prevalence of
depression in patients with breast cancer.
Finally, the symptomatology of many psychological disorders, especially
depression and anxiety disorders, may worsen and remit throughout the diagnostic and
treatment processes (Trask, 2004), so the time of assessment could also contribute to
variability in prevalence estimates. Existing research suggests the first 13 months after
diagnosis produce the most distress, with decreasing levels thereafter (Helgeson, Snyder,
& Seltman, 2004). Long-term studies suggest that after this period, psychiatric disorder
prevalence rates of women that were diagnosed with breast cancer approach those of the
general population (Coyne, Benazon, Gaba, Calzone, & Weber, 2000). While the rates of
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psychiatric disorders for women that are more than one year post-diagnosis may be only
mildly elevated relative to the general population, subclinical distress and impairment in
excess of average rates are evident (Rowland & Massie, 1998). These considerations are
in addition to those of age, race, subculture, and differences between self-report measures
that typically contribute to variability.
Elevated levels of depressive and anxious symptomatology have consistently been
reported by patients with newly diagnosed breast cancer on self-report measures
(Cimprich, 1999; Compas & Luecken, 2002). For example, a large survey reported that
33% of patients with breast cancer suffered from significant distress (Zabora,
Brinzenhofeszoc, Curbow, Hooker, & Piantodosi, 2001). However, studies investigating
the prevalence of psychological disorders in these patients have yielded conflicting
results. In a recent study using a semi-structured diagnostic interview that followed
patients longitudinally, at least borderline criteria for a depression or anxiety disorder as
listed in the Diagnostic and Statistical Manual of Mental Disorders – Third Edition
(DSM-III; APA, 1987) were endorsed by 33% of patients at diagnosis, 24% at three
months after diagnosis, and 15% one year after diagnosis (Burgess et al., 2005).
However, another study of newly diagnosed patients using a semi-structured interview
found the prevalence of psychiatric disorders to be 18%, similar to that of community
epidemiological surveys (Dausch et al., 2004). It should be noted that the latter study was
comprised of psychosocial treatment-seeking individuals and excluded patients with a
history of a psychotic psychiatric disorder or current metastatic disease. These differences
could account for the discrepancy between the two studies.
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Studies of psychological well-being, specifically, have been supplemented by
studies of the broader quality of life concept. The term quality of life is multidimensional
(Aaronson, Bullinger, & Ahmedzai, 1988; Cella, 1994), and its measurement typically
assesses social, emotional, physical, and functional well-being and may also include
spiritual, financial, and sexual well-being (McQuellon, Kimmick, & Hurt, 1997). Several
studies have noted improved quality of life within the first year after completing
treatment (Land et al., 2004; Stanton, Danoff-Burg, & Huggins, 2002). Still, the research
literature contains several reports of elevated symptomatology years after diagnosis or
treatment, including increased fatigue (Bower et al., 2000).
The abundance of methodological issues complicating assessment of psychiatric
morbidity and quality of life in patients with breast cancer explain the strikingly disparate
estimates sometimes found in the literature. In evaluating these estimates, the
appropriateness of existing criteria, assessment methods and interviewers to the patient
population should be considered. The patient’s place in the course of diagnosis and
treatment should also be considered.
Clearly, methodological differences contribute to significant variability in
psychiatric morbidity and quality of life in patients with breast cancer, but some patterns
have emerged. Generally, the available literature suggests that women who are diagnosed
with breast cancer experience increased distress and impaired quality of life for at least
the first year after diagnosis. However, it appears that despite the continued presence of
some residual symptoms resulting from breast cancer diagnosis and treatment, long-term
psychological morbidity prevalence rates and quality of life improve following successful
treatment of breast cancer.
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Intrusions
Intrusions are defined as “unwanted thoughts and images related to the stressor”
(Antoni, Wimberly, et al., 2006, p. 1793). Intrusions have also been defined as
“intrusively experienced ideas, images, feelings, or bad dreams” (Zilberg, Weiss, &
Horowitz, 1982, p. 407). They can be elicited by environmental stimuli associated with
the stressor or internal stimuli such as thoughts associated with the stressor.
Intrusions related to a stressor are, in addition to being unwanted, typically
distressing to the individual. As reactions to a stressor, intrusions are categorized as a
type of psychological distress (Horowitz, & Wilner, 1979). As a type of distress,
intrusions compromise emotional well-being, a component of the patient’s quality of life.
Surprisingly, intrusions do not always correlate highly with generalized distress. Cancerrelated intrusions and distress were only mildly associated with each other (r = .34) in a
study of patients that had been recently diagnosed with cancer at several different sites,
with the most prevalent being breast cancer (37%; Epping-Jordan, Compas, & Howell,
1994). Patients in this study varied with respect to cancer site, with breast cancer being
the most common diagnosis. Different results were found in a study of people who were
registered as outpatients at an oncology department and had immigrated to Israel from
Russia between the years of 1989 and 1992. These patients also had varied cancer sites,
with breast cancer being the most common (44%). Cancer-related intrusions and distress
were more strongly correlated (r = .64) among the women in this study (Baider,
Kaufman, Ever Hadani, & Kaplan De-Nour, 1996), though this could be influenced by
the stress of immigration.
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Although it was initially developed to study individuals during bereavement, the
Impact of Event Scale (IES) has frequently been employed to measure reactions to
trauma (Sundin & Horowitz, 2002). The IES measures two aspects of trauma: intrusions
and avoidance. Diagnostic criteria for Posttraumatic Stress Disorder (PTSD) include reexperiencing of the traumatic event and avoidance of event-specific cues as symptoms of
the disorder. The re-experiencing criterion includes intrusions, as well as other
manifestations such as dreams of the event or feeling as though one is reliving the event.
A diagnosis of PTSD requires that the reaction be in response to a traumatic event, so
intrusions are consistent with psychiatric morbidity that is tied to the original stressor. As
a result, intrusions are an indicator of continued distress or impairment related to a
stressful event. However, as persisting cues to think about a stressor, intrusions can
prompt continuing stress for the individual. Consistent with this idea, intrusions have
been conceptualized as efforts to process new information (Park & Folkman, 1997),
suggesting that processing is necessary to resolve these thoughts. Ehlers and Steil (1995)
proposed a model of intrusive memories and thoughts asserting that when intrusions are
assigned a negative meaning, the individual is more likely to engage in avoidance, which
increases the frequency of intrusions. This model suggests that intrusions will recur,
especially when an individual engages in avoidant coping.
Intrusions related to breast cancer are prevalent, with 35% of patients endorsing
“repeated, disturbing memories of cancer treatment or your experience with cancer” in
one study of women who were primarily more than one year post-diagnosis (Jacobsen et
al., 1998). Scores of 20 or more on the Intrusions subscale of the Impact of Event Scale
(IES) are considered indications of a stress response syndrome (Bleiker, Pouwer, van der
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Ploeg, Leer, & Ader, 2000; Horowitz, & Wilner, 1979). High levels of cancer-related
intrusions associated with a score of 20 or more on the IES intrusions subscale have been
observed in 16% of patients two months after surgery, while scores in the moderate range
of 9-19 in IES intrusions were observed in 30% of the same patients two months after
surgery. Of the patients endorsing high levels of intrusions, 60% continued to report high
intrusions 21 months after surgery, suggesting temporally stable distress resulting from
the diagnosis (Bleiker et al., 2000). Intrusions are likely to be associated with other
psychological morbidity and have been related to anxiety and depression at the time of
diagnosis and 3 months post-diagnosis in a sample of patients with cancer at varying sites
(Epping-Jordan et al., 1994) and at 6 months post-diagnosis in a sample consisting
entirely of patients with breast cancer (Primo et al., 2000).
The relationship between intrusions and endocrine alterations in people who have
endured a traumatic event (Yehuda, 2002), the high prevalence of intrusions in patients
with breast cancer, and the prominence of PTSD among mental disorders observed in
women recently diagnosed with breast cancer (Dausch et al., 2004) suggest that cancerrelated intrusions may be a more sensitive index of a patient’s response to breast cancer
than are general measures of stress or distress. Consequently, intrusions present an
intriguing psychological variable with respect to physical health. Research on this
relationship is not extensive, but cancer-related distress, as measured by the sum of all
intrusion and avoidance items on the IES (Horowitz, & Wilner, 1979), has been related to
several indicators of immunosuppression in women who had received surgical treatment
for breast cancer in the past four months and had not yet begun adjuvant treatment.
Overall cancer-specific distress was associated with impaired ability of natural killer

11

(NK) cells to attack target cells, decreased proliferative response to T-cell receptors, and
decreased response to mitogens (Andersen et al., 1998).
Because cancer-related intrusions are a significant and common problem for
patients with breast cancer, a cognitive-behavioral intervention has been designed to
target these intrusions and has demonstrated evidence of efficacy in women receiving
surgical treatment for breast cancer (Antoni, Wimberly, et al., 2006). A supportiveexpressive therapy trial targeted and reduced overall traumatic stress symptoms in
women with metastatic breast cancer (Classen et al., 2001). In addition, patients with
high overall cancer-specific distress, which includes an intrusion subscale, have realized
greater mood improvement from psychological intervention (Andersen et al., 2004).

Diagnosis of Cancer as a Trauma
A breast cancer diagnosis has been shown to produce symptoms consistent with
those used to determine a diagnosis of Posttraumatic Stress Disorder (PTSD) diagnosis in
some patients (Andrykowski, Cordova, Studts, & Miller, 1998). These findings are
mirrored by an inclusion of life-threatening illness among the Criterion A events that can
potentially precipitate PTSD in the DSM-IV (APA, 1994). Symptoms consistent with
PTSD must be present for at least one month to meet criteria for a diagnosis of PTSD.
Prior to that time, trauma-related symptoms may meet criteria for Acute Stress Disorder,
though more dissociative symptoms are required for diagnosis of Acute Stress Disorder,
as opposed to PTSD (APA, 1994). One study of patients in remission and six or more
months removed from treatment found that 6% of patients met criteria for PTSD
(Andrykowski et al., 1998). Another study assessed women 3-6 weeks after diagnosis and
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found that while only 18% of the sample met criteria for a mood, anxiety, or adjustment
disorder, 8% of these diagnoses were for PTSD or Acute Stress Disorder (Dausch et al.,
2004). In women responding to self-report questionnaires 6-60 months after completing
treatment for early stage breast cancer, 5-10% responded in a way suggestive of a
diagnosis of PTSD (Cordova et al., 1995). A study of women who were 4-12 months
post-treatment for early stage breast cancer found that 3% of women met strict current or
past criteria for PTSD based on the cancer diagnosis as the traumatic event, but
subsyndromal PTSD symptoms were commonly reported. Cancer-related intrusive
thoughts were reported by 36% of these patients, 48% met the re-experiencing criterion,
and 36% endorsed three or more symptoms of PTSD (Green et al., 1998).
At first glance, the disparity between intrusions and PTSD diagnoses may be
surprising because intrusions are part of the diagnosis of PTSD. Some of this disparity
could be attributed to methodological differences between measurement of intrusions,
which are often assessed using self-report measures, and PTSD diagnoses assessed by
interview. Further, although it is clear that intrusions are present to a significant degree in
women diagnosed with breast cancer (Butler, Koopman, Classen, & Spiegel, 1999),
PTSD is only an appropriate diagnostic category for a subset of these women. PTSD
criteria specify that intrusions consist of recollections, dreams, or re-experiencing of the
traumatic event, but intrusive thoughts reported by women with breast cancer may consist
of future-oriented worry about treatment, cancer progression, recurrence or death that are
not truly intrusions and does not fit PTSD criteria (Green et al., 1998). Existing research
on traumatic reactions is consistent with findings regarding other psychiatric diagnoses in
that the primary elevations in the prevalence of PTSD occur shortly after diagnosis.
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In addition to being linked with general distress, intrusions may influence
physiology. Intrusions have demonstrated relationships with impaired immune responses
(Andersen et al., 1998). Intrusions have also been linked with immunosuppression in
students anticipating an examination (Workman & La Via, 1987). In addition, in men
undergoing testing for HIV, intrusions were correlated with increased cortisol at 1 week,
3 weeks, and 5 weeks after being informed of test results (Antoni et al., 1990).

HPA axis description
A model of HPA axis activation is presented in Figure 1 below. Human
physiological responses to stress appraisals have consistently demonstrated activation of
a specific pathway beginning with the hypothalamus (corresponding to arrow A in the
model depicted in Figure 1) (McEwen, 1998), which secretes corticotropin-releasing
hormone (CRH) (arrow B). CRH triggers the pituitary gland to secrete
adrenocorticotropic hormone (ACTH) (arrow C), causing the adrenal cortex to secrete
cortisol (arrow D). Cortisol produces metabolic changes, mobilizing energy by promoting
the conversion of protein and lipids to usable carbohydrates, providing the organism with
the energy resources to confront a stressor (McEwen, 2004) and ideally alter
characteristics of the stressor to make it less stressful. The neurohormonal cascade
resulting in cortisol secretion is a physiological negative feedback loop, with cortisol
actively inhibiting subsequent activation of this system (arrow E). As a result of
heightened secretion under stress, cortisol presents one means of assessing the effects of
psychosocial stress on physiological functioning. The neurohormonal pathway described
above is collectively referred to as the Hypothalamic-Pituitary-Adrenal (HPA) axis.
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Figure 1. An illustration of the Hypothalamic-Pituitary-Adrenal (HPA) axis.

HPA Axis
Stress Appraisal
A

Hypothalamus
B

CRH

Pituitary
C

ACTH

Negative
Feedback
E

Adrenal
D

Cortisol Secretion

Figure 1 illustrates stress-related activation of the hypothalamic-pituitary-adrenal (HPA)
axis. The arrows represent different phases of the HPA activation process A) Appraisals
of stress stimulate the hypothalamus; B) The hypothalamus secretes corticotropinreleasing hormone (CRH); C) CRH stimulates the pituitary gland to secrete
adrenocorticotropic hormone (ACTH); D) ACTH stimulates the adrenal gland to secrete
cortisol; and E) Cortisol inhibits subsequent activation of the HPA axis.

Changes in HPA axis reactivity have been reported in association with chronic
stressors such as anxiety (McEwen, 1998), early childhood trauma (Heim, Ehlert, &
Hellhammer, 2000), socioeconomic status (Brandtstadter, Baltes-Gotz, Kirschbaum, &
Hellhammer, 1991), and depression (Heim et al., 2002). HPA axis reactivity has also
been evident in response to short-term distress (Seeman, Burton, Rowe, Horwitz, &
McEwen, 1997), including completion of a mammogram (Porter et al., 2003) and
laboratory stressors including a public speaking task (Kirschbaum, Wust, & Hellhammer,
1992) and a distress-inducing vigilance task in healthy adults (Lundberg & Frankhaeuser,
15

1980). Taken together, these studies support the notion that distress is associated with
increased cortisol production and argue for the usefulness of cortisol as a physiological
measure of stress reactivity.
The physiological responses to acute stressors aimed at short-term adaptation have
been termed allostasis, meaning “the ability to achieve stability through change”
(McEwen, 1998, p. 171). Allostasis incorporates responses from several systems in the
body, including the HPA axis, the autonomic nervous system, and the cardiovascular,
metabolic, and immune systems. Stress-related activation of the HPA axis as part of
allostasis results in cortisol secretion and the associated mobilization of energy through
the availability of carbohydrates (McEwen, 2004). Once a stressor is removed, allostatic
responses aimed at addressing acute stressors are generally inactivated, returning HPA
axis activity to its baseline state.
Although the adaptation promoted by allostasis is critical, accommodations to stress
can exact a toll on the body over time due to chronic underactivation or overactivation of
bodily systems influenced by allostasis. The wear and tear on the body associated with
repeated stress or insufficient deactivation of allostatic responses has been termed
allostatic load (McEwen & Stellar, 1993). Allostatic load can develop due to exposure to
frequent and varied stressors, failure to adapt to repeated stressors of the same type, or
failure of stress responsive systems to return to baseline following the removal of the
stressor (McEwen, 1998). In these instances, chronic overexposure to stress hormones
such as cortisol can bring about pathophysiologic consequences. For example, chronic
overactivation of the HPA axis can lead to disruption of circadian physiological rhythms,
which may be linked with suppressed immune function, sleep disruption, and increased
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cancer incidence and progression (Sephton & Spiegel, 2003). Continued overactivation of
the HPA axis has also been associated with varying conditions including memory
impairment, hypertension, osteoporosis, insulin resistance, and cardiovascular disease
(Chrousos & Gold, 1998). Among the effects of HPA axis activation on the body are
alterations of the immune system. End-products of the HPA axis such as cortisol inhibit
cytotoxicity, the ability of some types of immune cells to destroy target cells. Stress
responses can also reduce availability in the body of immune cells such as lymphocytes
and affect secretion of cytokines such as interleukin-2 (essential to fighting infection) and
interferon-γ, which has anti-tumor properties (Elenkov & Chrousos, 1999).
Just as overexposure to stress hormones can be problematic, hyporesponsivity of the
HPA axis can also lead to allostatic load. The immune system component of allostasis is
typically regulated by glucocorticoids such as cortisol. When cortisol levels are
insufficient for inactivation of the immune response following removal of the stressor,
the organism is at increased risk of autoimmune or inflammatory disturbances associated
with a sustained exposure to inflammatory cytokines (McEwen, 1998).

Transactional Model
The transactional model of stress, coping, and adaptation originally proposed by
Lazarus and Folkman (1984) asserts that the person and his or her environment are in a
“dynamic, mutually reciprocal, bidirectional relationship” (p. 293). Stress is defined in
this model as “a relationship between the person and the environment that is appraised by
the person as taxing or exceeding his or her resources and endangering his or her well-
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being” (Lazarus & Folkman, 1984, p. 21). Figure 2 illustrates the transactional model of
stress and coping.
In this model, an individual engages in a primary appraisal evaluating whether,
and to what extent, an encounter is challenging, threatening or harmful (i.e. stress). If an
encounter is deemed stressful, the person then engages in secondary appraisal, an
evaluation of the availability of coping options, the effectiveness of available coping
options, and the person’s ability to enact these coping options. Secondary appraisals and
primary appraisals work together to determine the precise degree of stress perceived by
the individual. Plentiful availability of easily enacted coping strategies that are expected
to be effective in reducing or ameliorating the stressor are likely to reduce a person’s
perception that the encounter is stressful. Conversely, the absence of cognitively
available coping options, ineffectiveness of available coping options, or a person’s doubt
in their ability to successfully enact coping responses may increase stress appraisals. It
should be noted that stress appraisals may not be significantly altered by secondary
appraisals. For example, this may be true for encounters in which a person appraises the
outcome stakes to be particularly high.
Following the appraisal process, coping efforts are employed. The outcome of the
coping process continues to work together with primary and secondary appraisals to
shape a person’s experience of an encounter as stressful. These relationships are complex
and likely to vary considerably between individuals, but discussion of ways in which
primary and secondary appraisals and coping could work together may illustrate their
conceptual relationships. For instance, if coping successfully reduces the threat or harm
produced by the stressor or ameliorates the effects of the stressor on the person’s
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emotional well-being, the encounter may be appraised as being less stressful.
Unsuccessful coping, in contrast, may modify secondary appraisals, lessening the
person’s perceptions that effective coping responses are available. This may influence
primary appraisals, strengthening the person’s conviction that an encounter is threatening
or harmful.
Figure 2. The transactional model of stress and coping

Figure 2 depicts the transactional model of stress, coping, and adaptation. When an event
occurs, appraisal determines whether the event is threatening, challenging, or harmful. In
addition, Coping efforts are consciously employed, and if the event is not favorably
resolved, distress results. Model adapted from: Folkman, S. (1997). Positive
psychological states and coping with severe stress. Social Science & Medicine, 45(8),
1207-1221.
According to the transactional model, characteristics of the person, stressor, and
situation influence how people appraise and cope with a potential stressor (p.147)
(Lazarus & Folkman, 1984). The implications of the dynamic features of the transactional
model are that it is desirable to specify relevant characteristics of a stressful encounter to
better understand the process involving stress and coping.
19

Coping
Coping is most commonly defined as “constantly changing cognitive and
behavioral efforts to manage specific external and/or internal demands that are appraised
as taxing or exceeding the resources of the person” (Lazarus, & Folkman, 1984, p. 141).
While stressors are often associated with physiological arousal, the relationship between
stressful events and an individual’s physiology and physical health is complex, and the
relationship is likely modified by coping strategies (Taylor, Repetti, & Seeman, 1997).
Research on physiological adaptation to stressors has noted that exposure to stressors can
lead to positive physiological changes and that these physiological changes are
influenced by the psychological responses of the individual including appraisals and
perceptions of control (Epel & McEwen 1998). As a result, the way in which coping
influences physiological adaptation to stressors has been investigated. Researchers have
used observational studies as one way to investigate the relationships of coping with
distress, physiological variables, and health outcomes, as reviewed below.

Active coping
Coping strategies have been categorized as either active or avoidant and outcomes
for the two types of coping strategies have been contrasted. Active coping is defined as
“the process of taking active steps to try to remove or circumvent the stressor or to
ameliorate its effects” (Carver, Scheier, & Weintraub, 1989, p. 268). Evidence indicates
that an active coping style, as opposed to an avoidant coping style, has generally been
associated with enhanced psychological adjustment (Luecken & Compas, 2002). Active
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coping has been found to predict better long-term psychological adjustment in women
with breast cancer (Epping-Jordan et al., 1999; Stanton, Danoff-Burg, & Huggins, 2002).
In addition, in women undergoing breast biopsy, patients who utilized coping efforts
characterized by actively confronting their illness reported less psychiatric morbidity
(Chen et al., 1996). Several studies have documented a possible relationship between
emotional expression, rather than inhibition of emotional responses, and slowed
progression of cancer (Gross, 1989). Although opinions on the effects of active coping on
survival differ (Faller, 2001; Petticrew, Bell, & Hunter, 2002), interview ratings of active
coping in patients with lung cancer have been related to increased survival (Faller, 2001).
Strategies for addressing or ameliorating the stressor, or problem-focuses coping
strategies, have also been studied in patients with breast cancer. Information seeking
shortly after being informed of a breast cancer diagnosis has predicted subsequent
improved physical quality of life six month post-diagnosis (Ransom, Jacobsen, Schmidt,
& Andrykowski, 2005). The mechanism of the effects of problem-solving coping on
physical health outcomes has not been established, but constructs such as information
seeking incorporate openness to different treatments (Ray et al., 1993). Improved health
behavior such as adherence to medical regimen, increased exercise, improved nutrition,
and decreased smoking are also possible consequences of problem-focused coping that
could improve physical health outcomes (Ransom et al., 2005).
Additionally, emotionally expressive coping, defined as the utilization of emotional
outlets as a means of intentionally focusing on the individual’s reaction to the stressor,
has predicted better quality of life, enhanced physical health, decreased psychological
distress and fewer medical appointments in HIV-infected men (Mulder, Antoni,
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Duivenvoorden, Kauffman, & Goodkin, 1995).
Watson et al. (1988) developed the Mental Adjustment to Cancer (MAC) scale to
measure a person’s mental adjustment to cancer, but it has since come to be used as a
measure of coping. Nevertheless, examination of the items on the MAC reveal that the
original conceptualization is likely more accurate. Although some items seem to assess
coping efforts or resources, most items assess psychological reactions more consistent
with distress, specifically depression and anxiety. Among the responses assessed is
hopelessness/helplessness, a psychological reaction characteristic of depression that
incorporates low expectation for future paired with a sense of inability to influence the
future. This subscale is assessed with questions such as “I think it is the end of the world”
and “I feel like giving up” (Watson et al., 1988). The disengagement that typically
accompanies feelings of helplessness is characteristic of avoidant coping. The MAC also
measured anxious preoccupation, which seemed to be a composite of anxiety and
generalized distress. This subscale included questions such as “I suffer great anxiety
about it” and “It is a devastating feeling” (Watson et al., 1994). Fatalism, another
subscale of the MAC, seemed to target acceptance with limited hope for the future and
used items such as “I’ve had a good life; what’s left is a bonus” and “I count my
blessings” (Watson et al., 1994). Finally, the MAC assessed fighting spirit, a construct
that is the polar opposite to hopelessness/helplessness and consists of “regarding cancer
as a challenge and adopting a positive attitude” (Greer, 2000, p. 847) and was measured
using items like “I am very optimistic” and “I am determined to beat this disease”
(Watson et al., 1994).
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Some inconsistencies exist regarding the relationship between cancer stage and
coping strategies employed. Patients do not restrict themselves to one type of coping
strategy. Patients may employ multiple strategies over time, and the coping strategy
employed could vary depending on the stage of the disease. A change from one strategy
to another may be in response to a perception that initial strategies have been
unsuccessful. The use of both active and avoidant coping concurrently may be adaptive
for individuals faced with different types of stressors. Some evidence suggests that active
coping strategies are used more often by women with early stage breast cancer (Schnoll,
Harlow, Stolbach, & Brandt, 1998) and advanced stage has been linked with increased
use of hopelessness/helplessness, anxious preoccupation, and fatalism (Schnoll et al.,
1998). Studies have observed associations between advanced stage and both increased
use of avoidant coping (Sandgren & McCaul, 2007) and decreased use of avoidant coping
(Reynolds et al., 2000). Earlier stage has been associated with an elevated “fighting
spirit” orientation to the disease (Lilja, 2003; Schnoll et al., 1998) and more problemfocused coping strategies (Cohen, 2002).

Avoidant coping
Horowitz and Wilner (1979, p. 210) characterized avoidance as involving
“ideational constriction, denial of meanings and consequences of the event, blunted
sensation, behavioral inhibition or counter-phobic activity, and awareness of emotional
numbness.” Avoidant coping is defined here as reducing one’s cognitive and behavioral
efforts to deal with the stressor (Carver, Scheier, & Weintraub, 1989). Consistent with its
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definition, avoidant coping has generally been associated with findings opposite to those
of active coping (Stowell, Kiecolt-Glaser, & Glaser, 2001).
Some evidence suggests a positive influence of avoidant coping, as one study
found that women awaiting mastectomy who were judged by interviewers to be using
denial coping strategies also report lower mood disturbance and state anxiety (Watson,
Greer, Blake, & Shrapnell, 1984), but other research has generally observed a robust
negative relationship between avoidant coping and psychological adjustment (Luecken &
Compas, 2002; McCaul et al., 1999; Montgomery et al., 2003; Shapiro et al., 1997;
Stanton & Snider, 1993; Wade, Nehmy, & Koczwara, 2005; Watson et al., 1991).
Avoidant coping at the time of diagnosis has been shown to be predictive of increased
distress as long as three years post-diagnosis (Hack & Degner, 2004). In breast cancer
patients, avoidant coping has been associated with increased distress in women with early
stage breast cancer (Carver et al., 1993) and increased fear of recurrence one year after
diagnosis (Stanton, Danoff-Burg, & Huggins, 2002). An association between increased
distress and avoidant coping in cross-sectional studies may seem counterintuitive, or at
least paradoxical, given the definition of avoidant coping as a collection of consciousness
lowering processes. It might be expected that avoidant coping would, by definition, be
associated with reduced self-reported short-term distress. To explain these findings, it is
necessary to draw on the distinction made by the transactional model of stress between
coping functions and coping outcomes. This means that a person may engage in avoidant
coping functionally without achieving or experiencing that outcome (Lazarus &
Folkman, 1984).
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In addition to effects on distress, avoidant coping has been researched as it relates
to physical and physiological outcomes. This research has included repression, a concept
that is similar to avoidant coping. Repression has been conceptualized as “a class of
consciousness-lowering processes” (Erdelyi, 2006), and this process is consistent with
reduction of efforts to deal with a stressor characteristic of avoidant coping (Brown et al.,
1996). An association of repression with increased basal cortisol levels has been observed
in college undergraduates (Brown et al., 1996). In a study of metastatic breast cancer
patients, repression was directly associated with a flatter diurnal cortisol slope (GieseDavis, Sephton, Abercrombie, Duran, & Spiegel, 2004), a variable previously found to be
predictive of survival in the same sample (Sephton, Sapolsky, Kraemer, & Spiegel,
2000). An association has also been noted between repression and cancer progression in
patients with breast cancer (Jensen, 1987).
In addition to the literature on the physiological effects of coping efforts on
patients with breast cancer, there is evidence of significant relationships in other
populations. Avoidant behavior marked by low exploration of novel environments and
situations was related to elevated morning cortisol levels in children (Kagan, Reznick, &
Snidman, 1988). Reaction formation, behaving a way opposite to something the
individual wishes to avoid, has been conceptualized as an avoidant response (Prins &
Beaudet, 1980) and has been associated with increased cortisol in non-swimming military
recruits taking a swimming test (Vaernes, Ursin, Darragh, & Lambe, 1982). Rhesus
monkeys that are slow to explore novel environments have been noted to have increased
cortisol levels in response to separation from the mother (Suomi, 1987). This finding
supports the notion of a contrast between active and avoidant coping and suggests that
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avoidant coping is associated with poorer psychological and physical adaptation. It is
noteworthy that harm avoidance, as a personality trait, has been linked with diminished
ambulatory measured motor activity throughout the day. Personality traits differ from
coping processes, but people high in Harm Avoidance have been described as having
learned to “inhibit behavior to avoid punishment, novelty, and nonreward” (Volkers et
al., 2002). This conceptualization suggests that individuals high in Harm Avoidance are
likely to exhibit avoidance behavior as a means of coping with stressors.
Coping has also been a significant variable in a number of studies of immunity,
suggesting that a person’s response to a stressor can influence the physiological impact of
stressors and the resulting distress. In HIV-positive men, active coping has been
positively associated with improved immunity marked by natural killer cell cytotoxicity
(Goodkin, Blaney, et al., 1992), lymphocyte proliferative response (Goodkin et al., 1996),
leukocyte proliferative response, and slower clinical progression (Mulder, Antoni,
Duivenvoorden, Kauffman, & Goodkin, 1995). Conversely, avoidant coping has been
associated with poorer immune function in HIV patients (Goodkin, Fuchs, Feaster,
Leeka, & Rishel, 1992) and reduced effectiveness of NK cells in patients with malignant
melanoma (Fawzy et al., 1990). Similarly, in a sample of patients with various cancer
sites, avoidance predicted disease status one year later (Epping-Jordan et al., 1994).
Existing literature on the HPA axis also suggests the distress associated with
medical problems is related to greater physiological disturbance when people utilize
avoidant coping. Research on avoidant coping and the HPA axis has noted increased
cortisol output following arthroscopic knee surgery (Rosenberger, Ickovics, Epel,
D'Entremont, & Jokl, 2004) and suppression of immune function in partners of patients
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receiving bone marrow transplants (Futterman, Wellisch, Zighelboim, Luna-Raines, &
Weiner, 1996). In addition to naturalistic studies of the HPA axis, the induction of stress
in a laboratory setting has proven to be a useful tool. The most common lab stressor used
is the Trier Social Stress Test, a task in which participants are asked to give a videotaped
mock job interview speech before a panel of judges for five minutes. After the speech is
completed, participants are then asked to serially subtract 13 from an initial value of
1,022 for 5 minutes (Young, Lopez, Murphy-Weinberg, Watson, & Akil, 2000). This task
induces a mild to moderate increase in psychosocial stress and cortisol in most
individuals (Kirschbaum, Pirke, & Hellhammer, 1993). As a result, this task can be used
to investigate the responsiveness of the HPA axis to a psychosocial stressor.
The relationship between coping and physiological variables could be complex
and may involve an interaction between stress, coping, and distress. Conceptualized
within the framework of the transactional model of stress and coping, the effect of a
stressor on outcomes may be influenced by coping. This relationship may be such that
stress is associated with undesirable outcomes only when maladaptive coping is high, or
adaptive coping is low. For example, there is variability in the ways in which individuals
respond to the Trier Social Stress Test (Young et al., 2000), suggesting a possible
influence of coping on the relationship between the stress induced in the laboratory and
the individual’s physiological response. Avoidant coping has been researched in people
with schizophrenia using the Trier Social Stress Test. Results from this study suggested a
blunted HPA axis response to the task in people reporting more avoidant coping (Jansen,
Wied, & Kahn, 2000). Similarly, an investigation of this relationship in caregivers of
family member with dementia noted that the interaction of perceived stress and avoidant
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coping was generally, though not always, related to poorer leukocyte proliferative
response to mitogens (Stowell et al., 2001).
Avoidant coping may influence the effect of stress or distress, specifically
intrusions, on physiological outcomes as discussed in the previous paragraph. Avoidant
coping may also directly influence physical or physiological outcomes, independently of
the level of stress or intrusions present. The former relationship is one in which research
asks “under which conditions does avoidant coping influence physiology?”, while the
latter relationship asks whether a simple influence of avoidant coping on physiology
exists. The majority of the studies reviewed above have investigated and reported direct
effects of avoidant coping on outcomes, with promising results. Consequently, direct
effects of avoidant coping on physiology are of interest. Still, research on direct effects of
avoidant coping may benefit from extension to the former question of identifying
conditions under which a given coping strategy is helpful or harmful.
Based on the existing literature reviewed above, avoidant coping strategies appear
to be an important component of response to breast cancer diagnosis and treatment with
potential negative effects on psychological adjustment, activity levels, immunity, and
cancer progression. Additionally, avoidant coping may be associated with increased
cortisol output in response to acute stressors and disrupted circadian cortisol profiles.

Self-Distraction
The avoidant coping category subsumes several more specific coping efforts. One
of these subtypes of avoidant coping, self-distraction, has also been referred to as mental
disengagement (Carver et al., 1989). This coping effort includes activities to reduce
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awareness of goals with which the stressor interferes (Carver et al., 1989) and typically
takes the form of engaging in thoughts or activities that absorb the person’s attention,
successfully distracting from thoughts about the stressor. Previous research on this selfdistraction suggests this construct is correlated with decreased optimism and perceived
control, as well as increased anxiety (Carver et al., 1989). In women with gynecological
cancer, pre-operative self-distraction predicted increased post-operative pain, presenting
evidence of a direct negative effect of self-distraction on long-term physical adaptation
(Cohen, Fouladi, & Katz, 2005). Self-distraction may be adaptive in preventing shortterm distress, as a study of women within three months of breast cancer diagnosis or six
months of completing treatment found that those high in self-distraction were less likely
to report problems interacting with health care providers (Collie et al., 2005).
Nevertheless, longitudinal research has reported no association of self-distraction and
distress in the pre-surgical period, but noted that post-surgical self-distraction was related
to increased distress as long as twelve months post-surgery (Culver et al., 2002). It is
possible that self-distraction cannot be sustained long-term and prevents the development
of other coping strategies.

Denial
A second avoidant coping subtype of interest to this study is denial. A number of
conceptualizations of denial exist, but the operational definition for this study is “reports
of refusal to believe that the stressor exists or of trying to act as though the stressor is not
real” (Carver, Scheier, & Weintraub, 1989, p. 270). Because self-reports of coping efforts
were employed in this study, it is crucial to note that the conceptualization of denial
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utilized in this study relies on reports of denial. Denial, when operationally defined as it
is in this study, has correlated with decreased self-esteem, stress hardiness, optimism, and
control, and increased anxiety (Carver, Scheier, & Weintraub, 1989). The use of denial as
a coping strategy, as well as increased serum cortisol, has shown to be predictive of
quicker progression from HIV to AIDS (Leserman et al., 2001). Limited research also
suggests that denial is associated with an exaggerated cortisol response (Frecska et al.,
1988), though the precise relationship is unclear because just as denial may alter cortisol
levels, increased cortisol may inhibit attention to stressors (Frecska et al., 1988).
As a form of avoidant coping, it is perhaps unsurprising that findings similar to
those observed in women exhibiting self-distraction coping have also been observed in
women using denial coping efforts. The degree to which women report using denial
immediately after breast cancer surgery has been shown to be predictive of health worries
12 weeks post-surgery (Wade, Nehmy, & Koczwara, 2005). Exploratory research has
yielded denial themes regarding physical symptoms and and medical care in women who
have presented with locally advanced breast cancer, a indication of a delay between
initial symptoms and the seeking of medical care (Mohamed, Williams, Tamburrino,
Wyrobeck, & Carter, 2005).

Behavioral Disengagement
A third subtype of avoidant coping is behavioral disengagement. Behavioral
disengagement includes reduction of efforts to deal with the stressor and efforts to
achieve goals with which the stressor is interfering, a behavior pattern that is consistent
with helplessness (Carver et al., 1989). It is when behavioral disengagement is not
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available that strategies such as self-distraction are often utilized. Relationships have
been observed between behavioral disengagement, and decreased self-esteem, stress
hardiness, type A personality traits, monitoring, social desirability, optimism, and control,
and increased anxiety (Carver et al., 1989).
Behavioral disengagement coping is of interest in people with chronic illness
partly due to the possible implications for behavioral health. In women diagnosed with
breast cancer, behavioral disengagement was related to impaired ability to interact with
medical professionals, a finding that suggests the behavioral health of women exhibiting
behavioral disengagement could be impaired, as meaningful interaction with medical
professional is likely beneficial to adherence to the patient’s medical regimen (Collie et
al., 2005). Effects of behavioral disengagement on patient symptoms have not been
extensively researched, but behavioral disengagement coping was predictive of increased
fatigue in a sample of patients with chronic fatigue syndrome, a finding the authors
argued as supportive of the need for increased activity levels in these patients (Ray,
Jefferies, & Weir, 1997). In a sample of oncological inpatients, behavioral disengagement
was among several variables related to impaired performance status, a rating of overall
functional impairment (Perez-Aranibar, C., Cordova, H., & Espinoza, M., 2002).
Behavioral disengagement may be related to physiological outcomes as well. In
adolescents with type one diabetes, behavioral disengagement was related to elevated
hemoglobin A1c levels, an indication of sustained harmful elevations in blood glucose
levels (Graue, Wentzel-Larsen, Bru, Hanestad, & Sovik, 2004).
Self-Distraction, Denial, and Behavioral Disengagement clustered together in a
factor analysis conducted by the author of the Brief COPE in a psychometric study of
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these constructs (Carver et al., 1989), lending support to the notion that they are part of a
larger avoidant coping category. In all, limited research on the three aspects of avoidant
coping of interest to this study indicates that if there is a relationship between each of
them and outcomes such as distress, physical symptoms and physiological outcomes,
aspects of avoidant coping are generally related to negative outcomes.

Avoidant coping and survival
Some coping strategies that have been investigated as predictors of survival in
cancer patients can be categorized, to varying degrees, as avoidant coping strategies.
Denial has been defined as “reports of refusal to believe that the stressor exists or of
trying to act as though the stressor is not real” (Carver et al., 1989, p. 270). This
definition aligns closely with the operationalization of avoidant coping as reducing
cognitive and behavioral efforts to deal with the stressor. Use of denial, or of a fighting
spirit, as a coping strategy three months post-surgery has been reported to be predictive
of increased 10-year survival (Pettingale, 1984), while denial was reported to be
predictive of decreased 3-year survival in another study (Achte, Vuhkonen, & Achte,
1979).
A more recent and larger study aimed at replicating Pettingale’s (1984) study
found that helplessness/hopelessness was predictive of decreased 5-year survival, and no
effect of fighting spirit was observed (Watson, Haviland, Greer, Davidson, & Bliss,
1999). However, because these two constructs are conceived by at least one author as
bipolar ends of a single continuum, the absence of an association between fighting spirit
and survival in this study has been questioned (Greer, 2000). It is interesting to note an
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effect of helplessness/hopelessness, a psychological reaction that is consistent with
avoidant coping, on survival in a larger and more recent study. Nevertheless, there is no
consensus on this issue, and the existing research is not extensive and is likely
insufficient to determine the predictive value of self-reported coping and psychological
reactions on cancer survival.

Psychosocial Factors and Cancer Incidence
A number of psychosocial variables have been explored as predictors of cancer
incidence. Psychosocial factors including marital disruption by divorce, separation, and
widowhood have been associated with increased breast cancer incidence (Lillberg et al.,
2003). However, several large studies have yielded no effect of psychosocial factors on
breast cancer incidence (Lillberg et al., 2001), and one study has found stress to be
related to decreased breast cancer incidence (Nielsen et al., 2005). A recent meta-analysis
attributed positive findings to statistical evidence of publication bias and concluded that
only death of a spouse was substantially related to subsequent cancer incidence
independent of publication bias (Duijts, Zeegers, & Borne, 2003).

Psychosocial Factors and Cancer Progression/Survival
Psychosocial factors have also been of interest to researchers investigating
survival in patients diagnosed with cancer. In observational studies, longer survival has
been linked to social involvement or social support (Hislop, Waxler, Coldman, Elwood,
& Kan, 1987; House, Landis, & Umberson, 1988; Maunsell, Brisson, & Deschens, 1995;
Reynolds & Kaplan, 1990; Weihs et al., 2005 ), active coping (Faller, Bulzebruck,
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Drings, & Lang, 1999), a “fighting spirit” coping style (Greer, Morris, Pettingale, &
Haybittle, 1990), suggesting that psychosocial resources may be involved with disease
progression. Other psychosocial factors, including depression (Brown, Levy, Rosberger,
& Edgar, 2003), helplessness/hopelessness (Greer, Morris, & Pettingale, 1979) emotional
suppression (Reynolds, et al., 2000), and cognitive and behavioral avoidance (EppingJordan et al., 1994), have also exhibited relationships with shorter survival.
Observational studies on psychosocial factors and survival have been criticized,
with one review of this literature concluding that there was little convincing evidence of a
relationship (Petticrew, Bell, & Hunter, 2002). This review cited several studies reporting
no significant association between psychosocial factors and cancer survival, with these
studies outnumbering those with a significant relationship for most psychosocial factors
included in this review. For studies that have not statistically controlled for known
potential confounding variables such as age and disease stage (Sainsbury, Anderson, &
Morgan, 2000), the validity of significant findings has been questioned. The possibility of
publication bias has also been raised, as studies linking psychosocial factors with cancer
survival generally had smaller sample sizes than those reporting no significant
relationship (Petticrew et al., 2002). Because studies with a larger sample size have
greater statistical power to detect a positive relationship, it is surprising that studies with
a positive finding have smaller sample sizes. Still, it is unclear whether the oddity in
sample sizes is attributable to publication bias. Based on currently available information
from observational studies on psychosocial factors and cancer progression, an influence
of psychosocial factors on progression can not be confirmed, but trends in this literature
are noteworthy. Significant findings reported by observational research have exhibited a
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trend toward prolonged survival that is associated with active coping (Faller, Bulzebruck,
Drings, & Lang, 1999) and availability of psychosocial resources (Weihs et al., 2005).
Conversely, shortened survival has been associated with avoidant coping and symptoms
consistent with depressive states. A number of studies have also observed no significant
relationship with survival using the same or similar psychosocial variables (Petticrew et
al., 2002). Based on these inconsistencies, it seems reasonable to suggest that if a
relationship exists between psychosocial variables and survival, it may vary as a function
of a number of possible variables such as disease site and stage.
In addition to observational literature on coping and psychosocial resources, the
possibility that psychotherapeutic intervention could influence cancer survival has been
investigated after randomized prospective trials showed evidence of increased survival
time for patients with metastatic breast cancer (Spiegel, Bloom, Kraemer, & Gottheil,
1989) and other cancers (Fawzy et al., 1993; Kuchler, Henne-Bruns, Wood-Dauphinee,
Bestmann, & Rappat, 1999), with a survival effect also observed in a mixed cohort study
(Richardson, Shelton, Krailo, & Levine, 1990). Although psychotherapeutic intervention
targets quality of life improvements, the possibility of prolonged survival as a secondary
benefit spawned further research. However, while subsequent interventions have
generally achieved the goal of decreasing psychological distress, several psychological
interventions in patients with breast cancer have not shown increased survival
(Cunningham et al., 1998; Edelman, Lemon, Bell, & Kidman, 1999;Goodwin et al.,
2001).
Research into the possibility that psychosocial intervention could prolong
survival, in addition to enhancing quality of life, has been controversial. Reviewers have
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noted the initial study reporting prolonged survival (Spiegel et al., 1989) was not
originally designed with the intention of testing survival and consequently did not have a
sufficient sample size for this analysis. As noted by Speigel, Kraemer, and Bloom (1998),
larger samples are generally desirable for detecting between-group differences, not for
supporting the null hypothesis. Questions have also arisen regarding the use of mean, as
opposed to median, survival times in comparing treatment and control groups on the basis
that survival curves are typically skewed, suggesting that the median would be a better
indicator of central tendency (Coyne, Stefanek, & Palmer, 2007). Although patients were
randomized to treatment and control groups in this study, subsequent review argued that
the control group was anomalous because the survival times of these patients were lower
than geographically-matched women with metastatic breast cancer from an available
database (Fox, 1998). Though this is an interesting and useful hypothesis, but it is
important to keep in mind that a control group assigned randomly from within the study
sample is a more internally valid comparison group than a community database (Spiegel,
Kraemer, & Bloom, 1998). Randomization is the preferred method for eliminating bias in
group selection. Despite the best efforts of researchers, the samples that comprise
interventions are treatment-seeking individuals that are willing to participate in research
and may systematically vary in other ways that are different from the population of all
patients in the community with cancer.
Two meta-analyses of psychosocial intervention and survival have been
published. Chow, Tsao, and Harth (2004) found no effect of intervention on 1-year or 4year survival for all cancers or for metastatic breast cancer, in particular. This report
noted that the available data were insufficient for evaluating a small effect size for
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survival (Chow et al., 2004). Another meta-analysis found that individual, but not group,
interventions exhibited a significant effect on prolonged survival, though only three
studies of individual therapy were included in this analysis (Smedslund & Ringdal,
2004). Spiegel and Giese-Davis (2003), in their review of studies on group therapy and
survival, found that 5 of 10 studies reported a prolonged survival effect, and no studies
reported a survival deficit related to psychotherapeutic intervention. More recent
randomized prospective trials have also found no effect of psychotherapeutic intervention
on survival (Goodwin et al., 2001; Kissane et al., 2007; Kissane et al., 2004). The
absence of a survival effect in a majority of studies questions the robustness of the
survival effect. It has been noted that the proportion of studies finding an effect of
psychosocial intervention on survival is greater than the proportion expected to be
observed by chance alone (Spiegel, 2002). In addition, no trials have reported decreased
survival for the treatment group, as compared to the control group, a further departure
from the expected pattern if no relationship existed between psychosocial intervention
and survival. Still, the possibility of publication bias in favor of positive results exists
(Palmer & Coyne, 2004).
Similarly, intervention research has produced inconsistent results. Based on the
existing data, a robust, moderate or large effect of psychotherapeutic intervention on
survival seems unlikely, but an effect of psychotherapeutic intervention on survival that
is small or restricted to certain conditions may be present. One striking trend in research
on a survival effect is that trials reporting a significant survival effect were generally
conducted longer ago, with more recent trials noting no survival advantage (Goodwin et
al., 2001;Kissane et al., 2007; Kissane et al., 2004; Spiegel et al., 2007). Spiegel (2002)
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commented that medical treatments and outcomes have advanced significantly since the
initial trials were conducted. Concurrently, support group availability and public
awareness and support of women with breast cancer have increased. As a result, the
variance in survival previously contributed by intervention may now be provided by
available social support and medical care.
In further reviewing the interventions that exhibited prolonged survival effects,
among the common elements specified as “necessary but not sufficient” (Spiegel, 2002)
for producing beneficial survival was quality of life improvement. In line with the
emphasis on quality of life improvement, the learning of coping skills was identified as
an essential component to interventions that may provide a survival benefit (Spiegel,
2002). Quality of life improvement is interesting in part because this was the achieved
target outcome for the initial trial that reported survival benefits for treatment participants
(Spiegel & Bloom, 1981), and an intervention that did not improve quality of life would
not be expected to improve survival (Coyne, Stefanek, & Palmer, 2007). The promotion
of quality of life improvements seems appropriate as a primary target of
psychotherapeutic intervention for patients with cancer regardless of the conclusion
provided by research into associated survival benefits.
The absence of a survival effect in more recent randomized trials with breast
cancer patients presents compelling evidence that there is no current survival effect,
though it may have been present prior to alterations in the culture surrounding breast
cancer diagnosis and treatment. Improvement in quality of life outcomes underscore the
utility of continued psychosocial intervention and presents an opportunity for needed
research into increased survival as a secondary benefit of intervention.
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Coping Mechanisms Targeted by Interventions
One motivation for investigating coping is that coping skills training has often
been a component of psychosocial interventions with demonstrated effectiveness (Antoni,
Wimberly, et al., 2006). Successful psychosocial interventions in patients with breast
cancer have generally incorporated active coping strategies, presumably to replace
avoidance strategies. The act of engaging in a psychosocial intervention is essentially a
form of active coping in the sense that the patient likely expects to confront the diagnosis
of breast cancer and reactions to the diagnosis.
Interventions for patients with breast cancer have aimed to enhance social
support. In most group interventions, patients likely benefit from the social support
provided by other group members (Spiegel & Diamond, 2001). Social support can consist
of instrumental support that provides advice, assistance, or information. Social support
can also be useful in ameliorating the effects of breast cancer through the provision of
emotional support. The social support from group therapy provides the opportunity to
interact with other people that are facing similar stressors and are typically more
comfortable discussing breast cancer-related distress and fears of death and dying
(Spiegel & Diamond, 2001).
Supportive expressive group therapy (SET), one treatment used in breast cancer
patients, facilitates emotionally expressive discussion on fears of dying and death,
reordering life priorities, improving support from and communication with family and
friends, integrating a changed self and body image, and improving communications with
physicians (Spiegel & Classen, 2000). By facilitating emotional expression, SET
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promotes active coping in that patients engage with the emotional effects of the stressor,
breast cancer. Research has supported the usefulness of coping with cancer through
actively processing and expressing emotions (Stanton et al., 2000). Emotional expression
may benefit patients through a decrease in the use of avoidant coping strategies such as
suppression (Giese-Davis et al., 2002) and repression as coping methods (Spiegel &
Diamond, 2001).
Finding meaning is relevant to coping with cancer in light of the existential
concerns presented when diagnosed with a life-threatening illness. Park and Folkman
(1997) extended the transactional model of stress and coping to include meaning-making
coping, conceptualizing it as “a coping process that is initiated by recognition of a
discrepancy between an individual’s appraised personal significance of an event and that
individual’s global beliefs” (p. 121). They described the resolution of these discrepancies
through 1) reappraisal of an event to assimilate it into the existing global meaning
structure, or 2) modifying the global meaning structure in a way that is consistent with
the event. Because this process requires active cognitive processing of the event,
situational meaning, and global meaning, avoidant coping that reduces awareness of the
stressor is a barrier to meaning-making coping. In contrast, emotional expression
regarding existential concerns is central to SET, as well as other interventions for patients
with breast cancer (Chan et al., 2006; Classen et al., 2001; Lee, Cohen, Edgar, Laizner,
& Gagnon, 2006;Spiegel et al., 1989). This focus on existential concerns may allow
meaning-making coping to take place.
Social-cognitive theory (Bandura, 1986) emphasizes reciprocal interactions
between the person, behavior, and the environment in explaining the acquisition and
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maintenance of behavior patterns. Social-cognitive theory includes the concept of selfefficacy, a person’s confidence in his or her ability to perform a specific behavior
(Bandura, 1977). Because self-efficacy for a given behavior is a strong predictor of the
person’s exhibiting that behavior (Bandura, 1977), it is a variable of interest. SET has
increased patients’ self-efficacy to focus on and enjoy the present (Fobair et al., 2002).
Self-efficacy for enjoying the present describes an individual that feels confident in
producing positive, present-focused experiences, which is more characteristic of active
coping. Because avoidant coping is incompatible with self-efficacy, an increase in selfefficacy is consistent with active coping, but it should be noted that self-efficacy is not
classified as a coping method.
It is also noteworthy that didactic teaching of coping skills is not part of SET.
Rather, active coping strategies such as seeking social support, emotional expression, and
cognitive reappraisal seem to be integrated into the treatment process, and these activities
are inconsistent with the use of avoidant coping strategies. Regarding outcomes, patients
in SET interventions have exhibited evidence of treatment gains including reductions in
trauma symptoms (Classen et al., 2001; Fobair et al., 2002; Spiegel et al., 1999), a target
of particular interest in patients with breast cancer. Patients participating in SET have
also reported decreased mood disturbance (Classen et al., 2001; Fobair et al., 2002;
Goodwin et al., 1998; Goodwin et al., 2001; Spiegel & Bloom, 1981; Spiegel et al.,1999)
and anxiety (Fobair et al., 2002; Spiegel & Bloom, 1981; Spiegel et al., 1999),
presenting evidence that the coping strategies embedded within this therapy may
influence psychiatric morbidity. SET has also exhibited evidence of effectiveness in
quality of life variables such as improved sleep (Fobair et al., 2002) and reduced pain

41

(Fobair et al., 2002; Goodwin et al., 2001; Spiegel & Bloom, 1981). Finally, participation
in SET may promote improved nutrition (Goodwin et al., 1998).
In addition to SET, other interventions have been used in a number of studies of
patients with breast cancer. Mindfulness-Based Stress Reduction (MBSR; Kabat-Zinn,
1990) is an intervention that utilizes meditation, yoga, focus on body sensations, and
group processes to cultivate mindfulness, a nonjudgmental awareness of moment to
moment experiences. MBSR includes discussion of mindfulness and acceptance, and
formally includes relaxation techniques such as yoga as part of the intervention. MBSR
also utilizes a body scan technique that encourages focus on physical sensations, even
those that are aversive and that patients may attempt to block from consciousness.
There is no consensus on the ways in which MBSR maps onto traditional
conceptualizations of coping, but there is some available research literature on the topic.
Activities such as meditation, yoga, and the body scan practiced in MBSR could be
employed in response to stressors and would provide a concrete active coping effort to
patients. Because avoidant coping involves attempts to remove distressing thoughts from
consciousness, the promotion of awareness that permeates MBSR runs counter to many
avoidant coping efforts. One study investigating the use of coping strategies in MBSR
participants has supported the notion that they generally report increased active coping
and decreased avoidant coping (Wilson, 2006). Examination of an intervention study has
revealed that the increased use of acceptance associated with participation in this
intervention mediated improved hemoglobin A1c levels in patients with diabetes (Gregg,
Callaghan, Hayes, & Glenn-Lawson, 2007). Patients in MBSR interventions have
exhibited evidence of treatment gains including reduced stress (Carlson, Speca, Patel, &
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Goodey, 2003; Carlson, Speca, Patel, & Goodey, 2004), improved quality of life (Carlson
et al., 2003) (Carlson et al., 2004), sleep (Carlson et al., 2003), and changes in the
production of cytokines (Carlson et al., 2003), an essential component of the immune
system.
Cognitive-behavioral therapy (CBT) has also been implemented for women with
breast caner. CBT is based on the idea that there are interactions between thoughts,
behaviors and emotions. This treatment orientation is the one most closely aligned with
the promotion of coping skills to be used in addressing stressors, and coping skills are
sometimes taught in a didactic manner. Confidence in these coping skills has shown
evidence of mediating the effect of intervention on quality of life outcomes, suggesting
that coping is essential to the relationship between the diagnosis of breast cancer and
clinically relevant outcomes (Antoni, Lechner, et al., 2006).
Several CBT interventions with breast cancer patients have formally incorporated
problem solving coping strategies (Cimprich et al., 2005; Doorenbos et al., 2005).
Problem solving is a domain of coping that encompasses several subsets of coping efforts
directed at altering the stressor (Carver et al., 1989). Problem solving typically consists of
assessment of the problem, generation of possible actions aimed at solving or altering the
problem, decision making, and implementation of the chosen plan (D'Zurilla & Nezu,
2001). Behavioral health goals such as smoking cessation, enhanced nutrition, and
increased physical activity have been targeted in breast cancer patients. This strategy can
be seen as a form of problem solving coping in the context of physical illness because
this coping strategy addresses the stressor, breast cancer, which is likely appraised by the
patient as threatening or harmful to her health, through health-promoting behavior.
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Methods of promoting relaxation are often provided in CBT interventions. These
strategies are typically suggested as methods of coping with and reducing anxiety
(Antoni, Wimberly, et al., 2006). Muscle relaxation and relaxing imagery techniques
have been used with patients with breast cancer (Antoni, Wimberly, et al., 2006). Muscle
relaxation typically consists of alternating tensing and relaxing of major muscle groups,
while imagery typically consists of visualizing a relaxing situation (Greenberger &
Padesky, 1996). These strategies are intended to arm patients with a way to ameliorate
the anxious symptoms associated with breast cancer, preparing patients to cope with the
stressor. The ability to enact active coping responses provides a viable alternative to
avoidant coping strategies. Consequently, the frequency of avoidant coping strategies
may be reduced.
Reappraisal of stressors, as described above, is another coping skill that has been
included in CBT interventions in patients with breast cancer (Antoni, Wimberly, et al.,
2006; Northouse, Kershaw, Mood, & Schafenacker, 2005). Improved communication
skills aimed at enhancing social support are also formally taught in CBT interventions
(Andersen et al., 2006)
Breast cancer patients in CBT interventions have exhibited evidence of treatment
gains including reduced breast cancer-related intrusive thoughts (Antoni, Wimberly, et
al., 2006). Available research also suggests that CBT is effective in reducing anxiety
(Antoni, Wimberly, et al., 2006; Cimprich et al., 2006), general distress (Simpson,
Carlson, & Trew, 2001; Tatrow & Montgomery, 2006), providing additional support for
the notion that active coping strategies are related to decreased psychiatric
symptomatology. Studies of CBT with breast cancer patients have noted improved pain
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experience (Arathuzik, 1994; Tatrow & Montgomery, 2006), reduced social disruption
(Antoni, Lechner, et al., 2006), decreased limitations associated with cancer-related
symptoms (Doorenbos et al., 2005), and decreased serum cortisol (Cruess et al., 2000);
improvements in mood (Antoni, Lechner, et al., 2005; Lewis, Casey, Brandt, Shands, &
Zahlis, 2006; Simpson et al., 2001), perceived social support (Andersen et al., 2004;
Cimprich et al., 2005), behavioral health (Andersen et al., 2004; Cimprich et al., 2005),
treatment adherence (Cimprich et al., 2005), and quality of life (Simpson et al., 2001),
increased perceptions of benefits related to breast cancer (Antoni, Lechner, et al., 2006;
Cruess et al., 2000; McGregor et al., 2004), and improvements in indicators of immunity
(Andersen et al., 2004; McGregor et al., 2004).

Daily Assessments
One feature of the transactional model of stress is that coping outcomes are likely to
affect appraisals or future coping efforts. Successful coping efforts might lead to
decreased stress appraisals, while unsuccessful coping efforts might lead to increased
stress appraisals and altered coping strategies. As this process is repeated, memories of
coping efforts will be expected to be altered. The transactional model predicts that
success or failure of coping efforts would alter the stressor, stressor-relevant appraisals,
and subsequent coping efforts. Thus, assessments of coping are likely to be highly
dependent on the time of assessment (Tennen & Affleck, 1996). A stressor could initially
be countered using denial, but after the stressor persists for several days, problem-solving
strategies could be used. If problem solving proves unsuccessful, the individual may cope
by seeking emotional social support. The coping method reported by this individual could

45

be denial, problem-solving, or seeking social support depending on the time of
assessment. Further, a trait-oriented assessment asking for a retrospective report of the
person’s typical coping strategy may yield a commonly employed coping effort.
However, this coping effort may not be used in response to the stressor of interest in a
given situation. The discrepancy between retrospective and daily assessments of healthrelevant information is supported by recall bias in chronic pain (Erskine, Morley, &
Pearce, 1990; Larsen, 1992) and panic attacks (Margraf, Taylor, Ehlers, Roth, & Agras,
1987; Rapee, Craske, & Barlow, 1990). In the same population, comparisons between
retrospective and daily assessments found that infrequently employed coping strategies
were significantly less likely to be recalled in retrospective reports as opposed to daily
assessments (Porter & Stone, 1996).
While many valuable findings have emerged from the coping literature, research
methods have in some ways been inconsistent with the transactional model of stress
(Lazarus, 2000). The rapidly fluctuating stress, coping, and adaptation process proposed
by this model suggests that retrospective report may be clouded by the success or failures
of coping efforts employed over the period of time for which respondents are reporting.
In response to this problem, coping assessments have been developed that focus on
measuring the coping process over a period of consecutive days. For example, diaries and
other self-report measures can be used to assess dynamic processes, such as day-to-day
coping. Use of such measures minimizes retrospective reporting bias due to assessments
that occur closer to the time of occurrence (Tennen & Affleck 1996). Furthermore,
individual data sets can be aggregated and group trends studied, preserving the strengths
of a nomothetic design.
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Cortisol Rhythms
Stress-related cortisol secretion has often been measured by noting the total
cortisol secretion in a given period of time or the cortisol level at one point during the day
(Kirschbaum & Hellhammer, 1994). Another marker of HPA axis activity is the deviation
of circadian cortisol rhythms. In approximately 90% of healthy people, cortisol levels
begin to rise immediately prior to awakening, peak 30-45 minutes after awakening, and
decrease slowly throughout the rest of the day (Posener, Schildkraut, Samson, &
Schatzberg, 1996). Diurnal cortisol slopes have been reported to exhibit significant
variation between individuals, with a small proportion of healthy individuals exhibiting
flat slopes (Stone et al., 2001).
Perhaps due to the sensitivity of the HPA axis to stress appraisals, studies have
observed an association of psychosocial variables with disrupted circadian physiological
functioning (Antoni, Lutgendorf, et al., 2006). In two different samples of patients with
metastatic breast cancer, lower perceived social support was related to disrupted circadian
cortisol slopes (Abercrombie et al., 2004; Turner-Cobb, Sephton, Koopman, BlakeMortimer, & Spiegel, 2000). Depression has been linked with persistently elevated
cortisol levels throughout the day (Deuschle et al., 1997). In another study, participants
who were unemployed exhibited significantly decreased evening cortisol levels relative
to their employed counterparts (Ockenfels et al., 1995). While findings are mixed, a
number of studies have found that people with PTSD exhibit diminished total daily
cortisol secretion and disrupted circadian cortisol profiles marked by a flattened diurnal
cortisol slope (Miller, Chen, & Zhou, 2007), without the morning elevations and evening
nadir characteristic of many healthy individuals (Posener et al., 1996).

47

Intrusions and Physiology
As a type of distress, it is not surprising to note that intrusions are associated with
alterations in physiology. The presence of breast cancer-specific intrusions was
associated with elevated cortisol during the work period in healthy women (Dettenborn,
James, Valdimarsdottir, Montgomery, & Bovbjerg, 2006). In Three Mile Island-area
residents, disaster-specific intrusions were associated with increased cortisol,
epinephrine, norepinephrine, and cortisol obtained by collecting urine between 6 p.m. and
9 a.m. Intrusions were also related to increased heart rate and systolic blood pressure
(Davidson & Baum, 1986). Intrusions have also been linked with immunosuppression in
students anticipating an examination (Workman & La Via, 1987). In addition, in men
undergoing testing for HIV, intrusions were correlated with increased plasma cortisol on
the day of sample collection at 1 week, 3 weeks, and 5 weeks after being informed of test
results. To reduce confounding from diurnal variation in cortisol values, blood samples
were provided by fasting participants between 7:30 a.m. and 10:30 a.m. (Antoni et al.,
1990). Finally, men that were within 1.5 years of returning from Operation Desert Storm
combat in Iraq exhibited evidence of a relationship between increased intrusions and
hypersensitivity to inhibition of cortisol secretion, one indicator of HPA axis dysfunction.
(Kellner, Baker, & Yehuda, 1997). Sensitivity to inhibition of cortisol secretion was
tested with the administration of a synthetic steroid called dexamethasone the night prior
to saliva collection. Because dexamethasone inhibits ACTH production, it typically
suppresses the level of cortisol secreted the following morning. The dexamethasone test
is used to assess the response of the HPA axis to inhibitory mechanisms (Kirschbaum &
Hellhammer, 1994). Taken together, these reports point to intrusions as a variable of
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particular interest in research on the effects of psychological distress on physiology,
specifically cortisol.

Circadian Cortisol Rhythms and Trauma
While the majority of research has supported the notion of increased cortisol
secretion in response to stress, the majority of studies of individuals that have been
exposed to traumatic events and developed PTSD have observed decreased cortisol
secretion (Miller et al., 2007). However, conflicting results have been noted across
studies. Yehuda (2002) reviewed studies of cortisol and trauma and concluded that
individuals exposed to trauma exhibited normal morning elevations in cortisol, but a
lower nocturnal cortisol nadir. A more recent meta-analysis found that individuals with
PTSD were characterized by consistently decreased cortisol output throughout the day,
with a flat diurnal slope. This review also found that time since the traumatic event was
negatively correlated with overall cortisol output and attributed conflicting findings to
variability in time since the stressor (Miller et al., 2007) Among the studies included in
this meta-analysis, the length of time since the trauma ranged from 1-720 months.
The distinct diurnal cortisol profiles of people with PTSD could be related to the
unique features of this disorder. The Diagnostic and Statistical Manual of Mental
Disorders, 4th Edition (DSM-IV; APA, 1994), criteria include a response of “intense, fear,
helplessness, or horror” to the traumatic event. The DSM-IV criteria also specify that the
individual re-experiences the event, suggesting that the intense responses that occurred
during the original event recur during the course of the disorder. The typical diurnal
cortisol profile has been conceptualized as healthy cortisol output for an individual that is
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not experiencing stress (Miller et al., 2007) because the decrease in cortisol throughout
the day allows for healing and growth following a short-term adaptation to awakening
through a cortisol increase (Epel & McEwen, 1998). In contrast, the flattened diurnal
cortisol slope characteristic of individuals who have experienced a traumatic event and of
patients with breast cancer could be viewed as an adaptive response to a chronic stressor
in that the individual must have energy available at all times to counter the stressor and
can not afford a decrease in cortisol throughout the day (Miller et al., 2007).
Nevertheless, a constant level of cortisol throughout the day has several potential costs.
First, invariability of cortisol availability could render the person less able to mount an
increased response to an acute stressor (Epel & McEwen, 1998). Second, the allostatic
load that can occur with chronic overactivation of the HPA axis could leave the person
vulnerable to illness onset or progression (McEwen & Stellar, 1993). Perhaps most
importantly, the disruption of circadian rhythmicity itself may be associated with illness
onset or progression (Antoni, Lutgendorf, et al., 2006).

Circadian Rhythms and Cancer
Although not studies of cortisol rhythms, several studies of women with abnormal
circadian activity rhythms have supported a link of these rhythms with elevated breast
cancer vulnerability (Davis, Mirick, & Stevens, 2001; Pukkala, Auvinen, & Wahlberg,
1995; Schernhammer et al., 2001). Disruption of circadian rhythms has been identified as
one possible contributor to the increased breast cancer incidence observed in women
whose occupations expose them to light at night time, resulting in an abnormal pattern of
activity and environmental stimuli. These large, epidemiological studies typically
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matched women with breast cancer diagnoses to control cases to compare the groups in
terms of night shift work. In one study, 7,035 Danish women employed in various
occupations that required work at night for at least one year exhibited elevated breast
cancer incidence as a group when compared to matched, employed control women
(Hansen, 2001). Additionally, within the sample of night shift workers in this study,
increased night shift work was related to increased breast cancer incidence. Similar
findings were reported in a study of 78,562 nurses in the United States that worked at
least three night shifts per month for at least one year. This study found that nurses
working at least 30 years of night shifts had increased breast cancer incidence relative to
nurses that had never worked rotating night shifts (Schernhammer et al., 2001). Night
shift work was also related to breast cancer incidence in a study matching women in the
United States diagnosed with breast cancer to age-matched controls recruited through
random-digit dialing (Davis et al., 2001).
Prior to these studies on breast cancer incidence in women performing shift work,
a study of Finnish flight attendants examined the relationship between this occupation
and breast cancer incidence. These flight attendants exhibited an elevated rate of breast
cancer incidence relative to the rate observed in the general population (Pukkala et al.,
1995). Although circadian disruption was not proposed as the mechanism for increased
incidence in this study, flight attendants often perform night shift work and are exposed
to inconsistent light/dark rhythms due to travel, suggesting circadian disruption as a
possible mechanism. As a whole, these studies support the relevance of sleep/wake
rhythms in cancer incidence. The precise mechanism of the connection between
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sleep/wake rhythms and breast cancer incidence is not established. Also of interest is the
question of whether sleep/wake rhythms and cancer progression influence one another.
The circadian physiological system is influenced by melatonin, a hormone
secreted by the pineal gland, which registers the amount of light taken in by the eye.
Using this input, the pineal gland alters the sleep-wake cycle by secreting more melatonin
when it registers less light, thus cueing sleep. Melatonin levels typically peak at night and
suppress estrogen production, but exposure to light inhibits the melatonin peak. As a
result, night shift work may lead to increased estrogen in the body, a factor related to
increased risk of breast cancer (Davis et al., 2001). Thus, melatonin is one possible
mechanism for the observed effect of night shift work on breast cancer incidence
(Bartsch & Bartsch, 2006; Stevens, 2006). While this mechanism is promising, other
possible effects of circadian disruption could also bring about alterations in cancer
incidence.
An estimated 30-70% of patients with breast cancer exhibit disruption of
circadian cortisol rhythms marked by limited diurnal variation, elevated cortisol secretion
throughout the day, or erratic profiles (Sephton & Spiegel, 2003). Flattened diurnal
cortisol rhythms have been demonstrated in women with breast cancer (Abercrombie et
al., 2004; Carlson et al., 2004) as well as a sample consisting of patients with cancer at
varied sites (Touitou, Bogdan, Levi, Benavides, & Auzeby, 1996). Cancer patients also
have altered metabolic, immunologic and rest-activity rhythms with greater circadian
disturbance in more advanced cases (Mormont & Levi, 1997).
The ability of circadian cortisol rhythms to predict disease progression was
investigated in women with metastatic breast cancer that were recruited to participate in a
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trial of Supportive/Expressive group therapy (SET). These women provided saliva
samples at 8am, noon, 5pm, and 9pm on three consecutive days prior to randomization to
treatment or control groups. This allowed for calculation of a diurnal cortisol slope by
regressing collection times on cortisol values. A flatter diurnal cortisol slope, in contrast
to the decrease in cortisol levels throughout the day that is characteristic of circadian
rhythmicity, was a significant predictor of mortality in this sample (Sephton, Sapolsky,
Kraemer, & Spiegel, 2000). This effect was independent of immune factors including the
numbers and activity of natural killer (NK) cells, an immune cell type that is particularly
important in tumor resistance. Other variables correlated with the diurnal cortisol slope
were statistically controlled in subsequent analyses. These variables included metastasis
to the chest wall or lymph nodes, as opposed to bones or internal organs, taking the
medication megestrol, nocturnal awakenings, and marital disruption. The predictive
ability of the diurnal cortisol slope was independent of each of the potential confounds
tested. The effect of the diurnal cortisol slope on survival was also independent of the
effects of common prognostic factors including age at diagnosis, estrogen receptor status,
and disease-free interval (Sephton et al., 2000). Survival was assessed an average of 5.9
years (range = 3.1-7.7) after cortisol data were collected. The robust relationship between
the diurnal cortisol slope and survival identified circadian cortisol rhythms as an
important variable for future research.
Interestingly, the circadian cortisol rhythm was not retained in a model predicting
prolonged survival using clinical predictors and the rest-activity rhythm. Additionally, the
rest-activity measure employed in this study was not significantly associated with the
circadian cortisol rhythm. This finding stands in contrast to the studies reviewed above
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reporting an association between sleep and circadian cortisol rhythms. Part of the
explanation for this finding may lie in the methodology. Serum samples used to measure
the circadian cortisol rhythm were collected at 8 a.m. and 4 p.m. on two consecutive
days. The circadian rhythm was estimated by subtracting the 4 p.m. value from the 8 a.m.
value to yield a difference score for each subject (Mormont et al., 2000). The study
reporting the diurnal cortisol slope as a predictor of survival in patients with metastatic
breast cancer sampled saliva on three consecutive days at four time points: 8 a.m., noon,
5 p.m. and 9 p.m. (Sephton et al., 2000). The circadian rhythm was operationally defined
by a diurnal slope derived from a regression of cortisol values on collection times. The
latter design benefits from an additional day of collection, and the added sampling times
likely increased the reliability of the assessment of the diurnal rhythm (Kraemer et al.,
2006). The collection of four samples throughout the day also offers potential benefit
because of added variability assessed in cortisol secretion. In addition, because the 4 p.m.
sample in the Mormont et al. study was the final sample taken, the evening nadir
characteristic of typical cortisol profiles was replaced in this analysis by an afternoon
value (Mormont et al., 2000). This reduced variability could have contributed to limited
predictive ability of the circadian cortisol rhythm and the absence of an association with
the rest-activity rhythm (Mormont et al., 2000). Saliva samples assess the level of free
cortisol, the amount that is unbound and active. Because serum samples assess the total
cortisol level, variance in circadian cortisol rhythms is introduced by the sampling
method employed. Finally, the regression slope employed in the Sephton et al. (2000)
study fits well with the concept of changes in cortisol availability with respect to time
throughout the day, while the difference between the two values employed in the
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Mormont et al. study indicates the magnitude of the difference between these two
measurements. Still, it is unclear whether differing methodologies account for the lack of
an association between rest-activity and circadian cortisol rhythms in this study.
Animal studies have also supported a relationship between circadian rhythms and
cancer progression. In mice, mutations to genes essential to circadian rhythmicity are
related to faster tumor progression (Fu & Lee, 2003; Fu, Pelicano, Liu, Huang, & Lee,
2002). Similarly, destruction of the murine suprachiasmatic nuclei that control circadian
rhythms of motor activity and adrenocortical secretion has produced faster tumor
progression (Filipski et al., 2002).
Research on the diurnal cortisol decrease has been complemented by research on
the cortisol awakening response (CAR). These studies focus on the rise in cortisol that
typically follows awakening. An increased CAR has been linked with stress (Schlotz, W.,
Hellhammer, J., Schulz, P., & Stone, A., 2004) and symptoms of depression (Pruessner,
Hellhammer, Pruessner, & Lupien, 2003). Conversely, a diminished CAR has been
linked with PTSD (Rohleder, Joksimovic, Wolf, & Kirschbaum, 2004), poor sleep in
patients with insomnia (Backhaus, Junghanns, & Hohagenet al., 2004), people with
chronic fatigue (Roberts, Wessely, Chalder, Papadopoulos, & Cleare, 2004), clinical
depression (Huber, Issa, Schik, and Wolf, 2006), and job burnout (Pruessner et al., 1999).
Cortisol typically reaches its nadir early in the evening, with a rise shortly prior to
awakening (Wilhelm, Born, Kudielka, Schlotz, Wust, 2007). Under laboratory
conditions, an increase in cortisol during the period immediately preceding awakening
was negatively correlated with the CAR (Wilhelm et al., 2007). These results may be
reconciled with research indicating that a later awakening time is associated with a
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decreased CAR in nonclinical samples (Stetler & Miller, 2005). With this in mind, an
increased CAR could be indicative of disrupted circadian rhythmicity marked by an
insufficient pre-awakening cortisol rise. However, the majority of CAR studies have
concluded that the CAR is driven by awakening, rather than by circadian cortisol
rhythms, suggesting no effect of sleep variables on the CAR aside from the time of
awakening (Hucklebridge, Clow, Rahman, & Evans, 2000; Stetler & Miller, 2005).
In contrast to studies suggesting that disruption of circadian rhythms may pose a
risk of cancer and stress-related conditions, new data present the potentially positive
effects of circadian regulation, suggesting that normalizing circadian periodicity may
promote tumor defense and enhance treatment effects (Fu & Lee, 2003). A cognitivebehavioral stress management intervention has resulted in reductions in serum cortisol in
breast cancer patients (Cruess et al., 2000), and a behavioral intervention also observed
reduced serum cortisol in patients randomized to the treatment group (Schedlowski, Jung,
Schimanski, Tewes, & Schmoll, 1994). Patients with breast cancer who participated in a
mindfulness-based stress reduction (MBSR) intervention also reduced saliva cortisol
levels at post-treatment, but only for those patients with elevated cortisol at the outset of
the study (Carlson et al., 2004), an effect also observed in plasma cortisol in an
experiential-existential group therapy intervention (van der Pompe, Duivendoorden,
Antoni, Visser, Heijnen, 1997). In the MBSR study, a reduction of cortisol in patients
exhibiting patterns marked by abnormally high afternoon values was also observed
(Carlson et al., 2004). A meditation intervention in healthy male adults resulted in
lowered morning basal cortisol levels and increased reactivity of cortisol to laboratory
stressors (MacLean et al., 1997). Increased responsivity to an acute stressor is likely a
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healthy endocrine response enabling short-term adaptation to environmental demands
(Epel & McEwen, 1998). Given more recent results underscoring the importance of the
circadian rhythm, future interventions measuring cortisol could investigate whether
reductions in overall cortisol are accompanied by regulated circadian cortisol rhythms.
Given these findings, the possible role of circadian disruption as a mechanism for
explaining the negative effects of psychosocial variables on disease is an important area
of research. The role of coping in mitigating deleterious effects of stress on circadian
disruption and quality of life is also in need of clarification.

Circadian Disruption in Response to Acute Stressors
Although conceptualizations of the destructive effects of stress on physiological
responses have often focused on the wear and tear that may result from exposure to
chronic stressors, disruption of circadian rhythms can also result from acute stressors.
High intraindividual variability in the morning cortisol increase and diurnal cortisol slope
has been noted between consecutive days of saliva sampling (Kraemer et al., 2006). The
morning cortisol increase, in particular, has been found to be sensitive to psychological
states such as stress (Hellhammer et al., 2007). This suggests that diurnal cortisol profiles
are responsive to acute events or psychological states, as opposed to being stable
characteristics that are only altered slowly over time.

Implications of Circadian Disruption
Further research is needed to clarify the implications of disrupted circadian
cortisol and rest-activity rhythms. These disruptions may be implicated in a poor
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response of this system to acute environmental stressors. This view is supported by
studies indicating altered circadian cortisol profiles in patients reporting depression
(Giese-Davis, et al., 2006; Lupien et al., 1999), a condition that typically incorporates
perceptions of helplessness and hopelessness, as well as inactivity. Similarly, laboratory
studies have noted a blunted cortisol response to social stressors (Burke, Davis, Otte, &
Mohr, 2005) and a blunted response to administration of a corticosteroid medication
called dexamethasone in those reporting depression (Burke et al., 2005; Giese-Davis et
al., 2006).
In recent work on circadian cortisol rhythms in women with breast cancer, a
flattened diurnal cortisol slope appeared to be related primarily to elevated evening
cortisol levels, with no relationship observed between the diurnal slope and awakening
levels. However, a flatter diurnal slope was associated with a more dramatic cortisol
increase in the 30 minutes after awakening. It should be noted that the awakening cortisol
value, and not the 30 minute post-awakening value, is used in calculating the diurnal
cortisol slope. In addition, the diurnal slope was not significantly associated with social
stress produced by the Trier Social Stress Test, suggesting that disrupted rhythms are not
due to acute stress. Rather, a flattened diurnal cortisol slope was associated with
diminished suppression of morning cortisol secretion in response to dexamethasone
administration. Dexamethasone acts on inhibitory mechanisms that reduce the secretion
of ACTH by the pituitary gland and, subsequently, the secretion of cortisol by the adrenal
gland. Because dexamethasone administration is expected to decrease cortisol secretion,
the blunted response in patients reporting depression suggests disruption of the HPA axis.
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Taken together, these findings suggested that the exaggerated cortisol response to
awakening and sustained cortisol secretion throughout the day was due to impaired
negative feedback inhibition (Spiegel, Giese-Davis, Taylor, & Kraemer, 2006). A study
dividing patients with metastatic breast cancer into a group with a depressive disorder or
taking antidepressant medication and a group without depression also found that
depression was unrelated to cortisol reactivity to the Trier Social Stress Test. Patients
with depression did exhibit an exaggerated awakening cortisol response, though no other
relationships with circadian cortisol rhythms were observed (Giese-Davis et al., 2006).
Considering previous work linking a flattened diurnal cortisol slope with an exaggerated
awakening response, it is interesting to note that distress, depression in this case, may
influence this circadian disruption. Finally, in a subset of women with metastatic breast
cancer, emotional expression during the first session of group therapy (SET) was related
to a steeper diurnal cortisol slope. It should be noted that saliva samples for cortisol assay
were provided prior to the initiation of treatment, suggesting that it is the propensity to
express emotion, rather then the expression that occurred in the videotaped session, that
was related to a more rhythmic diurnal cortisol profile (Giese-Davis, DiMiceli, Sephton,
& Spiegel, 2006). This finding builds on the observation that depression may be related
to disruption of circadian cortisol rhythms by suggesting that active coping, specifically
emotional expression, may be associated with a more normalized circadian cortisol
rhythm.
The sustained hypersecretion of cortisol characteristic of people with depression
has been observed in several studies of patients with cancer (Andersen, 2002), including
gynecological (Evans, McCartney, Nemeroff, 1986) and pancreatic cancer (Joffe,
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Rubinow, Denicoff, Maher, & Sindelar, 1986). These blunted responses to acute stressors
suggest impairment of the HPA axis to be responsive to environmental demands. If an
individual lacks the physiological response needed to cope with an acute stressor,
adaptation could be compromised. Conversely, if the HPA axis does not inhibit cortisol
secretion in response to physiological cues, overexposure to cortisol and catabolic
processes may suppress immunity and break down muscle tissue.
Stress-related disruption of circadian rhythms may also reduce the effectiveness
of chronomodulated chemotherapy. Chronomodulated chemotherapy attempts to target
tumors with chemotherapeutic drugs at a point in the day at which normal cells are not
expected to be actively mitotic to minimize the side effects on these cells. If circadian
rhythms are disrupted, the expected benefits of this method of administration would be
eliminated (Sephton & Spiegel, 2003).
A recent review and meta-analysis of cortisol research has described the condition
under which cortisol profiles become flattened. This review concluded that a stressor that
is threatening to physical integrity, traumatic, and uncontrollable is most likely to elicit a
flattened diurnal cortisol profile (Miller et al., 2007). A diagnosis of breast cancer
typically has these features. A diagnosis of metastatic breast cancer may fit particularly
well with these features because advanced disease likely promotes a sense of imminent
threat and uncontrollability. These conceptualizations lend coherence to the robust
predictive effect of the diurnal cortisol slope on survival in patients with metastatic breast
cancer (Sephton et al., 2000). It is important to note that Miller et al.’s assertions
regarding disruption of circadian cortisol rhythms suggest that distress and appraisals
regarding the stressor are related to circadian disruption, as opposed to circadian
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disruption driven exclusively by physiological effects of chronic illness. Primary breast
cancer also threatens physical integrity, though likely to a lesser extent. Cancer is a lifethreatening illness and produces elevations in intrusions (Bleiker, Pouwer, van der Ploeg,
Leer, & Ader, 2000). Although medical treatments offer a chance at remission and
psychosocial interventions and coping can influence the effects of cancer on quality of
life, cancer can only be controlled to a limited extent. Consequently, alterations in
circadian cortisol rhythms are of particular interest in women with breast cancer.

Sleep Disruption in Breast Cancer
Patients with breast cancer have consistently reported sleep disturbance (Payne,
Piper, Rabinowitz, & Zimmerman, 2006). This sleep disturbance has included difficulty
with sleep onset and maintenance, as well poor sleep quality (Roscoe et al., 2007). At
least one form of sleep disturbance was reported by 63% of women with metastatic breast
cancer (Koopman et al., 2002). Of these sleep concerns, nocturnal awakenings were the
most frequent problem, with 44% of the sample noting this disturbance. Another study of
patients with breast cancer found that 61% reported significant decrements in sleep
quality (Fortner, Stepanski, Wang, Kasprowicz, & Durrence, 2002). Overall, patients
with breast cancer report sleep disturbance that is approximately twice that of the general
population (Savard, Laroche, Simard, Ivers, & Morin, 2003).
Distress related to the diagnosis of breast cancer has been identified as a likely
contributor to the development of sleep disturbance (Roscoe et al., 2007). Specifically,
depression predicted subsequent worsening of sleep disturbance in patients with breast
cancer. Because sleep disturbance is a symptom of depression, this item was excluded
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from analysis, with no alteration to the observed results (Palesh et al., 2007). Even after
completing treatment for breast cancer, these women continue to report elevated sleep
disturbance (Couzi, Helzlsouer, & Fetting, 1995). Evidence suggests that sleep
disturbance is predictive of decreased subsequent quality of life in patients with breast
cancer (Fortner et al., 2002). Based on these observations, a recent review has called for
interventions specifically designed to reduce sleep disturbance in patients with cancer
(Berger et al., 2005).
Not surprisingly, sleep disruption and disruption of circadian cortisol rhythms
appear to affect one another (Koopman et al., 2002; Van Cauter, Leproult, & Kupfer,
1996), though not in all studies (Mormont et al., 2000). Circadian rhythmicity is essential
to sleep functioning. This rhythmicity is largely generated by the suprachiasmatic nuclei
(SCN) in the hypothalamus and affects both cortisol rhythms and sleep. The SCN
circadian disruption is a recognized cause of sleep difficulty. The American Academy of
Sleep Medicine describes eight groups of sleeping disorders, with one group being
circadian rhythm sleep disorders. These include sleep disturbance resulting from
alterations to the circadian timing system (American Academy of Sleep Medicine, 2005).
Perhaps due to the availability of energy produced by elevated cortisol, elevated cortisol
during the night is related to sleep disturbance (Van Cauter et al., 1996). Decreased sleep
has been associated with higher cortisol levels in the evening (Koopman et al., 2002), a
time when cortisol is typically approaching its nadir. Elevated evening cortisol values
have been observed in women with breast cancer, and elevated evening cortisol is
consistent with the flattened cortisol profile characteristic of women with breast cancer
(Spiegel, Giese-Davis, Taylor, & Kraemer, 2006). Cortisol increases are also associated
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with nighttime awakenings and increased stage 1 sleep, which is lighter and less
restorative sleep, throughout the night (Born et al., 1986; Follenius, Brandenberger,
Bandesapt, Libert, & Ehrhart, 1992).
Just as elevated cortisol, especially in the evening when cortisol is typically at its
nadir value, is associated with sleep difficulty the following night, disruptions in sleep are
associated with altered cortisol during the subsequent day. In patients with breast cancer,
increased nocturnal awakenings have been associated with a flatter diurnal cortisol slope
(Sephton, Sapolsky, Kraemer, & Spiegel, 2000). In a study of healthy adult men, the day
following sleep deprivation was marked by increased total cortisol and delayed decrease
of cortisol after the morning peak, suggesting that sleep disturbance could reduce the
resiliency of the stress response system (Leproult, Copinschi, Buxton, & Van Cauter,
1997). Awakenings also appear to be related to increased nocturnal cortisol levels (SpathSchwalbe, Gofferje, Kern, Born, & Fehm, 1991).

Actigraphy
In addition to endocrine circadian rhythms, the circadian activity rhythm, or
sleep/wake rhythm, has been a variable of interest in patients with cancer. Actigraphy, or
the recording of body movement, measures circadian rest-activity rhythms, or waking
and sleep activity (Ancoli-Isreal et al., 2003). Polysomnography is typically considered
the preferred method of distinguishing sleep from wakefulness. While sleep/wake
indentification is similar, actigraphy does present several advantages over
polysomnography. Using actigraphy to assess circadian rest-activity rhythms provides an
unobtrusive measure of circadian rhythms and sleep-wake cycles (Ancoli-Isreal et al.,
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2003). Once they are initialized, watchlike devices worn on the nondominant wrist record
activity levels throughout the day and night without any need for maintenance. The
unobtrusive nature of actigraphic assessments allows for naturalistic observation of sleep.
Actigraphy also allows for long-term observation of circadian rhythms throughout 24
hours and across multiple days.
The rest-activity circadian cycle has been used as a reference for chemotherapy
administration at specific times to improve tolerability and efficacy (Mormont & Levi,
2003). This measure has demonstrated prognostic survival value in a study of patients
with metastatic colorectal cancer in which cortisol rhythms did not exhibit prognostic
value (Mormont et al., 2000), supporting the use of multiple measures of circadian
function. Actigraphic recordings correlate well with results obtained by traditional
polysomnography, with correlations for total sleep overnight typically at or above .85
(Acebo & LeBourgeois, 2006). Actigraphy also correlates well with measurements of
melatonin and core body temperature rhythms (Ancoli-Isreal et al., 2003; Selmaoui &
Touitou, 2003). The usefulness of actigraphy in assessing activity rhythms is supported
by the difficulty inherent in self-reported activity levels. Subtle changes in activity levels
may be challenging to remember and accurately report. Also, self-reported sleep
disturbances are sometimes not found when assessed with actigraphy (Dagan, Zinger, &
Lavie, 1997).
Actigraphy has proven particularly useful as a tool for investigating quality of life
and clinical features of breast cancer. Given the disruption of circadian physiology
observed in cortisol rhythms in patients with breast cancer, it is not surprising that these
women have also reported marked sleep disturbance in a sample of patients studied prior
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to the initiation of chemotherapy (Ancoli-Israel et al., 2006). In women with breast
cancer, actigraphy yielded unique data when compared with sleep diaries in one study. A
sample of women with breast cancer who were participating in a sleep intervention
reported fewer awakenings and less total rest in sleep diaries when compared with
actigraphic recordings (Berger et al., 2002). In addition, nighttime awakenings noted by
actigraphic recordings were observed to be related to increased fatigue following
chemotherapy (Berger, et al., 2002).
In a study of circadian rhythms and cancer progression, Mormont et al. (2000)
carried out a study using actigraphy as a measure of circadian rhythms in a sample of
patients with metastatic colorectal cancer referred for chronomodulated chemotherapy.
Actigraphic recordings and serum samples used to calculate circadian rhythms were
collected prior to the initiation of chemotherapy. Actigraphy data yielded an
autocorrelation as a measure of circadian rhythmicity and a variable that quantified the
amount of motion while in bed as a measure of rest-activity rhythm. The rest-activity
measure was related to tumor progression and survival in this study (Mormont, et al.,
2000), lending support to the idea that sleep disturbance is of prognostic significance in
patients with cancer.
The studies reviewed above indicate that actigraphy provides an unobtrusive,
naturalistic estimate of sleep that is comparable to polysomnography, the gold standard
for sleep assessment. Research indicates that actigraphy provides an objective measure
yielding data not available from sleep diaries. In patients with colorectal cancer, the 24hour rest-activity rhythm was predictive of tumor progression and survival, supporting
the clinical importance of actigraphy in patients with cancer. However, the explanation
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for disrupted circadian actigraphy rhythms is unclear. Further research is needed to
determine whether psychosocial factors may influence disrupted circadian actigraphy
rhythms. Investigation of psychosocial factors that may be related to circadian activity
rhythms, a prognostic variable of interest in this population, may specify psychosocial
variables or symptoms that merit close monitoring during the course of treatment.
Monitoring of these symptoms may assist in identification of patients most likely to
benefit from intervention. This research may also inform the structure and content of
future interventions by identifying psychological symptomatology that may be related to
disruption in circadian actigraphy rhythms. The relationship between psychological
symptoms and actigraphy rhythms are particularly interesting because actigraphy
rhythms are essentially a behavioral variable that may be amenable to influence by the
patient. Although actigraphy has demonstrated relationships with melatonin and body
temperature rhythms, the relationship between actigraphy and cortisol rhythms is not
established and is of interest in this study.

Hypotheses
Figure 3 illustrates the proposed relationships between cancer-related intrusions,
coping, and circadian disruption in this study. It was hypothesized that cancer-related
intrusive thoughts would disrupt rhythms of both salivary cortisol and rest-activity
rhythm as measured with actigraphy. The extent to which cancer-related intrusions
disrupt circadian rhythms was hypothesized to vary as a function of the level of avoidant
coping used. Specifically, it was hypothesized that increased avoidant coping would be
associated with a stronger positive relationship between cancer-related intrusions and
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circadian disruption. Finally, it was hypothesized that cortisol and rest/activity rhythms
would be associated.
Figure 3. Hypothesized relationships between cancer-related intrusions, avoidant coping, and
circadian disruption
Hypothesis 1a: Cancer-related intrusions

will be significantly and positively
associated with circadian disruption, as
measured by salivary cortisol and

Cancer-related
Intrusions (IES)

actigraphy.
1b
1a

Avoidant
Coping

Hypothesis 1b: Avoidant coping will

Circadian
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moderate the relationship between cancerrelated intrusions and circadian disruption.

Diurnal
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Hypothesis 2: Diurnal salivary cortisol

2
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slope and rest-activity rhythm obtained by
actigraphy will be significantly and
positively associated.

Figure 3. Possible relationships between cancerrelated intrusions, avoidant coping, and circadian
disruption.
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Hypothesis 1a: Cancer-related intrusions will be significantly and positively
associated with circadian disruption, as measured by salivary cortisol and actigraphy.
Cancer-related intrusions are of particular interest in women that have recently
been informed of their diagnosis of breast cancer because of the potentially traumatic
effect of the diagnosis (Andrykowski, Cordova, Studts, & Miller, 1998) and the
subsyndromal PTSD symptoms often observed following diagnosis (Butler, Koopman,
Classen, & Spiegel, 1999). A finding in breast cancer patients that cancer-related
intrusions are associated with circadian disruption would support research suggesting
circadian disruption as a mechanism for the effect of psychological distress on health by
investigating whether a relationship exists between distress and the proposed mechanism,
circadian disruption. Limited studies of the effects of intrusions on cortisol exist. In
people living close to the damaged Three Mile Island nuclear power station, intrusions
were associated with increased 15-hour overnight urinary cortisol (Davidson & Baum,
1986). In addition, intrusions have been related to increased plasma cortisol levels in
homosexual males receiving HIV testing (Antoni et al., 1990). These studies examined
alterations in cortisol production, but they did not include a description of circadian
cortisol rhythms. This suggests that cortisol is responsive to intrusions following a
specific event. Clearly, though, further research is needed to clarify this relationship.

Hypothesis 1b: Avoidant coping will moderate the relationship between cancerrelated intrusive thoughts and circadian disruption.
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Exploring the moderation of these relationships by coping will inform debate
about possible psychological intervention. Participants in cognitive-behavioral
interventions have demonstrated reduced cortisol in comparison to a wait-list control
group (Cruess et al., 2000; Gruber et al. 1993), suggesting that active engagement of the
stressor may influence the effect of the stressor on clinical outcomes. Undergoing
psychosocial treatment typically includes engagement of the stressor through direct
discussion of the experience of having breast cancer and learning coping skills aimed at
ameliorating the effects of illness. Active coping efforts are in contrast to avoidant coping
strategies that might otherwise be ineffectively used to manage intrusions.
Horowitz’s (1976) view on stress response patterns was that initial intrusive
thoughts are followed by avoidance that impairs adaptation to a traumatic experience. In
addition to delayed processing of a negative event, avoidance could impair adaptation by
preventing the implementation of other coping strategies (Jim, Richardson, GoldenKreutz, & Andersen, 2006). Given the life-threatening nature of a diagnosis of breast
cancer, it is expected that cancer-related intrusions will be prominent immediately after
being informed of the diagnosis. However, avoidant coping is hypothesized to influence
the effects of cancer-related intrusive thoughts on circadian disruption. When avoidant
coping is low, intrusions may be part of adaptation to the stressor. It has been proposed
that this adaptation is marked by the expression of catabolic hormones such as cortisol
that are balanced by the expression of anabolic hormones that promote recovery from
acute stressors and growth (Epel & McEwen, 1998). In this way, patients that are low in
avoidant coping may not experience disruption of circadian rhythms related to intrusions.
Rather, they may engage in emotional processing, which can promote meaning-making
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and reduced distress (Kennedy-Moore & Watson, 2001). Conversely, intrusions related to
a diagnosis of breast cancer may be related to circadian disruption in patients that inhibit
processing by engaging in avoidant coping.
Research into avoidant coping as a moderator of the effects of breast cancerspecific intrusions on circadian disruption is lacking. As a result, the influence of
avoidant coping on this relationship is unknown. Based on available research, it seems
likely that avoidant coping will aggravate the effects of intrusions on circadian
disruption, but the opposite relationship is possible. The patients in this study had learned
of their diagnosis of breast cancer within the past few weeks. It is possible that avoidant
coping could shield the patient from circadian disruption for a short period of time. If this
is the case, elevated avoidant coping would be expected to be related to decreased
circadian disruption, and decreased avoidant coping would exhibit an association with
increased circadian disruption. In addition, it should be noted that direct effects of
avoidant coping on psychological and physiological adaptation have also been
researched. This is an interesting relationship because avoidant coping may have
deleterious effects on circadian disruption regardless of the distress caused by a stressor
such as breast cancer. It is possible that avoidant coping brings about a state in which
individuals do not cognitively process a stressor and consequently are continually
confronted by it (Park & Folkman, 1997). Due to the exploratory nature of this study, all
possibilities will be considered.

Hypothesis 2: Diurnal salivary cortisol slope and rest-activity rhythm obtained by

actigraphy will be significantly and positively associated.
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Cortisol rhythms assessed using salivary samples and rest-activity rhythms
assessed using actigraphy are both used as measurements of circadian disruption. The
nature of these variables suggests they are related. The relationship between cortisol and
rest-activity rhythms will be explored to investigate their effects on one another and the
necessity of using both assessment methods in studies of circadian disruption.
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METHOD

Participants
Because the transactional model is process oriented, it focuses on an individual’s
response to a specific stressor (Folkman, Lazarus, Dunkel-Schetter, DeLongis, & Gruen,
1986). In this study, the stressor (breast cancer diagnosis), setting (outpatient clinic), and
timing (between diagnosis and initiation of treatment) were relatively consistent. The
experience of having breast cancer is likely to vary considerably over time (Lazarus &
Folkman, 1984, p. 146). Women often acquire information regarding cancer and its
treatment that changes their understanding of the stressor. The rigors of treatment could
worsen intrusions, or treatment could provide some relief in that efforts are being
undertaken to address the illness and perhaps send the cancer into remission. Once
treatment is initiated, the prognosis could improve or worsen depending on the cancer’s
response to treatment.
To attempt to control for variance in the stressor and timing, women with breast
cancer that had been recently diagnosed were recruited between the time of diagnosis and
the initiation of treatment. Because women with the same chronic illness (breast cancer)
at the same body site (breast) make up this study, all of the participants share this stressor
in common. By keeping the timing of diagnosis and treatment relatively consistent,
variance in breast cancer as a stressor is reduced. In their presentation of the transactional
model of stress and coping, Lazarus and Folkman (1984) argued against the
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conceptualization of dominant coping responses that are employed across time
andsituations. Rather, the investigation of coping efforts undertaken in response to a
given type of psychological stress and at a certain time was identified as a topic in need
of research.

Recruitment Procedure
Although study amendments modified the protocol during the accrual period, all
participants in this study were women diagnosed with breast cancer who enrolled and
completed data collection between the time of diagnosis and the initiation of treatment.
Patients who were initially eligible for this study included newly diagnosed women
referred for surgical treatment of breast cancer who spoke and read English proficiently
enough to adequately complete questionnaires. The first participant was enrolled on
6/3/05. Nine patients were enrolled prior to the approval of an amendment on 1/31/06
that sought to eliminate variance in disease characteristics by restricting enrollment to
patients with primary breast cancer. One additional patient was enrolled under this
protocol before inclusion criteria were widened, due to accrual rate concerns, to all
patients with stage I-IV (primary, metastatic, or recurrent) breast cancer on 3/17/06.
Fourteen patients were enrolled under this protocol. To allow for secondary hypothesis
testing, an amendment adding the collection of nipple aspirate fluid from the surgical
procedure, when available, was approved on 10/27/06, and 20 patients were enrolled
under this protocol. The final protocol stated that women diagnosed with stage I-IV (primary,
recurrent, or metastatic) breast cancer who had not begun curative treatment such as lumpectomy,
mastectomy, chemotherapy, or radiation and spoke and read English proficiently enough to

adequately complete questionnaires would be eligible for the study.
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Patients who were referred for surgical consultation were informed of the results
of their biopsy, an examination of breast tissue by a pathologist to determine whether a
malignancy is present. There are four types of breast tumor biopsy. A core biopsy uses a
hollow needle to remove tissue from an area of the breast suspected of being cancerous.
A fine needle aspiration uses a thinner needle to remove cell samples from an area of the
breast suspicious for cancer. An excisional biopsy surgically removes suspicious tissue
from the breast as well as some healthy tissue in the surrounding area. An incisional
biopsy surgically removes a portion of the suspicious tissue from the breast. A vacuumassisted biopsy uses a needle to take multiple samples from the suspicious area of the
breast with one needle insertion.
Patients referred for this study had been diagnosed in several different ways. Some
patients referred for this study had received feedback regarding biopsy results during the
visit that immediately preceded their invitation to enroll in this study. However, some
patients received biopsy information from another physician prior to being referred for
surgical consult. In addition, some patients were informed of pathology results indicating
a diagnosis of breast cancer over the phone prior to their surgical consult visit. Finally, it
should be noted that some patients were told that they likely had breast cancer based on
preliminary testing, prior to undergoing the pathology testing necessary for a definitive
diagnosis. As a result, most patients reported they had learned of their breast cancer
diagnosis prior to the date of their clinic visit and enrollment in this study. These patients
completed testing needed to confirm a diagnosis of breast cancer before being referred to
this study, which accounts for the time lag between self-reported diagnosis date and
referral to this study. At the conclusion of their clinic visit, eligible patients were
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introduced to the study by the surgeon, and then met with a research assistant to receive
information about the study and an invitation to enroll.
Because chart reviews did not reveal the precise time of diagnosis, the time lag
between diagnosis and enrollment in this study was calculated as the number of days
between each participant’s reported date of diagnosis and the day the first daily
questionnaire was completed. Because participants were asked to complete the first daily
questionnaire one day after enrollment into the study, one day was subtracted from the
difference between diagnosis date and the first day of data collection. Four participants
did not provide a diagnosis date, so the earliest reference to a diagnosis of breast cancer
available in the medical chart was used for these participants. The time between diagnosis
and enrollment ranged from 0 to 122 days, with a mean of 17.8 days (SD = 21.2) and
median of 14 days.
All of these patients completed data collection prior to undergoing surgical treatment
for breast cancer. Surgeries typically occurred approximately four weeks after patients
were informed of the diagnosis of breast cancer. Figure 4 demonstrates the timeline for
patient treatment and recruitment into the study. Patients diagnosed with ductal
carcinoma in situ (DCIS), cancerous cells that line the milk ducts but have not grown into
the surrounding breast tissue, were not targeted for this study because study materials
discussed the diagnosis of breast cancer, and these patients had been informed that they
had precancerous, as opposed to cancerous, cells. Patients with DCIS were not
specifically excluded from the study in initial inclusion/exclusion criteria, and one patient
with DCIS was enrolled based on referral for breast cancer, but later pathology results
indicated this patient had DCIS, as opposed to invasive breast cancer. Because patients

75

with DCIS confronted the option of surgery and previous research has indicated a
significant psychological impact of DCIS on patients (DeMorgan, S., Redman, S., White,
K., Cakir, B., & Boyages, 2002), the three patients with DCIS who were enrolled were
included in analyses.
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Figure 4. Study assessments with respect to the expected timeline of medical treatments.
At the “Pre-surgical Clinic Visit”, patients met their surgeon regarding breast cancer
diagnosis, then enrolled in the study and were given materials for home-based data
collection. All data collection was completed prior to surgery. After completion of four
days of “Home-based Collection”, patients returned study materials to the investigator.
Home visits were arranged as needed.
Patients were recruited at the Brown Cancer Center, Norton Healthcare Pavilion
and Children’s Foundation Building by referral from surgeons Dr. Anees Chagpar and
Dr. Kelly McMasters. Medical charts were reviewed at the outset of the clinic day to
screen for potentially eligible patients. Because a confirmed diagnosis of primary breast
cancer was required for inclusion, the surgeons determined patient eligibility during the
clinic visit. Eligible patients that were not referred to the study due to demands on clinical
time, patient unavailability due to scheduled events that did not allow for interview with
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research staff, or research staff unavailability due to being occupied with other patients
were identified by speaking with medical staff at the end of the clinic day. These patients
were contacted by phone and invited to participate in the study. Three of the twelve
patients approached in this manner were enrolled and provided enough data to be
included in analyses. After the surgeon had introduced the study, a research assistant met
with the patient at the clinic, provided information about the study, and answered any of
the patient’s questions. All participants recruited for participation in the study were asked
to sign informed consent and HIPAA Research Authorization protocols approved by the
University of Louisville Institutional Review Board on the use of human subjects in
research.
Participants were given two questionnaire packets, a saliva collection kit, and an
actigraphy device. A research assistant explained the rationale and procedure for filling
out daily questionnaires assessing the previous day’s intrusions, coping, and data
collection each morning. The research assistant also explained saliva collection using
collection materials, and participants were invited to practice using these materials.
Patients who met eligibility criteria for this study were initially recruited by phone
after a call from the clinic to a research assistant following the patient’s appointment with
the surgeon. Due to poor accrual early in the study, graduate research assistants were
given space behind the nursing desk to monitor patient flow and ensure that patients were
referred to the study. Research assistants actively worked together with clinic staff to
build relationships, discuss issues or problems, and encourage referrals.
Seventy-four potentially eligible patients were referred for this study between
May 2005 and June 2007. Five patients referred after leaving the clinic because of
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patients’ time demands were unable to be contacted by phone. Of the 18 patients who
declined to participate, 15 declined due to time constraints and/or response burden, two
did not specify a reason, and one stated she was uncomfortable consenting to chart
reviews. Seven patients enrolled in the study but were unable to provide enough data to
be included in any primary analyses. Of these seven patients, one patient provided no
data due to acute illness and another patient provided no data due to the time demands of
attending to visiting family. Two patients provided complete data except for rest/activity
rhythms due to technical problems with the actigraphy device and were not included in
analyses with actigraphy variables, but data provided by these two patients were part of
analyses with no actigraphy variables, including analyses for hypotheses 1a and 1b with
cortisol as an outcome variable. Similarly, one patient provided complete data except for
saliva samples, so she was eligible for analyses testing effects on actigraphy outcomes for
hypotheses 1a, 1b, and 2, but not in analyses testing effects on cortisol outcomes. One
patient was excluded from all analyses with cortisol variables because she reported taking
systemic steroids, which alter salivary cortisol. The remaining patients who provided
incomplete data did not provide questionnaire data sufficient for analysis, with one of
these patients also missing the majority of the saliva samples requested in the study
protocol. Forty-five patients provided enough data to be included in analyses.

Daily Assessments of Intrusions and Avoidant Coping
Daily self-reports of breast cancer-specific intrusions and avoidant coping were
collected to assess coping efforts employed in a given day, as opposed to trait-oriented
measures that ask participants to recall which coping strategies they usually employ. A
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drawback of trait-oriented measures of coping is that, even if a participant has a dominant
coping response, it may not be used in response to a given stressor at a given time. In
contrast, questionnaires used in this study asked about the participant’s coping efforts that
occurred over the course of one day in response to the experience of having breast cancer.
The data obtained by daily assessments aim to minimize the influence of the daily
variability in intrusions and coping on the assessments obtained.
Daily assessments also present an opportunity to reduce retrospective reporting
bias by placing the time of the assessment close to the time of the event of interest. Recall
of breast cancer-specific intrusions and avoidant coping that occurred yesterday is likely
to be better than recall of coping efforts that occurred a longer period of time prior to the
assessment. Previous studies suggest that retrospective report bias alters recollection, and
that daily assessments provide different data than retrospective reports relying on
memory to assess events occurring farther from the time of assessment (Erskine, Morley,
& Pearce, 1990; Larsen, 1992; Margraf, Taylor, Ehlers, Roth, & Agras, 1987; Rapee,
Craske, & Barlow, 1990). Also, the transactional model of stress and coping used to
inform the design of this study is dynamic, with coping efforts and outcomes continually
altering one another and the stressor. These alterations magnify the retrospective
reporting bias for the topic of research. An assessment at the outset of the collection
period would sample only a small portion of the data available over that time span.
Conversely, an assessment at the end of the collection period would likely prompt
participants to describe their coping based on heuristics, personal beliefs about the stress,
coping and adaptation process, or salient events (Tennen & Affleck, 2000). As a result,
daily assessments provide a means of collecting data over the entire study period while
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minimizing problems associated with retrospective reporting of these phenomena.
Overall, the use of daily assessments in this study adheres more faithfully to the
transactional model of stress and coping by assessing coping as an effort undertaken
within a specific context, as opposed to assessing a coping strategy as it applies broadly
to all contexts. Daily assessments reduced retrospective reporting bias by asking
participants to report on a brief period of time, one day, that occurred recently.
Participants were asked to complete daily assessments each morning, as opposed
to completing them immediately before going to sleep, to minimize the effect of the
assessments on sleep. Intrusions, in particular, are of concern because pre-sleep intrusions
are likely to be related to sleep disturbance (Gross & Borkovec, 1982; Wicklow & Espie,
2000). While investigation of this relationship is one focus of the study, an influence of
study methodology would limit the generalizability of any knowledge obtained by this
study. If participants were prompted by questionnaires on breast cancer-specific
intrusions and avoidant coping to think about breast cancer immediately prior to going to
bed for the night, findings regarding a relationship between intrusions and circadian
disruption may not apply to most patients with breast cancer, who are not typically
prompted to think about breast cancer-specific intrusions prior to going to bed. Pre-sleep
assessments could also disrupt participants’ bedtime routines by including an extra
activity. To the extent that this disruption would alter participants’ sleep, the disruption of
bedtime routines would further compromise the validity of the circadian rhythmicity data
obtained.
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Physiological Data Collection
Circadian Disruption
Salivary Cortisol - Cortisol has a strong circadian rhythm that is measurable in saliva, and
it is an important messenger in the circadian control of peripheral tissues by the central
clock (Mormont & Levi 1997). Salivary cortisol provides a reliable estimate of free
hormone levels in blood (Kirschbaum & Hellhammer, 1994). Salivary cortisol was
measured in a series of twelve saliva samples collected by participants at home over 72
hours. At the time of enrollment a study coordinator met with the patient to explain saliva
collection procedures, demonstrate the use of study materials, and allow the patient to
practice using these materials. Written instructions for saliva sample collection is
provided in Appendix A. Participants were given multiple phone numbers of study
coordinators and encouraged to call with any questions about the study or data collection.
Participants received twelve pre-labeled “salivette” tubes (Walter Sarstedt Inc.,
Newton, North Carolina). Collection was requested for three consecutive days at waking,
30 minutes after waking (+30 min), at 4 p.m., and just before going to bed. The sampling
times were selected because they allow calculation of the diurnal cortisol slope, a variable
that is prognostic for survival in metastatic breast cancer patients (Sephton et al., 2000).
Medication Event Monitoring System (MEMS) bottles and caps (Aardex, Ltd.) were used
to store cotton saliva collection swabs. MEMS caps contain microelectronics that record
the exact time and the date the bottle is opened, and a software program stores collection
time data. An interface was used to download Medication Event Monitoring System
(MEMS; Aardex, 2001) data on times of saliva sample completion onto computer after
these devices had been used to assess the times at which participants had removed cotton
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swabs to provide saliva samples.
Participants were asked not to eat, drink, brush teeth, use mouthwash, chew gum,
or smoke for the 30 minutes prior to saliva sample collection. The purpose of the MEMS
devices in recording sample collection times was explained to participants, and they were
asked to open the MEMS devices only when providing a saliva sample and to close the
lid tightly when done using the device. Participants were instructed to also record sample
collection times on stickers placed on the salivettes with a marker provided in the
collection kits. Participants were asked to refrigerate samples as soon as possible after
collection but informed that it was permissible to leave samples unrefrigerated if
necessary, such as a 4pm sample provided while at work. They were advised that samples
could not be left unrefrigerated for more than a day.
Cortisol assays were conducted by Elizabeth Lush and Robyn McLean at the
Biobehavioral Research Laboratory at the University of Louisville. A research assistant
centrifuged, aliquoted, and froze saliva samples at -80 °C. Assays were conducted using
an enzyme immunoassay (EIA) developed for use in saliva (Salimetrics, Inc., State
College, PA). The sensitivity of the assay was 0.007 ug/dL. The inter-assay coefficient of
variation was 7.4% using the low control and 3.4% using the high control. The intraassay coefficient of variation was 5.7% using the low control and 2.8% using the high
control. Because cortisol values are typically positively skewed, cortisol values were logtransformed prior to analysis for all primary cortisol outcomes. Calculated variables were
the diurnal mean (mean of all 12 log-transformed values), diurnal slope (unstandardized
beta weight of natural log-transformed cortisol regressed on collection time excluding
+30min sample), mean waking level, and cortisol awakening response (CAR) slope,
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calculated by regressing the unstandardized beta of the wake and +30min log-tranformed
cortisol values on the collection times, and mean bedtime cortisol. The wake cortisol
value was chosen as the first value for the calculation of the diurnal cortisol slope to
reduce collinearity with the CAR slope and because using the waking value to anchor the
calculation of the diurnal slope has been shown to promote more reliable calculation
across days (Kraemer et al., 2006). The CAR slope was chosen as the primary measure of
the HPA response to awakening because the CAR % increase and area under the
awakening curve are more influenced by the level of the awakening cortisol value and
consequently were not considered as valid an index of the response to awakening as the
CAR slope.
For secondary analysis, CAR % increase was calculated using the mean percent
increase from the wake to the +30min raw cortisol values, and the area under the
awakening cortisol curve was calculated using log-transformed cortisol values for the
wake and +30min samples. The area under the awakening cortisol curve was calculated
using log-transformed cortisol values because the raw values did not have a normal
distribution. A questionnaire was used to query sample collection times as well as factors
that may affect cortisol secretion, such as medications, stressors, sleep, exercise, and
menstrual cycle phase.

Actigraphy
Actigraphy, or the recording of body movement, measures circadian rest-activity
rhythms, or waking and sleep activity. Body movements were recorded by a device called
the Mini-Motionlogger (Ambulatory Monitoring Systems, Inc., Ardsley, NY 10502), and
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stored for later analysis. An interface was used to transfer data from actigraphy devices
onto computer (Ambulatory Monitoring, 2004) after participants had worn the device on
their wrists for three consecutive days. These devices were worn on participants’ wrists
where a piezoelectric beam generated voltage each time the device moved. Data were
quantified using the proportional integration mode of the Mini-Motionlogger. This mode
performed better than other modes when comparing scores to polysomnography (JeanLouis, 2001). Motions were recorded in 60-second segments, with voltage signals from
each minute creating a curve, allowing for calculation of area under the curve (AUC). A
moving average AUC is calculated for seven-minute segments that include the previous
four and subsequent two minutes. Segments are scored as “wake” or “sleep” using
calculations based on the University of California – San Diego (UCSD) Sleep Scoring
Algorithm (Cole, Kripke, Gruen, Mullaney, & Gillin, 1992).
The circadian rhythm in activity was estimated using the autocorrelation
coefficient calculated based on 24-hour time lags. This autocorrelation assesses the
association of data in a given 1-minute time period with data in that same 1-minute time
period on other days. Dowse and Ringo (1989) described the autocorrelation calculation
as follows: “If Xi is the measurement at time i, the correlation coefficient rk, between Xi
and Xi+k is computed for lags k, with k = 1 to 4320 minutes (72 hours)”. Briefly, the
autocorrelation is a measure of circadian consistency, the similarity of rest/activity
patterns across days (Roscoe et al., 2002). Using this calculation, a higher autocorrelation
is indicative of a more pronounced circadian rhythm. Participants with a strong circadian
rhythm would be expected to exhibit similar activity levels at similar times of day,
yielding a high autocorrelation. Circadian rhythmicity was also assessed using two
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dichotomy indices. The dichotomy index for time in bed yields the percentage of time
spent in bed in which the activity level falls below the median activity level for time out
of bed. Conversely, the dichotomy index for time out of bed yields the percentage of time
spent out of bed in which the activity level falls below the median activity level for time
in bed. In both cases, a higher dichotomy index indicates more frequent inactivity, but
inactivity while in bed is consistent with strong circadian rhythmicity, while inactivity
while out of bed is consistent with circadian disruption. Sleep variables yielded by
actigraphy data included sleep latency, total sleep time, sleep efficiency (% of time in bed
that the participant is asleep), and awakenings. Someone with a strong circadian rhythm
would be expected to exhibit high dichotomy index percentages for time in bed and low
dichotomy index percentages for time out of bed. Table 1 presents circadian rhythm
variables, calculation methods, and implications.
Table 1. Circadian rhythm variables, their methods of calculation, and descriptions of
their meanings. All cortisol values measured in (µg/dL).
Actigraphy
Variable

Calculation

What it Means

Autocorrelation

Correlation of 1-minute
epoch on one day with same
epoch on different days
% of time in bed in which
activity falls below median
activity for time out of bed
% of time out of bed in
which activity falls below
median activity for time in
bed

Lower value indicates
disrupted circadian activity
rhythm
Lower value indicates more
activity while in bed
(circadian disruption)
Lower value indicates less
activity while out of bed
(circadian disruption)

Mean natural logtransformed cortisol value
across all saliva collection
days

Cortisol level immediately
after first waking

Dichotomy/Inside (D/I)
Dichotomy/Outside (D/O)

Cortisol
Waking Cortisol
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Variable

Calculation

Morning Slope

Waking and +30min
natural log-transformed
cortisol regressed on
collection times
Mean % increase from
waking to +30min using
raw cortisol

CAR % increase

Area Under the Awakening
Cortisol Curve

Diurnal Cortisol Slope

Overall Diurnal Mean
Cortisol
Bedtime Cortisol

What it Means

Primary measure of CAR,
higher values indicate
greater HPA activation in
response to awakening
Secondary measure of CAR,
higher values indicate
greater HPA activation in
response to awakening
Total area under slope
Secondary measure of CAR,
from mean waking to mean higher values indicate
+30min using raw cortisol greater HPA activation in
values, then total was
response to awakening
natural log-transformed
Waking, 4pm, and bedtime Higher values indicate
natural log-transformed
abnormal rhythms that can
cortisol regressed on
include low morning level,
collection times
peaks occurring in the
afternoon or evening, or
flattened rhythms
Mean of all natural logTotal cortisol secretion
transformed cortisol
samples
Mean of all natural logCortisol levels at bedtime
transformed bedtime
cortisol samples

Blood Pressure and Heart Rate
Patients presenting at the surgical clinic typically underwent assessments of blood
pressure and heart rate that were available in the patient’s medical record. Chart review
sought to obtain these data. When more than one assessment was available in the
patient’s medical record, the assessment closest to the time of study enrollment was
recorded in the study database.
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Data Storage and Management
Data were retrieved by coordinating with patient hospital visits, arranging to meet
at the patient’s treatment center, or a research assistant driving to the patient’s house.
Questionnaires were reviewed to ensure completeness, and patients were asked to
complete items that they missed, though they retained the option to decline to answer
these items.

Assessments
Potential control variables
Participants completed a brief background questionnaire assessing demographics
such as age at diagnosis, ethnicity, marital status, religious affiliation, family size,
education, employment, household income, medical history, and current medications. All
ages were calculated based on the most recent diagnosis, as opposed to the time of the
first cancer diagnosis in cases of recurrent cancer.
The participants’ medication regimens were assessed on the day of study
enrollment as part of the initial interview. Each participant was prompted to report the
medication, dosage, number of times per day or week it was taken, and the reason it was
taken. Medications were then entered the database according to their medication class. In
the database, the first column listed the total number of medications from a given class
the participant reported taking. The next column presented the generic name of the
specific medication taken. If multiple medications from one class were part of the
participant’s medical regimen, a third column listed all of them.
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Systemic steroids were separated from other steroids (e.g. nasal steroids) in the
database because systemic steroids are known to affect cortisol assessments. Oral, patch,
and vaginal ring contraceptive medication were recorded as systemic contraceptives,
separately from other forms of contraception because systemic contraceptives likely alter
cortisol levels. One participant was excluded from analyses involving cortisol summary
variables due to reporting use of oral fluticasone A sleep variable was created that
included all medications patients reported taking for the purpose of sleep because
circadian rhythms and sleep were a focus of this study. Medications were included in this
category even if they belonged to another medication class. Finally, antidepressants were
among the classes of drugs recorded in the database, as they likely influence cortisol
levels.
Data on disease status (diagnostic testing, age at diagnosis, time since diagnosis,
stage, grade, time since diagnosis, age at diagnosis) was collected by chart review.
Reviews were conducted by study personnel Eric Dedert, Elizabeth Lush, and Meagan
Martin in the medical records office at the Children’s Foundation Building in Louisville,
Kentucky. Reviews were conducted for all patients. A medical review form containing
the variables listed above was used to standardize the variables sought in review.

Breast cancer-specific intrusions
Impact of Event Scale (IES) – The IES (Horowitz & Wilner, 1979) is a 15-item measure
that was developed based on studies of responses to stressful events. In particular,
intrusions and avoidance associated with the event are assessed. In this study, the event
was specified as the diagnosis of breast cancer. Participants rate whether comments on
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the scale are true for them “Not at all”, “rarely”, “sometimes”, or “often”. Scores are
obtained by assigning the weights 0, 1, 3, and 5 to the frequency categories indicated.
Participants rate how frequently these symptoms were true for them on a four-point scale.
The IES has been utilized in several samples, including patients with breast cancer
(Cordova et al., 1995). A review of psychometric properties of the IES reported high
internal consistency indicated by a mean alpha reliability coefficient of 0.86 for the
intrusions subscale (Sundin & Horowitz, 2002). A study with patients scheduled for
breast biopsy reported reliability of .89 for the intrusions subscale and .85 for the
avoidance subscale (Lebel et al., 2003). In the current study, Cronbach’s alpha was .930
for items collapsed across days, with alpha coefficients for individual days ranging
between .856 on day one and .930 on day four,
The initial report on the IES noted a correlation of .41 between the two subscales,
intrusion and avoidance, suggesting that these subscales are related but not redundant
(Horowitz & Wilner, 1979). Studies have generally found moderate correlations between
these two subscales (Sundin & Horowitz, 2002). Examination of convergent validity by
comparing the IES with the Mississippi Scale for Civilian PTSD, an existing measure of
reactions to a traumatic event, revealed that the two measures were moderately correlated
(r = .51; Devilly, Spence, & Rapee, 1998).
The IES is particularly well suited to this study because breast cancer can be
specified as the stressor, allowing for a more focused analysis of the intrusions related to
being diagnosed with breast cancer. The original instructions prompt respondents to
provide data on how frequently statements were true for them during the past seven days.
To orient responses specifically to intrusions related to breast cancer in the past day, a
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portion of the instructions for the daily questionnaire were modified to read “Please fill in
each item, indicating how frequently the comments were true for you YESTERDAY
regarding your diagnosis and treatment of BREAST CANCER”. The 7-item intrusions
subscale of the IES was completed upon awakening on four consecutive mornings and
asked about the previous day’s intrusions. All daily questionnaires were completed after
participants had provided an awakening saliva sample. The awakening saliva sample was
given priority because any delay in this sample would be likely to obscure the true
awakening cortisol value due to the sharp increase in cortisol that typically occurs within
minutes after awakening (see Appendix A for data collection instruction in “Daily
Questionnaire”). The mean intrusions score from the four consecutive mornings was used
in analyses.
The IES was initially conceptualized as a measure of intrusions and avoidance,
but subsequent studies of the factor structure of this measure have argued for alternative
conceptualizations. In addition to examining the intrusions and avoidance subscores,
examination of the summary score of the entire IES has been proposed based on a study
with Vietnam veterans (Hendrix, Jurich, & Schumm, 1994). A three-factor model,
including a sleep disturbance scale as well as the traditional intrusions and avoidance
subscales, has also been proposed (Larsson, 2000). Finally, a proposed four-factor model
has added a numbing factor to those included in the three-factor model. This study found
that four factors produced the best fit in a sample of police officers and fire fighters
assessed eight years after they had been involved in rescue work at the site of an airplane
crash (Witteveen et al., 2006). The sleep disturbance factor of the four-factor model was
comprised of item 4 (“I had trouble falling asleep or staying asleep, because of pictures or
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thoughts about it that came into my mind”) and item 6 (“I had dreams about it”). The
content of these two items supports an interpretation of them as indicators of sleep
disturbance in addition to, or as opposed to, intrusions characterized by disturbing
dreams. To determine whether the inclusion of these two items influences the relationship
between intrusions and circadian disruption, secondary analyses were conducted with
these two items removed.
Although the IES includes items assessing avoidance, these items were not
included in the daily questionnaire. The IES avoidance items were also not used in
analyses of avoidant coping because the IES conceptualizes and measures avoidance as a
symptom of distress. (Horowitz, 1976). Consequently, the avoidance items from the IES
are not appropriately conceptualized as avoidant coping, and a measure of avoidant
coping efforts was used instead of the avoidance subscale of the IES. An attempt was
made to keep the daily assessment procedures as brief as possible because participants
were recruited at a site at which the research group had not previously recruited and were
adjusting to a recent breast cancer diagnosis, and it was unclear what response burden
might be most appropriate. In addition, there was concern that lengthy assessment
procedures completed at a specific time of day might interfere with circadian rhythms. In
addition, intrusions were a focus of this study because they are a measure of distress that
was expected to be especially closely connected to the diagnosis of breast cancer.

Avoidant coping
Brief COPE – The Brief COPE is a 28-item self-report measure (Carver, 1997) that is an
abbreviated version of the original 60-item COPE (Carver et al., 1989). Validation
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studies of the COPE supported the 14 factor structure of the measure (Carver et al.,
1989). The Brief COPE was developed because the author found that the original version
had considerable redundancy and was found to be too lengthy by respondents (Carver,
1997). Subscales from the COPE were reduced to 2-item subscales for the Brief COPE in
a study of residents recovering from a hurricane in their community. Items were chosen
for inclusion in the Brief COPE based on high loadings with its factor in the original
study and clarity based on feedback from prior studies (Carver, 1997). In the current
study, the ‘denial’, ‘self-distraction’, and ‘behavioral disengagement’ subscales were
used to derive the avoidant coping subscale score. In the original validation study, the
alpha reliability coefficients for these scales were .54, .71, and .65, respectively (Carver,
1997). In validation studies for the original COPE, the 4-item subscales that ultimately
became the 2-item denial, self-distraction, and behavioral disengagement subscales
correlated negatively with optimism and perceived control, and positively with anxiety
(Carver et al., 1989). Factor analysis has supported the use of the denial, self-distraction,
and behavioral disengagement scales to comprise an avoidant coping scale (Rudnicki,
Graham, Habboushe, & Ross, 2001). Avoidant coping was assessed in this study using
the two items from self-distraction, denial, and behavioral disengagement on the Brief
COPE, for a sum of six items.
The original development of the COPE had instructions that read “this
questionnaire asks you to indicate what you generally do and feel when you experience
stressful events”. There was also a situational version that asked respondents to think
about the most stressful event that had happened to them over the past two months and
report on the coping they used in response to that event (Carver et al., 1989). For the
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current study, the instructions were modified to read “This questionnaire asks you to
indicate what you did and felt yesterday, when you experienced stressful events related to
having breast cancer”. The author has supported the adaptation of this measure to
research applications through the alteration of the measure’s instructions and verb tense
of the items (Carver, 1997), and this has previously been done in studies of breast cancer
patients’ coping with breast cancer (Bellizzi & Blank, 2006). The Brief COPE has been
used in studies of patients with breast cancer (David, Montgomery, & Bovbjerg, 2006;
Fogel, 2004).
In the current study, the 6-item avoidant coping scale was completed on four
consecutive mornings and asked about the previous day’s avoidant coping. As with the
IES, daily assessments of avoidant coping aimed to minimize measurement error due to
retrospective reporting bias while increasing adherence to the transactional model of
stress. Questionnaires were completed after participants had provided the awakening
saliva sample. The avoidant coping score used for analyses was the mean avoidant coping
score from the four collection times. The IES avoidance subscale was not included in
daily assessments and not used in any analyses. Cronbach’s alpha for the 6-item scale
was .939 when items from all four days were assessed, with alpha reliability coefficients
for individual days ranging from .710 for day four to .851 for day three.

Profile of mood states (POMS)
The POMS (McNair et al., 1971) is a 65-item scale assessing six dimensions of
affect. It was designed to assess rapid fluctuations in mood and conceptualized moods as
rapidly changing. The POMS has been used in a number of studies of patients with
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cancer (Cassileth et al., 1985). The POMS was administered in a packet with other
measures to be used for future analyses, to be completed at a time during the four day
data collection period that was convenient for the participant. In contrast to the daily
assessments, the POMS was completed only once during the course of data collection. In
the current study, the depression-dejection subscale was used to identify participants that
may be suffering from clinically significant depression in secondary data analysis
(Patterson et al., 2006).

Data Reduction and Analysis
Control Variables
All questionnaire data were manually entered, cleaned, and examined for
abnormal responses. Bivariate correlations were used to examine relationships of control
measures with cortisol and actigraphy variables and evaluate these variables as potential
candidates for inclusion in hierarchical regression equations. Age at diagnosis and
summary stage were used as control variables in all analyses. Additional potential control
variables included racial background education, income, weight, systolic blood pressure,
diastolic blood pressure, tumor size, nodal involvement, estrogen receptor status at the
time of diagnosis, progesterone receptor status at diagnosis, human epidermal growth
factor receptor (her2/neu) status at diagnosis, tumor grade at diagnosis, time since
diagnosis, each class of medications taken by at least 5% of the sample, and all
medications taken for the purpose of sleep.
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Approach to Primary Analyses
Data were analyzed using an exploratory approach, as opposed to a confirmatory
approach. The aim of an exploratory approach is to maximize the depth of investigation,
develop a better understanding of a dataset, and to generate hypotheses for future
research. Consequently, no formal adjustments for multiple comparisons, such as a
Bonferroni correction, were used in this study. The drawback to exploratory research is
that statistically significant findings must be viewed with skepticism because a large
volume of analyses is likely to yield some significant relationships that are spurious
(Babyak, 2004). As a result, it is crucial to exploratory research to be cautious in
interpreting the results obtained.
Exploratory analyses are useful for investigating relationships that are not yet well
understood. Although significant research on breast cancer-specific intrusions and
avoidant coping has taken place, the relationships between these variables and circadian
physiological and rest/activity rhythms have not ever been studied. In addition, Lazarus
(Lazarus, 2000) noted the limits of the search for causal variables in coping and
adaptation research, and called for more detailed analyses of coping and adaptation aimed
at developing a richer understanding of a process. He acknowledged that this research
would likely need to proceed with smaller sample sizes and a less sophisticated
understanding of causal variables. Nevertheless, he added that these more detailed studies
would be as valuable as traditional studies of causal variables in contributing to research
in coping and adaptation (Lazarus, 2000).
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Preliminary Analytical Procedures
The assumption of normal distribution of variables was evaluated for all variables
by examining boxplots and histograms. For variables that did not exhibit a normal
distribution, Spearman correlations were used, as opposed to Pearson correlations.
Exploratory bivariate correlations were calculated to allow for examination of
relationships between potential control variables and circadian disruption variables.

Predictor Variables
The IES was initially conceptualized as a measure of intrusions and avoidance,
but subsequent studies of the factor structure of this measure have argued for alternative
conceptualizations. In particular a three-factor model with sleep disturbance
supplementing the two traditional factors (Larsson, 2000) suggests a 5-item version of the
intrusions scale is more appropriate. Due to conflicting conceptualizations of items four
and six as indicators of intrusion (Horowitz, 1979) or sleep disturbance (Witteveen,
2006), separate calculations of intrusions scores were conducted. For all primary
analyses, the traditional IES intrusions subscale was derived from a summary of the
seven items on the intrusions scale of the IES (Horowitz, 1979). An alternative intrusion
subscale was constructed with items four and six removed, and the remaining five items
summed to yield a score that was used in secondary analyses only.

Actigraphy Data Reduction
Dr. Ehab Dayyat, a researcher with the University of Louisville, Department of
Pediatrics who is experienced in scoring actigraphy data, was consulted to develop
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competency in determining cutoff points for the beginning and ending of deleted data
periods and in setting sleep onset and awakening times. Participants were asked to
remove the actigraphy device only if they were participating in an activity that was likely
to get the device wet. Device removals were recorded on the daily questionnaire (see
Appendix A “Daily Questionnaire”). These reported removals were compared against
actigraphy data to identify episodes to be deleted from actigraphy data files and excluded
from calculation of outcome variables. Actigraphy files were also examined to identify
extended periods of zero values that likely indicated actigraphy device removal to be
deleted prior to outcome variable calculation.
Sleep intervals were set for each participant by integrating self-reported sleep
onset and awakening times with actigraphy data. When the reported sleep interval was
not concordant with the sleep interval indicated by the actigraphy data, preference was
given to actigraphy data. The participant’s typical level of activity during wake periods
was compared with typical levels of activity during sleep to inform determinations of
sleep onset and awakening. The sleep onset time was set at the first epoch in which a
sustained period of time characteristic of the level of activity observed during sleep. The
awakening time was set as the first epoch with a level of activity characteristic of waking
levels that was followed by similar activity levels shortly afterward.
Actigraphy data were scored using the University of California San Diego
(UCSD) Scoring Algorithm (G. Jean-Louis, Kripke, D., Mason, W., Elliott, J.,
Youngstedt, S., 2001) that was optimized using polysomnography as the criterion.
Scoring of sleep/wake data was performed by the Action4 software (Ambulatory
Monitoring, 2004).
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To minimize an observed bias toward over-scoring wake in the UCSD algorithm
(Cole, 1992), rescoring rules were developed by Webster, Kripke, Messin, Mullaney, and
Wyborney (Webster, 1982) to improve accuracy of actigraphic sleep/wake estimates.
However, data on more recent devices have revealed that these rescoring rules increased
the sensitivity to wake of the algorithm but decreased the specificity of wake estimates,
resulting in considerable bias. More importantly, Webster’s rescoring rules did not
improve the accuracy of the algorithm when compared to polysomnography (G. JeanLouis, Kripke, D., Cole, R., Assmus, J., Langer, R., 2001). Consequently, Webster’s
rescoring rules were not used with the actigraphy data in this study.

Data Reduction
Reports from at least two of the four daily reports of intrusions or avoidance were
necessary for inclusion in analyses involving one or both of these variables. Mean
substitution was used to replace missing values if at least half of the items were
completed for a given measure of subscale. For each participant, all daily assessment
responses for a given measure were summed. This sum was then divided by the number
of days for which data were available. The resulting dividend was the mean daily score
for intrusions or avoidance across the assessment period. This dividend was used for all
analyses.
Saliva sample collection times were available from MEMS devices that recorded
openings. Participants also recorded the collection times on the salivettes while providing
the sample. The MEMS and self-reported collection times correlated very highly
(Spearman’s r = .977), suggesting that participant reports of collection times were reliable
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and comparable to other reports (Kraemer et al., 2006). Recent data argue the inclusion of
MEMS caps may increase participant response burden without increasing protocol
adherence (Kraemer et al., 2006). However, the possible response burden introduced by
MEMS caps has already been incurred and data indicate it is possible that MEMS
collection times are more reliable than self-reported collection times (Kirschbaum, 1994).
As a result, MEMS collection times were given preference of self-reported collection
times. Self-reported collection times were used when there was no MEMS time available,
such as a series of two samples with a MEMS opening recorded for the first sample only.
This was taken as an indication that the participant removed two cotton swabs during one
opening (Kraemer et al., 2006) to increase the convenience of sample provision. In
addition, no MEMS data were available for three participants due to device malfunctions.
A total of 48 of an overall total of 528 saliva samples included in analyses used selfreported collection times because MEMS times were not available. Collection times that
were more than four standard deviations from the mean time for a given sample period
(awakening, +30min, 4pm, and bedtime) were identified as outliers and examined for any
possible confounds by considering participant comments and actigraphy data. Collection
time outliers were limited to one patient who did have cortisol time outliers and reported
she worked third shift sometimes, including portions of the data collection period for this
study, and had an abnormal sleep schedule. Since it would be a threat to validity to
exclude patients with marked circadian disruption, she was enrolled. Because she
collected samples at unusual times due to her typical schedule, as opposed to
nonadherence to the study protocol, her samples were included in analyses.
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Awakening samples with MEMS times more than 10 minutes after the selfreported awakening time were examined to explore the time lag between awakening and
the provision of the awakening saliva sample. Actigraphy data were examined, and the
awakening time estimated by actigraphy examination was compared with the saliva
sample collection time. If both the self-reported awakening time and the awakening time
estimated from actigraphy were more than 10 minutes from the sample provision time, a
cortisol value for the awakening time estimated from actigraphy was computed. This
value was estimated by regressing the wake and +30min cortisol values on collection
time. When an awakening cortisol value was estimated statistically, the +30min sample
was retained only if it was within a time window of 15-60 minutes post-awakening. If the
wake cortisol value was estimated statistically and the +30min sample was deleted due to
being outside the sample collection window, the wake cortisol value was used as the
+30min sample, provided its collection time was within 15-60 minutes after the
awakening time estimated from actigraphy. All cortisol analyses were first conducted
using the original cortisol values, with no estimated values. All analyses were then
repeated using the data set with estimated awakening cortisol values.
Cortisol values more than four standard deviations from the mean for that
collection time were identified as outliers and examined for any possible confounders
such as sample contamination, abnormally high nicotine or caffeine intake, or deviation
from the requested sample time. Elimination of outliers was determined depending on
confounding factors and degree of deviation from the mean.
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Primary Analyses: Tests of Hypotheses
Hypothesis 1a: Cancer-related intrusions will be significantly and positively associated
with circadian disruption, as measured by salivary cortisol and actigraphy.
A hierarchical regression equation predicting circadian disruption was calculated
for each of the two measures of circadian disruption, salivary cortisol and rest/activity
rhythms as measured by actigraphy. All analyses statistically controlled for two
theoretically-derived variables, age at diagnosis and cancer stage. A third, empiricallyderived control variable was included in regression models. This control variable was
chosen from among demographic and medical variables that were found to be
significantly and most strongly correlated with outcome measures in preliminary
analyses. Control variables were entered on the first step of the regression equation. The
mean of the daily intrusion scores was then entered on the second step. Outcome
variables included the autocorrelation coefficient, dichotomy indices for time in bed and
out of bed, mean log-transformed awakening cortisol, cortisol awakening response
(CAR) slope, diurnal cortisol slope, and overall diurnal mean log-transformed cortisol.

Hypothesis 1b: Avoidant coping will moderate the relationship between cancer-related
intrusive thoughts and circadian disruption.
If the R2 value of IES in the equation calculated for hypothesis 1a was significant,
a similar equation was calculated for hypothesis 1b. This equation utilized methods
recommended by Baron and Kenny (Baron, 1986). Although a more recent
conceptualization of moderators advised alternative analytical methods, these methods
were not available for this analysis because they would require that intrusions precede
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avoidant coping efforts temporally (Kraemer, Stice, & Kazdin et al., 2001). Because the
study is cross-sectional, the temporal precedence requirement was not met.
The analytical procedure used to test hypothesis 1b includes mean-centered
intrusion and avoidant coping scores (Baron & Kenny, 1986), as well as a cross-product
of intrusion and avoidant coping composed of mean-centered scores. These terms are
mean-centered to minimize collinearity with the interaction term. To limit the model to
four predictor variables, only one additional control variable was selected by determining
whether age at diagnosis or cancer stage was most strongly correlated with the outcome
in a given regression equation. Due to concerns about overcontrolling noted in the
analysis plan for hypothesis 1a, analyses were repeated using only the three predictors
necessary to perform this test.

Hypothesis 2: Diurnal salivary cortisol slope and rest-activity rhythm obtained by

actigraphy will be significantly and positively associated.
With conservative intent, a Spearman correlation was calculated to determine
whether there is any association between variables yielded by two measures of circadian
disruption, actigraphy and cortisol. Each actigraphy variable used as a measure of
circadian disruption was correlated with each cortisol variable used as a measure of
circadian disruption. Actigraphy variables included the 24-hour autocorrelation, the
dichotomy indices both for time inside bed and time outside of bed. The cortisol variables
included mean awakening cortisol, CAR slope, diurnal cortisol slope, and overall diurnal
mean cortisol.
Because this analysis sought to characterize the relationship between two
measures of the same construct, variables that likely influence circadian disruption and
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were considered possible confounds in other analyses were not considered confounds for
testing hypothesis 2. As a result, no tests attempted to determine whether the association
of these two measures was independent of a third variable.

Secondary Analyses
To further the aim of conducting exploratory analyses of the relationships
between intrusions, avoidant coping, and circadian disruption, secondary analyses were
conducted. Because a maximum of 45 participants provided enough data to be included
in some analyses, regression equations for all secondary analyses were limited to a total
of four predictor variables, including age at diagnosis, cancer stage, an empirically
selected third control variable, and the predictor of interest.

Modified Intrusions Analysis
As noted above, one factor analysis of the IES has reported that two items of the
intrusions subscale load onto a separate sleep disturbance factor (Larsson, 2000). To
investigate the possibility that these sleep disturbance items confound the predictor
variable (intrusions) with the criterion variables (circadian disruption) in Hypothesis 1a
and 1b of the primary analyses, an intrusions score without the two items that some
researchers have conceptualized as sleep disturbance items (Larsson, 2000) was utilized
as a predictor of circadian disruption.
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Sleep Outcomes
The sleep intervals specified for each participant’s actigraphy data were used to
calculate several sleep variables, including sleep latency, total sleep interval, total sleep
time, time awake after sleep onset, sleep efficiency, and awakenings. These outcomes
were tested with intrusions as a predictor, and with age at diagnosis and cancer stage as
control variables.

Avoidant Coping and Circadian Disruption
The avoidant coping score generated by the mean of the daily assessments was
evaluated as a predictor of circadian disruption. Analytical methods were similar to those
used with intrusions as a predictor of circadian disruption. All regression equations were
limited to a total of three predictor variables.

Daily COPE Subscales Analysis
The Denial, Self-Distraction, and Behavioral Disengagement subscales that
comprised the version of the Brief COPE completed on four consecutive mornings were
tested separately as potential moderators of the effects of intrusions on circadian
disruption. These analyses were only conducted when significant relationships between
intrusions and circadian disruption were observed.

Secondary Cortisol Outcomes
All of the cortisol variables included in primary analyses were re-calculated with
replacement of awakening cortisol values that were provided outside the ten minute time
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window for these samples. If the awakening sample was not provided within a valid time
period, the saliva collection time was regressed on the awakening and 30 minute postawakening cortisol samples that had been provided. Using the slope from this linear
regression, a cortisol value was estimated for the awakening time provided by actigraphy.
The summary cortisol variables re-calculated with these estimated awakening values
included in the dataset were analyzed in secondary analyses. The CAR % increase and
CAR area under the awakening curve were also included in secondary cortisol analyses
to supplement primary analysis of the CAR slope.

Cortisol and Sleep
Exploratory analyses explored the relationship between several diurnal cortisol
values and the following night’s sleep. Regression analyses used age at diagnosis and
cancer stage as control variables. Cortisol variables used in previous analyses, as well
mean bedtime cortisol values, were tested as predictors of the sleep variables used as
outcomes in analyses described above. The bedtime cortisol values were added to explore
whether high bedtime cortisol was related to disrupted sleep.

Removal of Patients Endorsing Depression
Because depression and symptoms associated with PTSD have been noted by
some to have opposite effects on circadian cortisol rhythms (Miller, 2007), it is possible
that the inclusion of participants experiencing depression suppressed the relationships
between intrusions and circadian disruption tested in hypothesis 1a. To eliminate this
possible confound, participants scoring more than 1.5 standard deviations from the mean
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standardization sample score on the Profile of Mood States (POMS) depression subscale
were deleted prior to repeated analyses of intrusions and circadian disruption. The
standardization sample used was a sample of 400 participants stratified by age, gender
and race according to United States census data (Nyenhuis et al., 1999). This
standardization sample and method of classification was demonstrated to successfully
classify people with HIV infection as having Major Depressive Disorder using the POMS
depression scale (Patterson et al., 2006). The use of 1.5 standard deviations as a cut-score
between clinical and nonclinical samples has been used with the Minnesota Multiphasic
Personality Inventory-2 (MMPI-2; Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer,
1989).
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RESULTS

Sample Characteristics
Demographic and medical characteristics.
Study participants ranged in age from 21 to 79 years with an average of 53.4 years
(SD = 13.2). Additional sociodemographic characteristics of the sample, including
ethnicity, marital status, education, annual household income and employment status are
presented in Table 2.
Table 2. Demographic characteristics of the sample (N=45)
_______________________________________________________________________
Variable
Frequency
Percentage
_______________________________________________________________________
Ethnicity
White/Caucasian
African American
Native American
Asian

25
17
2
1

56
38
4
2

Marital Status
Married
Divorced
Never Married
Widowed

18
12
6
8

40
27
13
18

Years of Education
Middle School (8 years)
High School (12 years)
AA/Technical School (14 years)
College Degree (16 years)
Master’s Degree (18 years)
Doctoral Training (20 years)

1
29
5
4
4
1

2
64
11
9
9
2
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_______________________________________________________________________
Variable
Frequency
Percentage
_______________________________________________________________________
Income
Less than $20,000
20,000 to 39,999
40,000 to 59,999
60,000 to 79,999
80,000 to 99,999
100,000 and Greater

15
11
4
4
2
5

33
24
9
9
5
11

Currently Employed
Yes
23
51
No
22
49
________________________________________________________________________

Medical Data
All participants provided consent for medical record review. The frequencies and
descriptive statistics for medical data obtained through chart review are presented in
Table 3. Cancer stage provides information about disease characteristics and prognosis.
Breast cancer stage is determined using the size of the tumor, the extent of regional
lymph node involvement, and whether the disease has spread to other organs or tissue.
Pathologic staging from chart review was used when available. Two patients did not have
pathologic staging data available because surgery was not ultimately performed, and
clinical staging based on the physical exam and imaging tests was used to determine
staging for these two patients. Grade is a measure of the aggressiveness of the tumor as
assigned by a pathologist. Only two patients elected to undergo lumpectomy, suggesting
mastectomy was clearly the preferred option within the sample of women enrolled in this
study. Due to the low frequency of lumpectomy chosen in this sample, group level
analyses of surgical decision could not be completed.
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Table 3. Staging and clinical data (N= 45)
Variable

Range

Stage

DCIS
Stage I
Stage IIA
Stage IIB
Stage IIIA
Stage IIIB
Stage IIIC
Stage IV

3
20
4
3
8
1
3
3

6.7
44.4
8.9
6.7
17.8
2.2
6.7
6.7

Grade

1
2
3
Missing

3
22
17
3

6.7
48.9
37.8
6.7

Tumor Size (T)

0
TI
T2
T3
T4
Missing

2
20
10
8
2
3

4.4
44.4
22.2
17.8
4.4
6.7

Nodal Involvement (N)

0
NI
N2
N3
Missing

26
7
7
3
2

57.8
15.6
15.6
6.7
4.4

Metastatic Status (M)

M0
M1
Undetermined

19
3
23

42.2
6.7
51.1

Age at diagnosis (years)
Time since diagnosis (days)
Breast Cancer Type

Frequency

53.4 (13.2) (Mean/SD)
18.8 (21.9) (Mean/SD)
Primary
Recurrent
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43
2

Percentage

21-79 (range)
0-122 (range)
95.6
4.4

Variable

Range

Previous Breast Surgery

Yes
No

1
44

2.2
97.8

History of Radiation*

Recent (past 2 mo.)
Yes
No

0
2
43

0
4.4
95.6

History of Chemotherapy

Recent (past 2 mo.)
Yes
No

0
2
43

0
4.4
95.6

History of Cancer at
Other Body Site

Yes
No

1
44

2.2
97.8

Comorbid Medical
Condition**

Yes
No

20
25

44.4
55.6

Menopausal Status

Pre-Menopausal
Peri-Menopausal
Post-Menopausal

18
3
24

40.0
6.7
53.3

Menstrual Phase

Pre-Menopausal,
7
Follicular Phase
Pre-Menopausal,
9
Luteal Phase
Pre-Menopausal,
2
Phase Undetermined
Peri-/Post-Meno.
1
Estrogen Therapy
Peri-/Post-Meno.
26
No Estrogen
Yes
0
No
45

15.6

Oral Contraceptives

Frequency

Percentage

20.0
4.4
2.2
57.8
0
100

Estrogen Replacement

Yes
No

1
44

2.2
97.8

Surgical Decision

Mastectomy
Lumpectomy
Missing

39
2
4

86.7
4.4
8.9
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______________________________________________________________________
Variable
N
Mean (SD)
Range
_______________________________________________________________________
Systolic blood pressure
41
140.1 (20.4)
100-194
Diastolic blood pressure
40
83.9 (11.2)
63-115
Heart rate
41
83.0 (13.2)
64-120
* Two participants reported receiving radiation in the past. None of the participants reported receiving
radiation in the past year.
** The participant endorsing a history of cancer at another site reported cervical cancer in 1985.
Comborbid medical diagnoses included hypertension (11 participants), diabetes (9), history of myocardial
infarction (2), arthritis (2), hypothyroidism (2), chronic obstructive pulmonary disease, scoliosis, chronic
fatigue syndrome, seizures, skin lesions, chronic hives, scleroderma, local positive antinuclear antibody,
supraventricular tachycardia, sarcoidosis, osteoarthritis, and asthma.

To ensure accurate recording of medications, participants were queried as to the
medications they were taking. Frequencies for each class of medication taken by at least
one participant in this study or those that are important to note because of conceptual
links with major study variables, are presented in Table 4. The participant who reported
taking Fluticasone, a systemic steroid, was deleted from all analyses including cortisol
due to the influence of systemic steroids on cortisol assessments.
Table 4. Medications (N= 45)
Medication

Frequency

Non-Steroidal Anti-inflammatory Agents
Antihypertensive Agents
Diuretics
Anti-Lipidemic
Antidepressants
Antidiabetic Agents
Cardiac Drugs
Opiate Agonists
Sleep Medications
Antihistaminic Agents
Anxiolytics
Bronchodilating Agents
Gastrointestinal Drugs
Thyroid Agents
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16
13
11
10
8
8
7
6
5
4
4
4
4
3

Percentage
35.6
28.9
24.4
22.2
17.8
17.8
15.6
13.3
11.1
8.9
8.9
8.9
8.9
6.7

Medication

Frequency

Percentage

Adrenergics
2
4.4
Analgesics
2
4.4
Antibiotics
2
4.4
Anticonvulsants
2
4.4
Antitussives
2
4.4
Benzodiazepine
2
4.4
Estrogen
2
4.4
Potassium Replacement
2
4.4
Sedatives/Tranquilizers
2
4.4
Urinary Anti-Spasmodic Agents
2
4.4
Vasodilating Agents
2
4.4
Anticoagulants
1
2.2
Antidiherreal Agents
1
2.2
Anti-psychotics
1
2.2
Antirheumatoids
1
2.2
Anti-Spasmodics
1
2.2
Anti-Viral Agents
1
2.2
Cathartics/Laxatives
1
2.2
Estrogen Replacement Therapy
1
2.2
Iron Replacements
1
2.2
Insulins
1
2.2
Leucotrine Antagonists Asthma Treatment
1
2.2
Prophylaxis (Preventive Medication)
1
2.2
Proton Pump Inhibitors
1
2.2
Para-Thyroid Hormones
1
2.2
Respiratory Muscle Relaxes
1
2.2
Skeletal Muscle Relaxants
1
2.2
Sulfonylureas
1
2.2
Systemic Contraceptives (Oral, patch, vaginal ring) 1
2.2
Systemic Steroids
1
2.2
Unclassified Therapeutic
1
2.2
Adrenals
0
0
Corticosteroids
0
0
Non-Systemic Contraceptives
0
0
_______________________________________________________________________

Daily Assessments
Over a period of four days, participants provided self-reports of intrusions and
avoidant coping, wore actigraphy devices, and provided saliva samples for cortisol assay.
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Descriptive statistics for these daily assessments are presented in Table 5. The mean for
daily IES assessments was 9.5 (SD = 5.6). The intrusions score was lower than those
reported (14.5) by women recently informed that they required a breast biopsy (Lebel et
al., 2003) and those reported by women who were within 1 year of breast cancer
diagnosis but had completed surgery (Koopman et al., 2002), but similar to the intrusions
score (9.61) reported in breast cancer patients an average of 19 months after bone marrow
transplant (Jacobsen et al., 1998). The mean intrusions score reported in this study was
lower than expected given the probable salience of the diagnosis such a short time after it
had been communicated. Previous research identified the period immediately following
diagnosis as a time of particularly high distress, but several possible explanations exist.
First, daily assessments may yield different results than self-report measures prompting
participants to report retrospectively over a longer period of time. Second, patients were
often assessed in the first few days after diagnosis in this study, and many of the previous
studies assessed women over a larger time window. Breast cancer-related intrusions may
increase in the weeks following diagnosis as women engage in elaborative processing.
Focus on breast cancer after diagnosis may promote association of the diagnosis with
more environmental cues, prompting subsequent intrusions as those environmental cues
are encountered in daily life. Intrusion levels may also be attributable to characteristics of
the recruitment setting. Patients in this clinic often met with their physician for 60-90
minutes and received information related to their diagnosis and treatment. The
communication of this information may have eased the process of deciding which
surgical treatment to pursue and reduced concerns about outcomes that were unlikely
given the characteristics of their illness.
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The mean for avoidant coping assessments was 11.2 (SD = 4.1), which is
comparable to levels observed using the same items with women seeking shelter after
surviving domestic abuse (12.92) (Street, Gibson, & Holohan, 2005). Diagnosis of a life
threatening illness and domestic abuse are both potentially traumatic events, so
comparable levels of avoidant coping are not unexpected. However, potential differences
between these events include the time of exposure to the stressor and the amenability of
the stressor to active coping efforts. While most of the women in the current study had
recently encountered the stressor for the first time, women suffering from domestic abuse
may have endured this stressor for a long time before seeking shelter and could have even
felt that the stressor was at or near its resolution because they had left the home. It is
difficult to discern which stressor may have been perceived as more amenable to active
coping. Although direct treatment of the tumor is largely undertaken by the patient’s
medical team, patients could engage in active coping such as seeking information related
to their disease, reorganizing activities to pursue treatment and choosing treatments, and
seeking emotional support from friends and family. Similarly, women suffering from
domestic abuse over a long period of time may have abandoned most active coping
efforts as they have proven ineffective in the past. Conversely, the act of seeking shelter
is an example of active coping, and sampling these women may underrepresent avoidant
coping levels in women experiencing domestic abuse.
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Table 5. Descriptive data for daily measures
Variable

N

Mean (SD)

Intrusions
Intrusions

45

9.5 (5.6)

0-21

45
45
45

11.2 (4.1)
5.2 (1.9)
3.2 (1.8)

6-20.3
2-8
2-7.75

45

2.8 (1.4)

2-7.5

42
42

7.26 (1.13)
6.47 (1.32)

4.35-10.02
2.75-8.34

42

48.8 (36.1)

15.67-168.75

42
42
40

88.6% (9.9)
12.6 (6.0)
41.0 (30.1)

50%-97%
1.25-30
0-128.7

.280 (.176)

-.066-.721

97.1% (3.6)

84.5%-100%

5.7% (5.2)

0.5%-20.05%

Coping
Avoidant Coping
Self-distraction subscale
Denial subscale
Behavioral Disengagement
Subscale

Range

Sleep
Nightly time in bed (hours)
Nightly time spent asleep (hours)
Nightly time spent awake after
sleep onset (minutes)
Overall sleep efficiency
(% of sleep interval spent awake)
Number of nightly awakenings
Sleep latency (minutes)

Circadian Disruption - Actigraphy
24 hour autocorrelation coefficient 42
Dichotomy index % for
time in bed (D/I)
42
Dichotomy index % for
time outside bed (D/O)
42
Circadian Disruption - Cortisol
CAR % increase (µg/dL)
CAR % increaseE (µg/dL)

40
40

35.8% (63.0)
41.1% (75.2)

Morning slopeL (µg/dL)
Morning slopeEL (µg/dL)

42
42

.012 (.181)
.052 (.330)

-.611-.586
-.611-1.728

Waking cortisol (µg/dL)
Waking cortisolE (µg/dL)

43
43

.354 (.278)
.360 (.278)

.087-1.628
.087-1.605

Area under the awakening curveL
(µg/dL)
40
Area under the awakening curveEL
(µg/dL)
40
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-74.1%-169.1%
-74.1%-293.5%

-1.762 (.661)

-3.693-(-0.184)

-1.757 (.635)

-3.690-(-0.180)

Variable

Diurnal cortisol slopeL (µg/dL)
Diurnal cortisol slopeEL (µg/dL)
Overall diurnal mean cortisol
(µg/dL)
Overall diurnal mean cortisolEL
(µg/dL)
Bedtime cortisol (µg/dL)L

N

Mean (SD)

Range

43
43

-.089 (.068)
-.092 (.072)

-.246-.076
-.246-.076

43

.241 (.146)

.088-.911

43

.242 (.145)

.088-.904

42

.121 (.121)

.015-.535

“E” subscripts are used to denote summary cortisol variables calculated with the estimated awakening
cortisol value included. “L” subscripts are used to denoted cortisol values that are presented after log
transformation to correct for non-normal distribution.

Preliminary Analyses
Normality
Potential control variables, predictors, and outcome variables were evaluated by
examining a histogram and boxplot for each variable to determine whether they met the
normality assumption for Pearson correlations. For all variables that did not meet this
assumption, Spearman correlations were used to evaluate bivariate relationships.

Control variables
Both theoretical and empirical methods were used to identify potential control
variables. Age at diagnosis and cancer stage were adjusted in all analyses due to likely
associations with both the predictor and outcome variables. Bivariate correlations of
racial background, education, income, weight, systolic blood pressure, diastolic blood
pressure, tumor size, nodal involvement, estrogen receptor status at the time of diagnosis,
progesterone receptor status at diagnosis, human epidermal growth factor receptor
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(her2/neu) status at diagnosis, grade at diagnosis, time since diagnosis, each class of
medications taken by at least 5% of the sample, and all medications taken for the purpose
of sleep. Of the variables that exhibited significant correlations with the outcome
variable, the control variables with the highest correlations were used as covariates in the
calculation of regression equations and partial correlations. Bivariate correlations
between demographic variables and outcome variables can be found in Table 6. Potential
control variables and outcome variables were evaluated to determine whether they were
normally distributed. Non-normally distributed variables were examined using
Spearman’s r, as noted on Table 6. Preliminary analyses of medical data as potential
control variables are presented in Table 7. All patients included in any analysis are
presented in these tables, resulting in 45 total participants.
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-.0621
.1431
-.1751
.1671
.1231
-.0991
.0741
.0231
-.0831

.0301
.0391
.1991
.2141

-.2291
.0291
-.243
-.395*
-.042
-.0781
.0531
.2621
.3071*
.0441
-.0641
-.1911
-.2381
.1671
.1611
-.0321
-.0531
.2161
.2491

Mean waking cortisolL
Mean waking cortisolEL

Morning slopeL
Morning slopeEL

CAR % increase
CAR % increaseE

Area under waking curveL
Area under waking curveEL

Diurnal cortisol slopeL
Diurnal cortisol slopeEL

Mean overall diurnal cortisolL
Mean overall diurnal cortisolEL

.0561
.0111

.1441
.1741

.3611*
.2701

-.3371*

.126

Race

Rest/activity autocorrelation
Dichotomy index –
% for time inside bed
% for time outside bed
Nightly time asleep
Awakenings
Wake after sleep onset
Sleep efficiency
Sleep onset latency

Age at
diagnosis

.4901**

-.0581
-.1191

-.1971
-.1521

.0241
.0261

.0391
.0281

-.1371
-.1761

.0821
.0021

.0691
.0321

-.1841
-.1101

.0301
.0331

.0791
.1201

-.2061
-.0451

.1191
.0811

.1951
.3421*
-.2891
-.2671
.131
.2801
.003
.1491
-.0591
-.0451
.1161
.0541
-.3781* -.0511

.316*

Education Income

-.1451
-.0541

.0491
-.0111

-.1801
-.1961

-.2051
-.2301

-.1401
-.1651

-.0071
.1421

-.2701
.0481
-.366*
.013
.0911
-.1031
.0551

-.297

-.0041
-.0021

.0281
.0551

.0511

-.0451

-.0021
.0041

.1621
.0711

.0691
.0061

-.3111
.1011
-.1191
.0681
.2151
-.1501
-.0151

-.0551

BP

.0591
.0671

.1161
-.2521
-.0841
-.1341
-.0091
-.0191
-.2231

.3561*

Status

-.0951

-.1031

.0731
.0921

-.0101
.0511

-.0591
-.0981

-.2711
-.2271

.0341
.0831

.3021 -.0151
.3371* -.0361

.1201 -.1031
.0901 -.0761

-.0631
-.1431

-.0861
-.0581
.0031
.2671
.1001
.0201
-.1191

-.1331

BP

Weight Systolic Diastolic Performance

Table 6. Bivariate correlations of outcome variables with demographic and biological characteristics (N=45)
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.0551

.2351

Race

-.1521

-.1291

Education Income

.0861

.0661

BP

.0481

BP

-.2841

Status

Weight Systolic Diastolic Performance

“E” subscripts are used to denote summary cortisol variables calculated with the estimated awakening cortisol value included.
“L” subscripts are used to denote cortisol values that are presented after log transformation to correct for non-normal distribution.
* p < .05.
** p< .01
“1” subscripts are used to denote Spearman correlations
Race is a dichotomous variable dividing the sample into Caucasian (scored as a 0) and minority groups (scored as a 1). A higher score
indicates that the variable is correlated with a minority racial background.

Bedtime CortisolL

Age at
diagnosis

.1461
.2031
.0071
.0531

.0351
-.0161
-.0681
-.0211
.0701
.1111
.0341
.0721
-.1141
-.0721
-.1011
-.1521

.0481
.0091

.0021
.0501

.0921
.1311

.0931
.1201

-.0691
-.0301

-.0551
-.0861

Mean waking cortisolL
Mean waking cortisolEL

Morning slopeL
Morning slopeEL

CAR % increase
CAR % increaseE

Area under waking curveL
Area under waking curveEL

Diurnal cortisol slopeL
Diurnal cortisol slopeEL

Mean diurnal cortisolL
Mean diurnal cortisolEL

.0321
.0511

.2341
.2211

.0071
-.0371

.2671
.2591

-.2311
-.2021

-.1701
-.1311

-.0221
.0491
-.086
.021
-.0551
.0821
-.1781

-.2261
-.2021

-.0651
-.0711

-.2821
-.2541

-.0821
-.0821

-.2701
-.2501

-.2241
-.1251

-.0491
.0661
-.113
.016
-.0331
.0601
-.050

.3421*
.2931

.3911*
.3911*

.1921
.2431

.2021
.3131

.1531
.0681

.1011
.0001

.0601
.0941
-.180
.041
.0941
-.0511
.179

-.311

Her2+ at
diagnosis

-.0351
-.0461

-.3061
-.2951

.0261
.0881

.0801
.1361

.2321
.2871

.1851
.1531

-.0931
.1421
.018
.184
.2271
-.146
.088

-.123

Tumor
Grade

-.0891
-.0801

-.0341
-.0391

.0131
.0011

-.1051
-.1261

-.1761
-.1361

.0281
.0701

.1161
-.1331
.3151*
-.068
-.257
.345*
-.211

.139

Time Since
Diagnosis

“E” subscripts are used to denote summary cortisol variables calculated with the estimated awakening cortisol value included.
“L” subscripts are used to denoted cortisol values that are presented after log transformation to correct for non-normal distribution.
“1” subscripts denote Spearman correlation
* p < .05
** p< .01

-.1101
-.1391

-.2121
-.1761

-.0181
.0111

.105
.0811

.0571
-.0431
.2471
.1091
.1161
-.0461
-.0481

.2731
-.2731
.4491**
.0961
-.0521
.1531
-.1351

.0581
-.1261
.239
.013
.1191
-.0351
-.1131

-.007

.040

.1881

.1681

PR+ at
diagnosis

Tumor Size
Nodal
ER+ at
at diagnosis Involvement diagnosis

-.028

Summary
Stage

Table 7..Bivariate Correlations for Medical Variables (N = 45)

Rest/activity autocorrelation
Dichotomy index –
% for time inside bed
% for time outside bed
Nightly time asleep
Awakenings
Wake after sleep onset
Sleep efficiency
Sleep onset latency
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Table 7 notes that larger tumor size was significantly correlated with more nightly
sleep (Spearman’s r = .449, p < .01). Not only is it surprising that these variables are
significantly correlated, but the correlation is in an unexpected direction. There is no
obvious conceptual reason why a larger tumor should be related to increased time spent
asleep. As a result, the distribution of nightly sleep was examined in a boxplot illustrated
in figure 5 below. Nightly sleep is slightly negatively skewed, as two participants lie
below the error bar. Examination of tumor size categories for these patients revealed that
one was classified as T = 1, the modal classification for tumor sizes in this study, and the
other was classified as T = 3, a value that would suggest a negative correlation between
tumor size and sleep. As a result these two patients did not account for the correlation of
tumor size and sleep. This distribution also indicates that there were no participants who
were outliers with abnormally high levels of sleep and large tumor sizes. It is possible
that this correlation is a spurious one due to the relatively small sample size. In any case,
no association of tumor size with overall 24-hour rhythms was observed, so any effect of
tumor size would be limited to sleep outcomes. Nevertheless, future studies might note
the relationship between these variables and build on the available understanding of their
relevance to tumors and sleep.
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Distribution of Nightly Sleep

500

400

300

200

Mean Nightly Sleep (in Minutes)

Figure 5. Distribution of mean nightly sleep in minutes for the sample. The line in the
middle of the box represents the median, and the edges of the box represent quartiles. The
error bars represent a 95% confidence interval.

Evaluation of Missing Cortisol Data
One participant was excluded from all analyses involving cortisol due to
nonadherence to the protocol. Of the 45 patients included in at least a portion of the
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primary analyses involving cortisol variables, 86.7% of all possible cortisol samples were
completed, judged to be provided at a valid time, without contamination, and with a valid
value. The number of missing cortisol samples was evaluated in terms of its relationship
with disease stage and intrusions to explore whether samples were missing for
systematic, as opposed to random, reasons. The number of missing cortisol samples was
not significantly correlated with disease stage (Spearman’s r = .043, p = .781) or
intrusions (Spearman’s r = .049, p = .751).
Next, the number of missing cortisol samples was correlated with cortisol
outcome variables to determine whether missing data might alter the summary variables
used in subsequent analyses. The number of missing samples was significantly correlated
with the diurnal cortisol slope (Spearman’s r = .375, p = .012). More missing values were
correlated with a flatter diurnal cortisol slope. This relationship remained significant
using the diurnal cortisol slope calculated with estimated awakening cortisol times
included (Spearman’s r = .359, p = .017). More missing samples were also significantly
correlated with elevated average bedtime cortisol values (Spearman’s r = .508, p = .001).
Analyses finding a significant relationship with one of these variables as an outcome
were followed up with analyses that controlled for the number of missing samples to
investigate whether the number of missing samples was a confound.
Although the MEMS collection times and self-reported collection times were
highly correlated (Spearman’s r = .977, p < .01), analyses sought to determine whether
differences between these two collection time measures came about systematically.
Correlations with disease stage (Spearman’s r = -.007, p = .965) and intrusions
(Spearman’s r = .236, p = .143), as measured by the daily IES measure, revealed no
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statistically significant relationship, suggesting that the differences between the two
measures of collection time would not confound results.

Primary Analysis for Testing Main Hypotheses
Hypothesis 1a: Cancer-related intrusions will be significantly and positively
associated with circadian disruption, as measured by salivary cortisol and actigraphy.
Hierarchical regression models were utilized to examine the hypothesis that
intrusions were significantly associated with circadian disruption. All analyses
statistically controlled for two theoretically-derived variables, age at diagnosis and cancer
stage. A third, empirically-derived control variable was included in regression models.
This control variable was chosen from among demographic and medical variables that
were found to be significantly and most strongly correlated with outcome measures in
preliminary analyses. The mean of the daily intrusion scores was then entered on the
second step.
Outcome variables for primary analyses included the autocorrelation coefficient,
dichotomy indices for time in bed and out of bed, mean awakening cortisol, cortisol
awakening response (CAR) slope, CAR slope, diurnal cortisol slope, overall diurnal
mean cortisol, and bedtime cortisol level. A total of nine outcome variables were
evaluated, including three actigraphy variables and six cortisol variables.
In the hierarchical regression model of intrusions predicting circadian disruption,
using autocorrelation as the outcome measure, control variables entered in the first step
(age, stage, and income) explained a significant amount of variance as a group (ΔR2 =
.222; F(3,35) = 3.335, p = .030). The addition of intrusions (ΔR2 = .146; F(1,34) = 7.853,
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p = .008) accounted for a significant proportion of the remaining variance, with intrusions
being related to a lower autocorrelation (partial r = -.433), a marker of less pronounced
circadian rhythm. The entire 4-variable model was related to the autocorrelation as well
(F(4,34) = 4.954, p = 0.003). These statistics, as well as statistics for other circadian
rhythm variables derived from actigraphy, are presented in Table 8. A scatterplot of the
bivariate relationship between the 7-item version of the intrusions subscale of the IES and
the autocorrelation is depicted in Figure 6. Regression equations with other circadian
disruption variables as outcomes revealed no other associations of intrusions with
circadian disruption that were independent of control variables, including both actigraphy
and cortisol outcomes.
In the hierarchical regression model of intrusions predicting circadian disruption,
using the mean CAR % increase as the outcome measure, control variables entered in the
first step (age and stage) did not explain a significant amount of variance as a group (ΔR2
= .043; F(2,37) = 0.839, p = .440). The addition of intrusions (ΔR2 = .101; F(1,36) =
4.245, p = .047) accounted for a significant proportion of the remaining variance, with
intrusions being related to an elevated CAR % increase (partial r = .325), a marker of less
pronounced circadian rhythm. The entire 4-variable model was related to the CAR %
increase as well (F(3,36) = 2.024, p = .128). The addition of intrusions on the second step
of a model predicting CAR % increase with estimated awakening values included also
contributed significantly to the explanatory power of the model (ΔR2 = .134; F(1,36) =
5.928, p = .020), with intrusions again being associated with elevated CAR % increase
(partial r = .376).
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Table 8. Summary of hierarchical regression analyses entering the 7-item intrusions
measure as a predictor of circadian disruption measured by actigraphy.
Variable
Autocorrelation
Step 1
Age
Stage
Income
Step 2
Intrusions

B

SE B

ß

.002
.007
.044

.002
.011
.014

.147
.093
.470*

-.013

.004

-.414*

.049
.271
1.569

.048
.061
-.372*

Dichotomy Index Inside (D/I)
Step 1
Age
.013
Stage
.104
Anti-lipidemic agents
-3.255
Step 2
Intrusions
-.110

.110

R2

ΔR2

p of ΔR2

N

.222

.222

.030

39

.368

.146

.008

.099

.099

.262

.024

.122

.322

42

-.162

Dichotomy Index Outside (D/O)
Step 1
.233
.233
.017
42
Age
-.063
.063
-.158
Stage
-.054
.363
-.022
Opiate Agonists
7.849 2.408
.491**
Step 2
.246
.013
.422
Intrusions
.064
.136
.073
_______________________________________________________________________
* p < .05
** p < .01
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Figure 6. Illustration of the bivariate relationship between intrusions and the rest/activity
autocorrelation (N = 42).

Rest/Activity Autocorrelation as a Function of Intrusions

Rest/Activity Autocorrelation
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The regression line for the bivariate relationship illustrated in Figure 6 had the following equation: y = 0.008x + .352. Partial r = -.233, p = .137.

Modified Intrusions Measure
The two items on the IES that some have argued assess sleep disturbance, as
opposed to intrusions, were removed from the IES, and a new intrusions score for the
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four collection days was calculated using a summary score of the remaining five items.
This intrusions score was used to explore whether the two “sleep” items had accounted
for the relationship between intrusions and circadian rhythms. Using this modified scale,
results were similar to those observed with the full, 7-item scale. The addition of
intrusions on the second step of a hierarchical regression predicting the autocorrelation
significantly added to predictive power of the model (ΔR2 = .113; F(1,34) = 5.798, p =
.022), such that intrusions were related to a lower autocorrelation (partial r = -.382). The
overall, four variable model was also predictive of the autocorrelation (F(4,38) = 4.293, p
= .006).
In contrast to the results observed using the 7-item version of the intrusions
subscale, addition of the 5-item intrusions subscale on the second step was not predictive
of the CAR % increase (ΔR2 = .088; F(1,36) = 3.634, p = .065), though it was a
significant, independent predictor of CAR % increase when estimated awakening values
were included (ΔR2 = .112; F(1,36) = 4.816, p = .035). Other regression equations
examining intrusions as a predictor of circadian disruption did not reveal significant,
independent effects of the 5-item intrusions subscale on circadian disruption.

Hypothesis 1b: Avoidant coping will moderate the relationship between cancer-related
intrusive thoughts and circadian disruption.
To evaluate daily avoidant coping reports as potential moderators of the
relationship between intrusions and circadian disruption, only the significant relationships
observed in analyses from hypothesis 1a were tested. Because a significant association of
intrusions with the autocorrelation was observed, a test of moderation was performed.
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Age at diagnosis was used as a covariate and entered on the first step with the meancentered avoidant coping variable and the mean-centered intrusions variable. The
intrusions and avoidant coping variables were moderately correlated (Pearson’s r = .554,
p < .001). In this hierarchical regression model, age was entered on the first step with the
mean-centered intrusions and avoidant coping variables. These variables did not explain a
significant amount of variance as a group (ΔR2 = .188; F(3,38) = 2.704, p = .060). In
addition, age (partial r = .009, p = .958) and mean-centered intrusions (partial r = .005, p
= .975) covariates were not significant predictors individually. Mean-centered avoidant
coping (partial r = -.358, p = .030) was a significant predictor individually. Using the
mean-centered avoidant coping and intrusions scores, a cross-product of these variables
was calculated and entered on the second step of this regression equation. This crossproduct did not account for a significant proportion of the remaining variance (ΔR2 =
.005; F(1,34) = 2.030, p = .662). It should be noted that avoidant coping was no longer a
significant individual predictor of the rest/activity autocorrelation (partial r = -.305, p =
.070) after the interaction term was added to the model. In a separate model, the addition
of a cross product between the mean-centered 5-item version of the intrusions subscale
and the autocorrelation on the second step of a regression equation also did not contribute
significantly to the predictive power of the model (ΔR2 = .002; F(1,37) = 0.067, p =
.796).
Because intrusions were related to the CAR % increase in hypothesis 1a analyses,
a model testing avoidant coping as a moderator of this relationship was tested. In this
model, age (partial r = -.157, p = .348), mean-centered intrusions (partial r = .192, p =
.247), and mean-centered avoidant coping (partial r = .155, p = .352) did not explain a
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significant amount of variance individually or as a group (ΔR2 = .159; F(3,36) = 2.275, p
= .096) and neither did the addition of the interaction between intrusions and avoidant
coping (ΔR2 = .064; F(1,35) = 2.887, p = .098). Similar results were observed when using
the interaction between intrusions and avoidant coping to predict CAR % increase with
estimated awakening values included (ΔR2 = .036; F(1,35) = 1.597, p = .215).

Hypothesis 2: Diurnal salivary cortisol slope and rest-activity rhythm obtained by

actigraphy will be significantly and positively associated.
Spearman correlations between actigraphy and cortisol measures of circadian
disruption were calculated to explore this relationship. Actigraphy measures included the
rest/activity autocorrelation and the dichotomy indices for time in and out of bed. Cortisol
variables included the awakening cortisol value, CAR slope, diurnal cortisol slope, mean
diurnal cortisol, and bedtime cortisol value. All correlations are shown in Table 9.
Significant correlations involving the diurnal cortisol slope or bedtime cortisol level were
followed up by partial correlations controlling for the number of missing cortisol values
because the number of missing values was correlated with these two measures and
presented a possible confound. The results of partial correlations are presented in Table
10.
A higher autocorrelation was correlated with a steeper decline in the diurnal
cortisol slope (Spearman’s r = -.613, p < .001), both indications of circadian rhythmicity.
This effect was independent of the number of missing cortisol values (partial r = -.638, p
< .001). A higher autocorrelation was also correlated with a lower bedtime cortisol value
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(Spearman’s r = -.459, p = .003), an effect that was independent of the number of missing
cortisol samples (partial r = -.476, p = .002).

Table 9. Actigraphy and Cortisol Correlations (N = 41)
24 hour
Autocorrelation

Dichotomy
Index Inside

Dichotomy
Index Outside

Mean Waking CortisolL

.273

.039

-.183

Morning Cortisol SlopeL

-.238

-.276

.348*

Diurnal Cortisol SlopeL

-.613**

-.302

.498**

Mean Diurnal CortisolL

-.078

-.114

.165

-.459**
-.273
.431**
Bedtime CortisolL
________________________________________________________________________
“L” subscripts are used to denoted cortisol values that are presented after log transformation to correct for
non-normal distribution.
* p < .05, ** p < .01
All correlations calculated using Spearman’s r

Significant correlations were noted between a higher D/O and a flatter diurnal
cortisol slope (Spearman’s r = .498, p = .001), independent of missing cortisol samples
(partial r = .471, p = .003). D/O was also associated with a steeper increase in the
morning cortisol slope (Spearman’s r = .348, p = .028), and elevated bedtime cortisol
(Spearman’s r = .431, p = .006), an effect that was also independent of missing cortisol
values (partial r = .408, p = .011). Because D/O reflects the amount of activity when out
of bed that falls below the median activity level for time in bed, a high D/O suggests
circadian disruption. Other results are presented in Tables 9 and 10.
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Table 10. Summary of partial correlations between actigraphy and cortisol. The number
of missing cortisol samples was statistically controlled.
Actigraphy

Cortisol

CV

partial r

p

Autocorrelation

diurnal slopeL

missing samples

-.638

<.001

Autocorrelation

diurnal slopeEL

missing samples

-.591

<.001

Autocorrelation

bedtime cortisolL

missing samples

-.476

.002

D/O

diurnal slopeL

missing samples

.471

.003

D/O

diurnal slopeEL

missing samples

.436

.006

D/O
bedtime cortisolL
missing samples
.408
.011
_______________________________________________________________________
“L” subscripts are used to denoted cortisol values that are presented after log transformation to correct for
non-normal distribution. “E” subscripts are used to denote summary cortisol variables calculated with the
estimated awakening cortisol value included.
* p < .05
** p < .01

Figure 7 illustrates the relationship between the rest/activity autocorrelation and
raw cortisol values throughout the day. Solely for the purpose of illustration, the sample
was split into “Low” and “High” autocorrelation groups using a median split. The two
groups derived from the median split of the autocorrelation were not used in any data
analyses.
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Figure 7. Contrasts between raw diurnal cortisol values for participants
characterized by a median split of rest/activity autocorrelations (N = 20 for each group).

Legend. A median split was used to divide the sample into low and high autocorrelation groups. These
groups were created solely to aide in illustrating the relationship between the autocorrelation and cortisol
values, and the autocorrelation median split was not used for any data analyses. All cortisol values are raw,
untransformed values and are in µg/dL.

Secondary Analyses
Secondary Analysis #1: Sleep Variables from Actigraphy as Outcomes
Actigraphy data were used to calculate the mean time spent asleep each night,
the mean amount of time awake after sleep onset, the mean sleep onset latency, the mean
number of awakenings, and the percentage of time spent asleep each night. These
variables were tested as outcomes in analyses similar to those used with circadian
disruption variables in previous analyses. The intrusion score, with and without the two
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“sleep” items was tested as a predictor of sleep outcomes. Analyses were performed with
age and stage as control variables and a third, empirically selected control variable. The
predictor of interest was entered on the second step. Intrusions were not significantly
related to sleep in any of these analyses.

Secondary Analysis #2: Direct Effects of Avoidant Coping on Circadian Disruption
Avoidant Coping Summary Scale
To determine whether avoidant coping was related to circadian disruption
directly, as opposed to moderating the effects of intrusions on circadian disruption,
regression analyses similar to those employed to test hypothesis 1a were used with
avoidant coping as the predictor entered on the second step. Regression equations were
calculated with a third, empirically selected control variable. Separate regression
equations were calculated for each of the following outcomes: rest/activity
autocorrelation, D/I, D/O, sleep time, awakenings, wake after sleep onset, sleep
efficiency, sleep onset latency, awakening cortisol value, CAR morning slope, CAR %
increase, area under the awakening cortisol curve, diurnal cortisol slope, and mean
diurnal cortisol, and bedtime cortisol value. All cortisol equations were calculated with
and without awakening values estimated using linear modeling.
The autocorrelation was regressed on age, stage, and income on the first step of a
hierarchical regression equation, and these control variables explained a significant
amount of variance as a group (ΔR2 = .222; F(3,35) = 3.335, p = .030). Similarly, the
addition of avoidant coping on the second step predicted the autocorrelaion (ΔR2 = .098;
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F(1,34) = 4.896, p = .034), such that avoidant coping was associated with circadian
disruption (partial r = -.355).

Table 11. Summary of Regression Equations Noting a Significant Relationship Between
Avoidant Coping and Actigraphy Measures of Circadian Disruption.
Variable

B

SE B

ß

R2

ΔR2

p of ΔR2

N

Autocorrelation
Step 1
.222
.222
.030
39
Age
.002
.002
.135
Stage
.007
.011
.085
Income
.036
.014
.384*
Step 2
.320
.098
.034
Avoidant Coping
-.013
.006
-.333*
-----------------------------------------------------------------------------------------------------------Dichotomy/Inside (D/I)
Step 1
.099
.099
.262
42
Age
.007
.045
.025
Stage
.123
.248
.072
Anti-Lipidemic Agents -3.534 1.411
-.404*
Step 2
.267
.168
.006
Avoidant Coping
-.366
.125
-.422*
________________________________________________________________________
* p < .05

In a hierarchical regression controlling for age, stage, and anti-lipidemic
medication, the control variables entered on the first step did not explain a significant
amount of variance in D/I as a group (ΔR2 = .099; F(3,38) = 1.385, p = .262). However,
when avoidant coping was entered on the second step, it was a significant predictor of D/I
(ΔR2 = .168; F(1,37) = 8.496, partial r = -.432, p = .006), such that avoidant coping was
related to less time in bed in which the activity level was below the median activity level
when not in bed. The bivariate relationship between avoidant coping and D/I is
represented in Figure 8. A lower D/I is likely characteristic of disrupted circadian
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rhythmicity. The entire, four variable model was not related to D/I (F(4,37) = 3.368, p =
.019). Results for actigraphy variables can be seen in Table 11. Avoidant coping was not
independently related to any other circadian disruption outcomes.

Figure 8. Illustration of the bivariate relationship between avoidant coping and the
dichotomy index for time in bed (D/I) (N = 41).

The regression equation for the bivariate relationship is y = -.366x + 101.398. Partial r = -.432, p = .006.

Secondary Analysis #3: Avoidant Coping Subscales and Circadian Disruption
Average scores on daily avoidant coping subscales were calculated and explored
as predictors of circadian disruption. Avoidant coping subscales included self-distraction,
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denial, and behavioral disengagement. Analytic procedures were identical to those used
for the summary daily avoidant coping score used as a predictor in secondary analysis #2.

Self-Distraction
With log-transformed area under the awakening cortisol curve (MAUC) as the
outcome, age and stage did not collectively predict MAUC (R2 = .177; F(3,36) = 2.576, p
= .069), but the addition of self-distraction on the second step did (ΔR2 = .106; F(1,35) =
5.186, p = .029). Self-distraction was related to increased MAUC (partial r = .359).
Similar results were observed when awakening values estimated using linear modeling
were included in the calculation of the area under the awakening cortisol curve, as the
addition of self-distraction was related to higher MAUC (ΔR2 = .119; F(1,35) = 6.151,
partial r = .387, p = .018). Significant results observed in models using self-distraction as
a predictor of circadian disruption are presented in Table 12.
When the log-transformed average awakening cortisol value was tested as an
outcome, the collection of age, stage, and bronchodilating medication was not related to
awakening cortisol (R2 = .107; F(2,40) = 2.385, p = .105), but the addition of selfdistraction on the second step was significantly associated with a higher awakening
cortisol level (ΔR2 = .088; F(1,39) = 4.280, partial r = .314, p = .045). Similar results
were observed when estimated awakening values were included, as the addition of selfdistraction on the second step was associated with a higher awakening cortisol level (ΔR2
= .091; F(1,39) = 4.377, partial r = .318, p = .043).
No other significant relationships were observed in models using self-distraction
as a predictor of circadian disruption, including all analyses with actigraphy outcomes.
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Table 12. Summary of Regression Equations Showing a Significant Relationship between
Self-distraction and Cortisol Awakening Response.
Variable

B

SE B

ß

R2

ΔR2

p of ΔR2

N

Area Under Awakening Curve (MAUC)
Step 1
.177
.177
.069
40
Age
.009
.008
.187
Stage
.049
.056
.144
Benzodiazepines
.966
.471
.322*
Step 2
.283
.106
.029
Self-Distraction
.115
.051
.344*
-----------------------------------------------------------------------------------------------------------MAUC with Estimated Waking ValuesE
Step 1
.203
.203
.040
40
Age
.011
.008
.218
Stage
.060
.052
.184
Benzodiazepines
.933
.445
.324
Step 2
.322
.119
.018
Self-Distraction
.117
.047
.365*
-----------------------------------------------------------------------------------------------------------Mean Awakening Cortisol
Step 1
.107
.107
.105
43
Age
.014
.007
.302
Stage
.070 .049
.223
Step 2
.195
.088
.045
Self-Distraction
.097
.047
.311*
_
-----------------------------------------------------------------------------------------------------------Mean Awakening CortisolE
Step 1
.101
.101
.119
43
Age
.015
.008
.307
Stage
.065 .052
.193
Step 2
.192
.091
.043
Self-Distraction
.104
.050
.315*
_________________________________________________________________
“E” subscripts are used to denote summary cortisol variables calculated with the estimated awakening
cortisol value included.
* p < .05
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Denial
In a hierarchical regression exploring denial as a predictor of D/I, control
variables including age, stage, and anti-lipidemic medication entered on the first step did
not significantly predict D/I (ΔR2 = .099; F(3,38) = 1.385, p = .262). Denial entered on
the second step independently predicted D/I (ΔR2 = .222; F(1,37) = 12.119, p = .001),
such that denial was associated with a lower D/I (partial r = -.497). The entire, four
variable model was also related to D/I (F(4,37) = 4.373, p = .005). Regression equations
yielding a significant effect of denial on circadian disruption are summarized in Table 13.
Table 13. Summary of Regression Equations Showing a Significant Relationship between
Denial and D/I, D/O, and Nightly Sleep.
Variable

B

SE B

ß

R2

ΔR2

p of ΔR2

N

Dichotomy/Inside (D/I)
Step 1
.099
.099
.262
42
Age
.023
.043
.083
Stage
.185
.239
.107
Anti-Lipidemic Agents -3.363 1.348
-.385
Step 2
.321
.222
.001
Denial Coping
-.933
.268
-.476*
Dichotomy/Inside (D/O)
Step 1
.233
.233
.017
42
Age
-.064
.056
-.159
Stage
-.143
.335
-.057
Opiate Agonist Agents 6.791 2.255
.424*
Step 2
.127
.360
.010
Denial Coping
1.035
.382
.366*
Nightly Sleep
Step 1
.197
.197
.041
41
Age
-.766
.904
-.119
Stage
7.090 5.218
.191
Weight
-.683
.245
-.387*
Step 2
.124
.321
.015
Denial Coping
-15.831 6.178
-.357*
________________________________________________________________________
* p < .05
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In a hierarchical regression controlling for age, stage, and opiate agonist
medication, the control variables entered on the first step were related to D/O as a group
(ΔR2 = .233; F(3,38) = 3.848, p = .017). Denial entered on the second step independently
predicted D/O (ΔR2 = .127; F(1,37) = 7.348, p = .010), such that denial was associated
with a higher D/O (partial r = .407). The entire, four variable model was also significantly
associated with D/O (F(4,37) = 5.205, p = .010).
The regression equation with mean nightly sleep as the outcome was significantly
predicted by the group of control variables age, stage, and weight (ΔR2 = .197; F(3,37) =
3.030, p = .041). The subsequent addition of avoidant coping to the model added to its
predictive power (ΔR2 = .124; F(1,36) = 6.567, p = .015), with denial predicting
decreased sleep (partial r = -.315). The resulting four variable model explained a
significant amount of variance in nightly sleep (F(4,36) = 4.256, p = .006).

Behavioral Disengagement
Hierarchical regression equations were used to investigate the relationship
between behavioral disengagement and circadian disruption. In a regression using
behavioral disengagement as a predictor of the autocorrelation, control variables included
age, stage, and income. The addition of behavioral disengagement on the second step of
this equation explained significant variance in the autocorrelation (ΔR2 = .110; F(1,34) =
5.620, p = .024), with behavioral disengagement being associated with a lower
autocorrelation (partial r = -.464), indicating more behavioral disengagement was related
to a weaker circadian activity rhythm. The entire, four variable model was also predictive
of the autocorrelation (F(3,34) = 4.236, p = .007). Regression equations resulting in a
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significant, independent effect of behavioral disengagement on circadian disruption are
summarized in Table 14.

Table 14. Summary of Regression Equations with Behavioral Disengagement Coping as
a Predictor of Actigraphy Measures of Circadian Disruption.
Variable
Autocorrelation
Step 1
Age
Stage
Income
Step 2
Behavioral Diseng.

B

SE B

ß

.002
.012
.032

.002
.011
.015

.134
.160
.338*

-.043

.018

-.373*

Dichotomy/Inside (D/I)
Step 1
Age
-.001
Stage
.317
Anti-Lipidemic Agents -3.306
Step 2
Behavioral Diseng.
-1.304

.043
.243
1.334
.361

R2

ΔR2

p of ΔR2

N

.222

.222

.030

39

.332

.110

.024

.099

.099

.262

.261

.235

.001

42

-.003
.184
-.378*
-.512*

Dichotomy/Outside (D/O)
Step 1
.233
.233
.017
42
Age
-.039
.058
-.097
Stage
-.284
.344
-.114
Opiate Agonist Agents 6.760 2.261
.422*
Step 2
.359
.126
.011
Behavioral Diseng.
1.405
.522
.382*
________________________________________________________________________
* p < .05

In a hierarchical regression exploring behavioral disengagement as a predictor of
D/I, control variables included age, stage, and anti-lipidemic medication. The control
variables entered on the first step did not significantly predict D/I (ΔR2 = .099; F(3,38) =
1.385, p = .262). However, behavioral disengagement entered on the second step
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independently predicted D/I (ΔR2 = .235; F(1,37) = 13.023, p = .001), such that
behavioral disengagement was associated with a lower D/I (partial r = -.510), indicating
more activity while in bed, likely a sign of circadian disruption. The entire, four variable
model was also related to D/I (F(4,37) = 4.623, p = .004).
In a hierarchical regression exploring behavioral disengagement as a predictor of
D/O, control variables included age, stage, and opiate agonist medication. The control
variables entered on the first step significantly predicted D/O (ΔR2 = .233; F(3,38) =
3.848, p = .017). Behavioral disengagement entered on the second step also
independently predicted D/O (ΔR2 = .126; F(1,37) = 7.245, p = .011), such that
behavioral disengagement was associated with a higher D/O (partial r = .405), indicating
more time of diminished activity while out of bed, likely a sign of circadian disruption.
The entire, four variable model was also related to D/O (F(4,37) = 5.171, p = .002). No
other independent relationships were observed between behavioral disengagement and
circadian disruption.
In terms of sleep outcomes, behavioral disengagement was significantly and
independently related only to increased time spent awake after sleep onset (ΔR2 = .096;
F(1,38) = 4.179, partial r = .315, p = .048). The covariates, age and stage, were not
significantly associated with wake after sleep onset (R2 = .029; F(2,39) = .592, p = .558).
The final, three variable model was also not statistically significant (R2 = .126; F(3,38) =
1.820, p = .160).
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Secondary Analysis #4: Additional Cortisol Measures
To supplement primary analyses with cortisol outcomes, secondary analyses
sought to investigate relationships previously tested in primary analyses with the addition
of two additional CAR measures: CAR % increase and the area under the awakening
curve. The CAR slope was used as the primary CAR outcome measure because it was
judged to be a better indicator of the HPA response to awakening as it measures the rate
of change from the wake sample to the +30min sample and is not as susceptible to undue
influence from extreme awakening values. In addition, analyses of cortisol variables were
repeated using the cortisol variables calculated with the awakening values estimated
using linear modeling. This was done to minimize the influence of missing values on the
cortisol outcomes.
In regression models using the 7-item intrusions scale as a predictor of
secondary cortisol outcomes, a hierarchical regression model of the CAR % increase with
estimated awakening values included was not significantly predicted by the combination
of age and stage (ΔR2 = .051; F(2,38) = 1.022, p = .370). However, the addition of the 7item intrusions scale on the second step significantly explained the CAR % increase (ΔR2
= .102; F(1,37) = 4.461, p = .041), with intrusions related to a more dramatic cortisol
increase (partial r = .328). Other models with the 7-item version of the intrusions subscale
as a predictor of secondary cortisol outcomes were not statistically significant. Models
testing associations of the 5-item intrusions scale with secondary cortisol outcomes did
not reveal and significant, independent relationships.
Intrusions were not significantly and independently related to other CAR
measures. This could have been due to the error introduced by the inclusion of estimated
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awakening values. In addition, because the awakening cortisol level is the denominator in
the calculation of CAR % increase, low awakening values can result in high % increases
without a large absolute difference between the awakening and +30min cortisol values.
Exploratory analyses similar to those employed for the evaluation of hypothesis
2 in the primary analyses were repeated with the secondary cortisol outcomes. These
correlations can be found in Table 15. The rest/activity autocorrelation was significantly
correlated with the area under the awakening curve when estimated awakening values
were included (Spearman’s r = .338, p = .035). In findings similar to those observed in
primary analyses, both the autocorrelation (Spearman’s r = -.561, p < .001) and the D/O
(Spearman’s r = .457, p = .003) were related to the diurnal cortisol slope with the
estimated awakening values included. These findings were both such that disrupted
activity rhythms were associated with a flatter diurnal cortisol slope. When the number of
missing cortisol samples was statistically controlled, significant relationships persisted
between the diurnal cortisol slope and both the autocorrelation (partial r = -.578, p <
.001) and the D/O (partial r = .401, p = .011).

Table 15. Actigraphy and Secondary Cortisol Variable Correlations (N = 40)
24 hour
Autocorrelation

Dichotomy
Index/Inside

Dichotomy
Index/Outside

Waking CortisolEL

.273

.039

-.160

Morning Cortisol SlopeEL

-.077

-.264

.228

CAR % increase
CAR % increaseE

-.155
-.180

-.081
-.076

.113
.125

Area under waking curveL
Area under waking curveEL

.191
.114

.067
.095

-.148
-.136
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24 hour
Autocorrelation

Diurnal Cortisol SlopeEL

-.561**

Dichotomy
Index/Inside

-.273

Dichotomy
Index/Outside

.457**

Mean diurnal cortisolEL
.114
-.176
.194
________________________________________________________________________
Legend. “E” subscripts are used to denote summary cortisol variables calculated with the estimated
awakening cortisol value included. “L” subscripts are used to denoted cortisol values that are presented
after log transformation to correct for non-normal distribution.
All correlations calculated using Spearman’s r.
* p < .05
** p < .01

Secondary Analysis #5: Relationships between Cortisol and Sleep
As a final secondary analysis, the relationships between cortisol and sleep
variables were explored. Sleep variables included total nightly sleep, awakenings, wake
after sleep onset, sleep efficiency, and sleep onset latency. The effects of daytime and
bedtime cortisol on sleep were explored by regressing sleep variables on the mean diurnal
cortisol, diurnal cortisol slope, and bedtime cortisol levels with age and stage statistically
controlled. In addition, the relationship of sleep to the cortisol awakening response was
explored by regressing the mean awakening cortisol, morning slope, % increase, and area
under the awakening cortisol curve on each of the sleep variables in separate equations
and with age and stage statistically controlled. No statistically significant, independent
associations of cortisol and sleep variables emerged from these analyses.

Secondary Analysis #6: Removal of Patients Reporting Depression
Previous literature has noted hypersecretion of cortisol, especially late in the
day, in participants reporting depression (Burke et al., 2005). It is possible that, in a
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portion of the sample, the hypersecretion associated with symptoms of depression would
counteract the diminished secretion of cortisol that could be expected to be associated
with intrusions, a symptom consistent with PTSD. To reduce confounding presented by
patients reporting high levels of depression, participants scoring more than 1.5 standard
deviations above the mean of the standard deviation observed in a standardization sample
receiving the POMS were removed from a repeated analysis of circadian cortisol
outcomes. Seven participants were removed based on POMS scores. Age and stage were
entered on the first step of a hierachical regression equation. Intrusions were entered on
the second step. These analyses revealed no significant and independent effects of
intrusions on cortisol. Similarly, no effects of the 5-item version of the intrusions
measure on cortisol were observed.
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DISCUSSION
Summary of Results
This study sought to explore relationships between breast cancer-related
intrusions, avoidant coping, and circadian rhythms. Breast cancer-specific intrusions over
a four day period between diagnosis and the initiation of treatment were used as an
indication of the distress associated with breast cancer. Because detailed investigation of
the relationships between intrusions and multiple measures of circadian disruption are not
available, an exploratory analytical approach was employed to develop a rich
understanding of the data collected and generate hypotheses for future research.

Primary Analyses
Hypothesis 1a: Cancer-related intrusions will be significantly and positively
associated with circadian disruption, as measured by salivary cortisol and actigraphy.
Analyses of the relationship between intrusions and circadian disruption revealed
that intrusions were significantly related to a lower autocorrelation coefficient for
rest/activity rhythms. These effects were independent of the effects of two theoreticallyderived control variables, age at diagnosis and cancer stage, as well as one empiricallyderived variable, income. This effect persisted when items from the IES intrusions scale
that discussed sleep were removed. Intrusions were not independently related to the
dichotomy indices of activity while in bed and while out of bed.
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Intrusions were also related to an increased CAR % increase, possibly indicating
an exaggerated response of the HPA to awakening. There is no consensus interpretation
of the cortisol awakening response, so the implications of these findings are not clear. An
elevated CAR% increase might be the result of an absent pre-awakening cortisol rise
characteristic of circadian disrupiton. Because this was a naturalistic study, assessment of
pre-awakening cortisol levels that have been performed in a laboratory setting were
unavailable. As a result, the association of intrusions with increased CAR % increase is
consistent with circadian disruption due to an absent pre-awakening cortisol rise, and a
pre-awakening cortisol rise is hypothesized as a mechanism, but this explanation cannot
be confirmed based on the data available in the current study. Further, an increased CAR
% increase could be indicative of stress appraisals in the morning, meaning such a result
could be interpreted as being consistent with circadian rhythmicity. Evidence of a
relationship between intrusions and circadian disruption is of clinical relevance for
several reasons. Significant levels of intrusion have been reported in 36% of patients after
receiving a diagnosis of breast cancer (Green, Rowland, & Krupnick, 2000), indicating
that this is a symptom experienced by a large number of patients. Any relationship of
intrusions with circadian disruption would apply to a notable proportion of patients who
have breast cancer. In light of studies identifying circadian disruption as a predictor of
shortened survival (Mormont et al., 2000; Sephton et al., 2000), it is clinically relevant to
note that distress, specifically intrusions, associated with the diagnosis of breast cancer
may also be related to circadian disruption.
It is interesting to note a possible relationship between intrusions and circadian
disruption was largely limited to the autocorrelation coefficient, especially in light of
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studies reporting a significant association of intrusions with cortisol (Dettenborn, 2006).
To date, most of the studies of intrusions and cortisol have investigated the overall
cortisol over a period of time, as opposed the circadian rhythmicity variables employed in
this study. An alteration in total output would not necessarily be reflected in measures of
circadian rhythmicity. However, the overall mean cortisol level was evaluated in this
study, and intrusions did not exhibit a significant association with this measure or with
log-transformed awakening and bedtime cortisol values.
The notion of allostatic load proposed by McEwen (McEwen & Stellar, 1993) is a
useful conceptual model for the disruption of endocrine functioning, including cortisol.
This model proposes that physiological adaptations to stress can take a toll on body
systems over time. The wear and tear of allostatic load that could result in disrupted
circadian rhythms may take place over a number of years. In this study, women had been
informed of their diagnosis of breast cancer recently, often on the same day as their
enrollment in the study. The physiological effects of stress may not have been observed
because these effects simply do not appear in response to stressors unless exposure to
these stressors persists over a long period of time. In fact, it has been argued that brief,
intermittent stressors present a challenge that promotes a healthy adaptation by the
individual (Epel & McEwen, 1998). Studies of circadian cortisol rhythms have reported
notable interdaily instability, suggesting that circadian rhythms are sensitive to
environmental and psychological stress. As a result, it is reasonable to expect that a
diagnosis of breast cancer would induce sufficient distress to alter circadian cortisol
rhythms. Still, changes in circadian cortisol rhythms may be attributable to influences
other than psychological distress, such as medications, diet, or exercise.
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In light of other possible explanations, interdaily variability in circadian cortisol
rhythms does not necessarily mean that these rhythms are sensitive to changes to
intrusions, the specific measure of psychological distress used here, but distress-induced
disruption is evident from other studies. It is hypothesized that a longitudinal study of
women with breast cancer would observe that post-diagnostic distress would be
predictive of later development of disrupted circadian cortisol rhythms. The finding that
post-diagnostic intrusions were more closely associated with disrupted rest/activity
rhythms than with cortisol rhythms suggests a new explanation for disrupted circadian
cortisol rhythms. It is possible that disrupted rest/activity rhythms mediate the
relationship between distress and circadian cortisol rhythm disruption. This model
hypothesizes that disrupted rest/activity rhythms would predict subsequent disruption of
circadian cortisol rhythms in longitudinal studies of women with breast cancer.
A larger sample size would be needed to appropriately test a more complex model
of the relationships between stress, coping, and adaptation. Future research in a larger
data set could include a self-report assessment of the degree to which patients perceived
the relevant event as stressful. Although a diagnosis of breast cancer is likely deemed
stressful by most patients (Rowland, 1998), the degree to which someone appraises the
illness as stressful varies, and this variable is also of significance to the model that guided
the design of the current study.
Distress was measured by the IES intrusions scale in this study because studies
have noted that intrusions are prevalent (Jacobsen et al., 1998) and predictive of longterm distress in patients with breast cancer (Bleiker et al., 2000). This measure also
allowed assessment that was explicitly tied to the diagnosis of breast cancer, as opposed
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to general distress. Future studies might benefit from a measure of general distress that
would assess the influence of breast cancer, or another stressor, or generalized distress as
well as measuring the influence of other significant stressors in the lives of people that
suffer from breast cancer. It is hypothesized that breast cancer-related intrusions would
be most strongly associated with post-diagnostic circadian disruption but that other
measures of distress would also exhibit modest associations with circadian disruption.
A number of studies employing daily assessments have measured dynamic
processes over many days (Tennen & Affleck, 1996). Daily assessments over a longer
period of time allow within-person daily fluctuations to be analyzed using advanced
statistical techniques (Tennen, 2000). These studies are not well matched for studies that
are conducted within a brief time window, such as between cancer diagnosis and
treatment, but patients could be followed throughout the course of long-term treatment or
during the remission phase of breast cancer. Alternatively, patients could be assessed
across several phases of diagnosis and treatment. Collection of daily assessments over a
longer time period would allow within-subjects statistical testing, using more advanced
statistical methods such as hierarchical linear modeling. These techniques would likely be
more sensitive to detecting the relationships hypothesized in this study. It is hypothesized
that data collection allowing for use of advanced statistical techniques would reveal
stronger relationships between intrusions and circadian disruption and would more
effectively discriminate between measures of circadian disruption that are affected by
intrusions and those that may be independent from distress.
The aim of capturing quickly changing phenomena closer to the time of their
occurrence is furthered by daily assessments, but a time lag between appraisals made,
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coping efforts undertaken, and intrusions experienced remains. Assessments could be
placed closer to the time of their occurrence using ecological momentary assessment,
devices that prompt participants to respond immediately regarding psychological
phenomena. Participants in this study wore actigraphy devices throughout the day and
reported little difficulty or obtrusiveness related to actigraphy devices, so it is possible
that these devices could be supplemented or replaced by other unobtrusive devices. These
devices differ in that actigraphy devices require no maintenance, other than removal in
situations in which they are likely to get wet. Despite the cost of using ecological
momentary assessment devices, based on the results observed in the current preliminary
study, the use of more resources to extend these findings may be merited. It is
hypothesized that utilization of devices that allow psychosocial phenomena to be
captured closer to their occurrence would provide more valid assessments and more
sensitive tests that would reveal stronger relationships between intrusions and circadian
disruption.
Because this was an exploratory study, this finding is preliminary, and it was not
observed with other actigraphy variables or with circadian cortisol rhythms, replication is
essential. Based on this study, it is hypothesized that breast cancer-related intrusions
would be related to disrupted rest/activity rhythms, but not necessarily to physiological
rhythms, in the period immediately following diagnosis. Replication of a relationship
between intrusions and disrupted rest/activity rhythms as well as extension of these
findings in a longitudinal study, would support the importance of available resources and
intervention to address distress associated with a breast cancer diagnosis. It is important
to address this distress primarily because of the clinical relevance of distress as a clinical
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outcome. However, an association of intrusions with the rest/activity autocorrelation, a
variable predictive of survival in one study (Mormont et al., 2000), would suggest the
possible presence of poor physical health outcomes influenced by intrusion levels.

Hypothesis 1b: Avoidance as a moderator of intrusion and circadian disruption
The relationship between intrusions and autocorrelation was carried forward to a
test of avoidant coping as a possible moderator of this relationship. Tests using the
overall avoidant coping score as well as the self-distraction, denial, and behavioral
disengagement subscales revealed no significant moderation of the effect of intrusions on
circadian rhythms.
The lack of moderation is reasonable given the low statistical power for tests with
an interaction term and the modest sample size for this study. Considering the modest
relationships often observed between psychosocial variables and physiological variables,
a number of factors could explain the lack of a moderation finding. In addition, the
intrusions and avoidant coping predictors were moderately correlated (Pearson’s r = .554,
p < .001), compromising the interpretability of the interaction term. Baron & Kenny
(1986) indicated that these conditions are not ideal for testing moderation effects. This
correlation may have influenced the absence of a finding with the interaction term tested
in this model.
The transactional model illustrated in the introduction places the appraisal of
threat, harm, or challenge before the onset of coping and distress (Lazarus, 1984). Based
on this conceptualization, it might be expected that coping could moderate the effects of
perceived stress on the resulting distress but can not moderate the effects of distress on
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physiology or behavior. However, the transactional character of the model means that the
variables interact extensively with one another. Lazarus (2000) has emphasized the
potential for any of these variables to act as predictors, moderators, and outcomes and has
called for richer investigation of the interrelationships between these variables. In
keeping with that goal, this study investigated avoidant coping both as a moderator and as
a predictor in models exploring circadian disruption.
It should also be noted that the stress, coping, and adaptation process renews as
distress continues and stressors persist. Thus, even if coping initially precedes distress in
response to the first exposure to a stressor, it is likely that coping will also follow distress
and influence the effects of distress on variables such as the physiology, sleep, and
rest/activity rhythms explored in this study. The figure illustrating the transactional model
of stress, coping and adaptation is shown on page 19. Still, it is interesting to note that
avoidant coping was predictive of circadian disruption when it was specified as a
predictor but not when it was specified as a moderator in models in this study.

Hypothesis 2: Diurnal salivary cortisol slope and rest-activity rhythm obtained by

actigraphy will be significantly and positively associated.
One of the strengths of this study is the use of multiple measures of circadian
rhythmicity. Consequently, exploration of the type and strength of the relationship
between these two measures is of interest. Generally, the expected relationships were
evident. A higher 24-hour autocorrelation generated from actigraphy data was related to a
steeper diurnal decrease in the cortisol slope. The relationship between these measures
suggests they will yield similar indications concerning circadian rhythmicity. The
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autocorrelation was related to a lower bedtime cortisol level, a result that is consistent
with stronger circadian rhythmicity, as cortisol is typically at its nadir in the evening.
This finding informs comparison of the two studies reporting that circadian rhythms were
predictive of cancer survival because one study used the rest/activity autocorrelation
(Mormont et al. 2000), and the other study used the diurnal cortisol slope (Sephton et al.,
2000). Preliminary evidence from the current study suggests these two variables measure
similar phenomena, as they were moderately to highly correlated in a sample of women
with breast cancer in this study. The correlation in this study (r = -.614) was such that
there appears to be a meaningful amount of independent variance between the
rest/activity autocorrelation and the diurnal cortisol slope, indicating that the inclusion of
multiple measures of circadian disruption would be a useful methodological characteristic
of future studies.
More frequent activity while in bed (D/I) was related to a flattened diurnal
cortisol slope in this sample, the sole significant, independent relationship of D/I with a
primary cortisol outcome. Because D/I is a measure of activity while in bed, typically at
night, it is interesting that D/I would be related to the diurnal decrease in cortisol. Due to
their proximity to getting into and out of bed, it might be expected that bedtime cortisol
or CAR variables would be more strongly associated with D/I. Due to the small sample
size of this study, relationships of D/I with CAR and bedtime cortisol cannot be
discounted, but they were not evident in the current sample.
The relationship of D/I to the diurnal cortisol slope is interpretable in that they are
both taken to be indicators of circadian disruption. It is interesting to note that inactivity
while out of bed (D/O) was also related to a flattened diurnal cortisol slope, meaning all
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of the actigraphy measures of circadian rhythms were related, in the expected direction,
to the diurnal cortisol slope. This lends further support to the comparability of these two
measures and the utility of the diurnal cortisol slope in characterizing circadian rhythms.
While abnormality in a given measure of circadian rhythmicity is noteworthy, weak
circadian rhythms would theoretically be expected to be evident in disrupted rhythmicity
throughout the day. The relationship between the diurnal cortisol slope and an overnight
measure of circadian disruption (D/I) is consistent with the idea of a stable circadian
rhythm, rather then transitory disruptions. Based on the robust relationship of the diurnal
cortisol slope with measures of circadian disruption obtained using a different modality,
actigraphy in this study, it is hypothesized that the diurnal cortisol slope would be related
to other indicators of circadian rhythmicity such as body temperature and brain wave
activity.
A higher D/O was also associated with higher bedtime cortisol levels. It is
noteworthy that frequent inactivity while out of bed is related to increased cortisol levels
in the bedtime. It might be expected that increased availability of glucose would be
related more activity, so this relationship is in need of further exploration. Conceptualized
from the perspective of circadian rhythms, inactivity during the day and elevated bedtime
cortisol levels are consistent with circadian disruption. In this case, circadian disruption
offers an explanation for a relationship that is otherwise counterintuitive, suggesting that
circadian rhythms are an important tool in understanding activity and physiology in
patients with breast cancer.
Finally, a higher D/O was related to a steeper morning cortisol slope. It is
interesting to note that frequent inactivity while out of bed is correlated with increased
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cortisol availability in saliva in the morning, similar to the results observed between D/O
and the bedtime cortisol level. A stronger CAR might otherwise be interpreted as a
mobilization of physiological resources for daytime activity, but these patients ultimately
exhibited decreased activity as indicated by the D/O. This could be explained by the
absence of a pre-awakening cortisol rise in patients with disrupted circadian rhythms, and
that a subsequent spike in post-awakening cortisol secretion was then observed.It is
possible that psychological states, such as stress appraisals, could have elevated cortisol
levels in the morning, though the intrusions measure employed in this study was not
related to the CAR measures. It is reasonable to hypothesize that future studies measuring
stress perceptions or additional measures of distress might find a relationship between
psychological states and the CAR in women with breast cancer. As with other
associations between measures of circadian disruption, the correlation between D/O and
the morning cortisol slope could be explained by their conceptual link as measures of
circadian rhythms.
Findings of a relationship between actigraphy and cortisol measures of circadian
rhythmicity are consistent with a study of patients with metastatic colorectal cancer
noting that patients within the upper quartile of the rest/activity autocorrelation had a
higher ratio of 8 a.m. to 4 p.m. serum cortisol samples than patients in the lower quartile
of the rest/activity autocorrelation (Rich et al., 2005). Similar to the results presented in
the current study, patients in the Rich et al., (2005) study also exhibited no relationship
between the autocorrelation and mean diurnal cortisol levels. The rest/activity
autocorrelation was also related to the difference between 8 a.m. and 4 p.m. serum
cortisol levels in a previous report on this sample of patients with metastatic colorectal
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cancer patients (Mormont et al., 2000). Similarities in the findings of the current study
and that of Rich et al. (2005) are noteworthy because of significant differences in
methods, including serum vs. salivary cortisol assessment, different calculations of the
cortisol rhythm, and differences in cancer site and timing within the disease course.
Overall, the data presented in this study support the conceptualization of these
two measures as circadian rhythms. Nevertheless, correlations between these two
measures were typically moderate, suggesting that while there is considerable conceptual
overlap between the two measures, they also provide unique data when used
concurrently.

Secondary Analyses
To further the aim of hypothesis generation that is essential to exploratory data
analysis, secondary analyses were conducted. These analyses explored additional
relationships among major study variables.

Sleep Outcomes
Sleep variables calculated from rest/activity data were examined as outcomes with
the same analysis plan as that used for the examination of other circadian rhythm
variables for hypothesis 1a. Sleep is a process characterized by the lack of consciousness,
presenting an obvious barrier to self-report as an assessment method. Consequently, the
availability of an alternative measure of sleep through actigraphy is valuable.
Intrusions were not significantly associated with sleep outcomes in any of the
regression models employed. This result contradicts recent research suggesting a
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significant relationship between the distress associated with breast cancer and sleep
disturbance in women receiving chemotherapy (Roscoe et al., 2007) and in another
sample of women with metastatic breast cancer (Palesh et al., 2007). However, caution is
merited due to the small sample size. While intrusions were not related to sleep
disturbance in this sample, other measures of distress may influence sleep, including
depression (Palesh et al., 2007). In addition, the sample from the current study was not
receiving treatment and most of the patients did not have metastatic disease. It is possible
that these factors in particular accounted for the sleep disturbance observed in previous
studies of women with breast cancer and explain the absence of findings in the current
study.
Each morning, participants completed a questionnaire assessing the prior night’s
sleep and actiwatch removals. The final question invited participants to provide
qualitative data on their sleep, and stated “do you have any other comments regarding last
night’s sleep”. Selected comments regarding the cancer diagnosis and sleep are presented
below.
“I couldn't stop thinking - so much was taking in a day and still not understanding if there
will be a tomorrow”
“nightmares about dying”
“first time to dream about cancer”
“just before sleep is when I have a deep sense of facing my mortality and dealing with the
prospect of physical pain to come”
“Kept coughing, had to get up and get drink. Kept worrying about that. Mind started
racing that cancer had spread to lungs”
“Dreamed about reading to make decision on type of cancer surgery”
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Qualitative data provide detailed self-reports regarding sleep. The statements
about intrusions regarding the diagnosis and treatment of breast cancer that appear
immediately prior to sleep suggest that these are relevant to the intrusions construct and
that it is important to include items that discuss sleep in the 7-item version of the IES
intrusions scale, as opposed to the 5-item version suggested by a more recent factor
analysis (Witteveen, 2006). In addition to breast cancer-related thoughts and dreams,
other life stressors and dreams were reported in response to the question about the prior
night’s sleep. It is important to keep in mind that although a diagnosis of breast cancer is
often a source of significant distress, pre-existing and co-occurring life stressors certainly
contribute to elevated distress. These sources of distress were not targeted by the
intrusions measure employed in this study. It follows that the absence of a significant
relationship between intrusions and sleep in this study does not rule out the possibility
that general distress was related to sleep disturbance in these patients.

Direct Effects of Avoidant Coping on Circadian Disruption
The transactional model of stress, coping, and adaptation allows for a number of
relationships among these variables (Lazarus, 2000), so avoidant coping was investigated
as a predictor of circadian disruption in an exploratory analysis. The analytical approach
for the evaluation of avoidant coping was similar to the one employed in the evaluation
of intrusions as a predictor in hypothesis 1a. In addition to the summary score for
avoidant coping, the self-distraction, denial, and behavioral disengagement subscales of
the avoidant coping measure were investigated as predictors of circadian disruption.
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The summary avoidant coping score was related to a lower autocorrelation, an
indication of circadian disruption. In follow-up analyses of the avoidant coping subscales,
only behavioral disengagement was significantly and independently related to the
autocorrelation, suggesting behavioral manifestations of avoidance have the most direct
influence on disruptions in the circadian activity rhythms. This finding is intuitive in that
activity levels are a behavioral variable as well, but the items of the behavioral
disengagement scale of the brief COPE does not refer to inactivity specifically. Rather,
the items refer to “giving up trying to deal with it” and “giving up the attempt to cope”,
which could possibly be interpreted as giving up cognitive and emotional coping efforts
in addition to behavioral efforts.
Avoidant coping is often characterized as a maladaptive way of coping with a
stressor, but it could alternatively be conceptualized as an adaptive means of maintaining
a life that is as normal as possible in spite of the stressor. This might be especially useful
over a short period of time. In the current sample, this did not appear to be the case, as
avoidant coping was related to disrupted rest/activity rhythms, suggesting that avoidant
coping failed to eliminate the stressor from awareness or failed to ameliorate the effects
of the stressor in terms of circadian rhythmicity. This informs models of avoidant coping
and contributes to a substantial literature linking avoidant coping with undesirable
outcomes. If further research supports the conceptualization of avoidant coping as
predictive of circadian disruption and other clinically relevant adverse outcomes, coping
techniques such as distraction could be viewed as potentially problematic, even during
short-term efforts to cope with a breast cancer diagnosis. Results suggesting avoidant
coping has an effect on a measure of circadian rhythmicity support conceptualization of
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influences of avoidant coping on circadian disruption, as opposed to models proposing
avoidant coping as a moderator of the effects of stress or intrusions on circadian
disruption.
In the model testing avoidant coping as a moderator of the association of
intrusions with the rest/activity autocorrelation, the mean-centered avoidant coping
variable entered as a covariate on the first step was significantly related to the
rest/activity autocorrelation. This is consistent with the significant association of avoidant
coping with a lower rest/activity autocorrelation observed in secondary analyses.
Avoidant coping was also related to more frequent high activity levels during time
spent in bed (D/I). Subsequent analyses of individual subscales of the COPE revealed that
the denial and behavioral disengagement subscales of this measure were related to
circadian disruption indicated by D/I, but the self-distraction subscale was not. While
avoidant coping was related to high activity levels in the time spent in bed, it is surprising
that avoidant coping was not related to sleep variables in this sample. Consistent with the
interpretations of other similar findings in this dataset, this finding may be taken as
support for the distinction between general circadian disruption and sleep, which
accounts for part of the circadian rhythm.
Although many of the analyses exploring relationships between avoidant coping
and circadian disruption did not result in significant, independent associations, no
analyses revealed a relationship between avoidant coping and improved circadian
rhythmicity. It follows that this study’s results suggest any link between avoidant coping
and circadian disruption is limited, but negative to the extent that a relationship exists.
There are several possible clinical implications of these results. Primarily, they are
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consistent with the idea of offering psychological treatment, emotional support, and
medical and psychosocial information. It is likely ill-advised to restrict a patient’s
autonomy by pressuring the patient to adopt a given view or coping style, but promoting
awareness of available resources might encourage engagement of the stressor without
carrying a negative connotation for the patient. Fears about interfering with avoidant
coping strategies that are successful for short-term coping are not furthered by the results
of the current study. In addition, within the limits of the circadian disruption outcome
investigated by this study, increased availability of outlets for expression, overt
discussion of matters related to the breast cancer diagnosis, and treatment of distress
makes sense in terms of health care policy.
Although there were no other analyses revealing an association of the summary
avoidant coping score with measures of circadian disruption that was independent of the
covariates in this study, additional analyses explored relationships of avoidant coping
subscales with circadian disruption. Elevation of the self-distraction subscale was
independently related to an increase in a secondary cortisol outcome, the area under the
awakening cortisol curve, a finding that was not observed with either of the other two
avoidant coping subscales. This finding remained when awakening values estimated
using linear modeling were included. Perhaps not coincidentally, elevation of the selfdistraction subscale was also independently related to a higher awakening cortisol level.
This finding was also not altered by the inclusion of estimated awakening values.
In considering the CAR, the pattern of findings observed with self-distraction
offers further insight. Because the area under the awakening cortisol curve includes the
awakening and 30 minute post-awakening values, an elevated awakening cortisol value
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has a heavy influence on the area under the awakening cortisol curve, even if the postawakening increase is not dramatic. The lack of a significant, independent relationship
between self-distraction and the other two CAR measures, slope and % increase, suggests
that the increased area under the awakening curve was primarily driven by elevated
awakening values. As a result, it is not hypothesized that self-distraction would be related
to CAR in future studies of women with breast cancer studied between the times of
diagnosis and initiation of treatment. However, relationships with the awakening cortisol
level would be hypothesized to be evident. Because the interpretation of the CAR as it
relates to self-distraction is not straightforward, it would be interesting to note the
longitudinal effects of an elevated awakening cortisol level during the post-diagnostic
period. A study designed to test whether post-diagnostic awakening cortisol levels are
predictive of subsequent indicators of circadian disruption would be useful in clarifying
the interpretation of awakening cortisol levels in women with breast cancer. Until studies
like these are conducted, the clinical implications of this finding are unclear.
The denial and behavioral disengagement subscale of the avoidant coping
measure were independently related to increased D/O, meaning these patients exhibited
more time out of bed in which activity levels fell below the median activity levels for
time in bed. This is likely an indicator of disrupted circadian activity rhythms. In support
of this inference, a higher D/O was related to cortisol measures of circadian disruption,
including a more dramatic increase in the morning cortisol slope, a flattened diurnal
cortisol slope, and elevated bedtime cortisol levels. It is perhaps unsurprising that selfdistraction was not related to daytime inactivity, as self-distraction is consistent with
activity during waking hours that might occupy the patient and divert attention from
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reminders of breast cancer. It is possible that patients attempt to avoid reminders of breast
cancer by restricting activities that might bring them into contact with other people who
might ask about their health condition or experience reduced enjoyment of activities due
to distress, especially cancer-related intrusions. It is hypothesized that these factors would
be evident in studies designed to assess them. This finding may offer preliminary support
for interventions increasing exercised for women with breast cancer, as daytime activity
could be particularly sensitive to avoidant coping in response to the cancer diagnosis.
In terms of sleep outcomes, a model of denial as a predictor of decreased nightly
sleep. Additionally, behavioral disengagement was related to increased time spent awake
after sleep onset. It is possible that cognitive avoidance strategies are more difficult to
enact when patients try to go to sleep because their attention is not taken up by other
activities. Consistent with findings in other analyses from this study, psychosocial factors
appeared to be more strongly related to circadian rhythms generally, as opposed to sleep
specifically. To the extent that denial is related to nightly sleep, ready availability of
resources and treatments that encourage engagement of stressors and expression
regarding the diagnosis of breast cancer may be supported. Brief behavioral treatments
and medications for addressing sleep problems are available, and these treatments may
promote improved circadian rhythmicity. Future research could utilize ecological
momentary assessment or brief questionnaires in the morning to assess the content of
thoughts experienced by women with breast cancer as they go to bed. It is hypothesized
that attempts to avoid or deny the presence of breast cancer would be linked with sleep
disruption.
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In modeling the variables studied, the cross-sectional nature of the study inhibits
causal inferences. Therefore, relationships between avoidant coping and circadian
disruption may both be caused by a third variable not included in analyses. The
pathophysiological processes associated with cancer are one possibility. This potential
confound was addressed by including cancer stage as a covariate in analyses.
Nevertheless, cancer stage as an estimate of disease severity may not fully capture the
physiological processes affecting psychosocial variables such as intrusions and avoidant
coping as well as circadian variables as indicated by actigraphy and cortisol. This study
also emphasized generalizability in applying relatively few exclusion criteria. However,
future studies might consider eliminating other potential confounds such as substance
abuse problems and psychological and medical diagnoses by conducting diagnostic
interviews or controlling for them statistically.
Longitudinal studies that begin at the time of initial breast cancer screening, such
as at the time of the mammogram, could track avoidant coping and circadian disruption
over time and contribute to understanding of whether avoidant coping precedes the
development of circadian disruption or speak to the possibility of the opposite temporal
relationship.

Secondary Cortisol Outcomes
In testing secondary cortisol outcomes, the seven item versions of the intrusions
subscale of the IES predicted increased CAR %. Ambiguities in CAR interpretation
reviewed above do not permit strong conclusions to be draw from this finding. In
addition, when awakening values estimated using linear modeling replaced values that
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were missing due to nonadherence to the protocol, intrusions were not related to CAR %.
Finally, no other CAR outcomes were significantly and independently associated with
intrusions. Despite these limits, a relationship between intrusions and a higher CAR % is
consistent with an interpretation of a more dramatic CAR as an indicator of distress.
Given the association of psychosocial stressors, including PTSD, with a diminished CAR,
it is certainly possible that an increased CAR indicates a healthy response of the HPA
axis. At this point, it seems reasonable to hypothesize that the CAR would be interpreted
differently depending on sample and situational characteristics.
Aside from interpretation issues, it is noteworthy that previous research has
reported a relationship between PTSD and a diminished CAR (Rohleder, Joksimovic,
Wolf, & Kirschbaum, 2004). It should be noted that intrusions are only one part of PTSD,
so elevated intrusions can not be equated with PTSD. This distinction is especially
relevant to the current sample, in which participants provided data shortly after being
confronted with the stressor of being diagnosed with breast cancer. As a result, the
observed results are in line with expectations. It is possible that the heightened cortisol in
response to awakening associated with cancer-specific intrusions in this study were part
of responsivity in the acute phase of coping with a stressor.
In repeats of hypothesis 2 using secondary cortisol outcomes, an elevated
rest/activity autocorrelation was related to increased area under the awakening cortisol
curve, but only when estimated awakening cortisol values were included in the
calculation. Cautious interpretation of this finding is needed because it was only observed
with estimated awakening values included. In this analysis, a more exaggerated CAR is
related to a measure indicating increased circadian rhythmicity, adding to the difficulty
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interpreting CAR findings. Longitudinal investigations into the outcomes predicted by
CAR variables would improve the interpretability of these results. Longitudinal studies
could also note relationships of CAR variables with other indicators of circadian rhythms
over time.
A higher rest/activity autocorrelation was related to a steeper diurnal cortisol
decline with estimated awakening values included. This is consistent with a finding
linking these two variables in hypotheses two analyses with no estimated awakening
values. An increased D/O, meaning more frequent inactivity during the day, was related
to a flatter diurnal cortisol slope with estimated awakening values included. This was also
consistent with results obtained in testing of primary cortisol outcomes in hypothesis two
analyses. These findings add to the robustness of the relationships between these
variables but do not alter the interpretation.

Cortisol and Sleep
Secondary analyses of the association between cortisol and sleep revealed no
significant, independent associations of circadian cortisol variables and sleep outcomes.
Because sleep is a component of circadian rhythms, it is surprising that circadian cortisol
variables and sleep outcomes would not be related more strongly. However, because type
II error is a clear possibility in a small sample, retention of the null hypothesis is in need
of cautious interpretation. It is hypothesized that in larger data sets, relationships among
more of the measures of circadian rhythms would be observed, based on their overt
conceptual links. Still, other interpretations are possible. There is a meaningful distinction
between 24-hour rhythms and sleep. Disrupted circadian rhythms may not ultimately
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manifest in sleep disturbance. The SCN is crucial in the regulation of circadian rhythms,
but sleep outcomes are influenced by a number of other variables, ranging from
behavioral variables targeted by sleep hygiene interventions to physiological variables
such as melatonin secretion.

Depression as a Potential Confound
The final of the secondary analyses sought to determine whether the effects of
depression influenced results obtained in previous analyses. Patients were removed from
analysis based on elevated scores on the depression subscale of the POMS, and
procedures employed in hypothesis 1a were repeated. No significant relationships
emerged from these analyses, possibly because the elimination of eight additional
participants limited the statistical power of an already small sample. Nevertheless, no
support was found for the notion that depression masked relationships in previous
analyses.

Strengths and Limitations
Multiple Measures of Circadian Disruption
Data collection for this study allowed for extensive analysis of two measures of
circadian disruption. Measures of physiological rhythms and activity rhythms, as well as
sleep assessment that did not rely on self-reported sleep, yielded interesting and
surprising results. Detailed analysis of multiple measures of circadian disruption sheds
some light on previous studies using different measures. Circadian disruption has been
predictive of cancer survival in two studies, but circadian rhythms have been measured
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with the diurnal cortisol slope (Sephton et al., 2000) and the 24-hour rest/actigraphy
autocorrelation yielded by actigraphy (Mormont et al., 2000). This is of particular interest
in cancer patients because circadian disruption can take many forms in this population
and increases with advanced illness. As a result, different measurement modalities may
be needed to fully capture the circadian disruption in cancer patients, and multiple types
of circadian disruption may need to be assessed.
Although it would be reasonable to speculate that measures of circadian
disruption would be associated, this hypothesis has not previously been formally tested.
As a result, the degree of concordance of these two findings in cancer patients, for whom
extensive dysregulation of circadian rhythms is evident, was unknown. Results from this
study indicate that these measures are related and in the expected direction. In light of
this finding, the idea that circadian disruption is a conceptual variable linking the diurnal
cortisol slope and rest/activity rhythm is supported. Circadian disruption can reasonably
be proposed as predictive of survival in two studies of patients with cancer.

Data on Homogeneous Group of Women
Generalization from these data are limited by the homogeneity of the sample in
that all participants were diagnosed with breast cancer of various stages and were
between the time of diagnosis and the initiation of treatment. These results may not
generalize to patients during the diagnostic testing, treatment, or post-treatment remission
phases of cancer. Results may have also have limited applicability to men and patients
suffering from cancer at other bodily sites. There was substantial diversity in race within
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this sample, as only 55% of the sample was Caucasian, so generalizability of results is
not expected to be limited to one racial group.
The common timing with respect to diagnosis, in particular, is not frequently seen
in studies of psychosocial aspects of patients’ experience of cancer. Because reactions to
cancer are likely to vary over time, patient similarities in the course of diagnosis and
treatment reduce variance in the illness as a stressor for participants in this study.
However, the stressors that patients are experiencing at the time of diagnosis, or that
confront patients during data collection, could not be held constant and likely influence
patients’ stress levels, intrusions, and possibly circadian rhythms.
Patients that enrolled in this study had recently been diagnosed with cancer and
were anticipating treatment. Many were likely considering several treatment options and
experiencing significant time constraints. As a result, coping, intrusions, and activity
rhythms were expected to change rapidly. Because of these features of the sample,
multiple assessments were deemed worthwhile to increase the reliability of self-report
variables, a practice that is commonly employed in assessments of circadian cortisol
rhythms. The collection of daily self-reports also promoted concordance among the spans
of time over which data were collected for cortisol, actigraphy, and self-report data.
While daily assessments are appealing from a conceptual perspective, results may have
limited generalizability to trait-oriented measures of intrusions and coping.

Sample Size
Collection of detailed data in a specific sample within a brief time window has the
potential to limit accrual. In this study, a total of 44 participants enrolled and provided
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enough data to be included in some analyses. Possibly due to the demands of being
recently diagnosed with cancer, complete data could not be collected for all participants.
The saliva samples that were missing, insufficient for assay, or collected outside the
specified time window presented a threat to validity to the extent that they might have
been missing in a nonrandom pattern. Analyses attempted to adjust for this problem by
controlling for the number of missing samples with the diurnal slope or bedtime cortisol
level as an outcome because the number of missing samples was correlated with these
outcomes.
While the sample size was expected to provide sufficient statistical power to
detect the effects proposed for primary analyses, the sample size was relatively small.
This small sample size likely limited the ability of this study to detect effect sizes in some
of the secondary analyses. The limits of a small sample size were ameliorated somewhat
because the study was exploratory in nature in an effort to capitalize on the rich data
provided by patients who participated in this study. None of the results from this study
are intended to present confirmatory conclusions regarding population relationships
among study variables. Relationships that were not statistically significant in this analysis
should not be discounted. The small sample size should also be considered in evaluating
relationships that were not statistically significant.

Comments and Implications
Because this was an exploratory study, the results observed do not determine
whether the relationships exist, but rather indicate the types of relationships that are
particularly interesting for more focused, confirmatory studies. Daily assessments of
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intrusions and avoidant coping prompted participants to tie responses to the experience of
having breast cancer, meaning the effects of psychosocial variables on circiadian
disruption are conceptually tied to the stress of breast cancer diagnosis specifically. Daily
psychosocial assessments at the same time as physiological and activity data collection
also allowed for increased reliability through multiple assessments.
Actigraphy and cortisol measures of circadian rhythmicity are likely to provide
unique variance simply as a function of the mode of assessment. While actigraphy
assesses rest/activity behavior, cortisol provides information on physiological rhythms.
They might also be expected to be distinct because cortisol rhythms are so responsive to
the regulation of the SCN. Rest/activity rhythms are almost certainly influenced by the
SCN, but they are also likely to be more responsive to fluctuations in daily occupational,
social, and recreation routines. It was interesting to note that a relationship between
circadian cortisol rhythms and sleep was often absent in this sample, but sleep is clearly
altered if environmental factors such as noise or the availability of appealing activities is
strong. Aside from environmental factors, cognitions often alter sleep outcomes, as well
as rest/activity pattern. Perhaps biofeedback could allow someone to learn to exert a
degree of conscious influence on cortisol secretion, but sleep can reliably be intentionally
delayed, and an individual can transition from rest to activity almost effortlessly. In this
way, it makes sense to conceptualize rest/activity circadian rhythms as being influenced
by a fairly balanced contribution of endogenous, exogenous, and psychological factors.
In contrast, circadian cortisol rhythms, while certainly influenced by exogenous and
psychological factors, are more often determined by endogenous rhythms.
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The unique variance in circadian rhythms provided by dual assessment of
actigraphy and cortisol is clearly useful in a study of primarily circadian rhythms, but
these measures may be differentially effective depending on the aim of the study. For
instance, a study of the influence of rhythms on cancer incidence or survival might favor
collection of cortisol rhythms if only one measure of circadian rhythmicity could be
completed, as cortisol is expected to be more closely linked with biology. However, a
study of the influence of psychological or behavioral variables on circadian disruption
might favor the use of actigraphy as a measure of circadian rhythms because rest/activity
patterns are expected to be more closely related to psychosocial variables.
There are also clinical reasons for determining which circadian rhythm measure to
use if only one can be chosen. The study of rest/activity rhythms could be more useful in
the context of psychosocial interventions because these rhythms could be directly
addressed by cognitive-behavioral interventions. These could include established
interventions targeting behavioral activation and sleep hygiene treatments, as well as
other interventions that could easily be developed with the aim of producing more
reliable circadian rest/activity rhythms. Given the results of the current study, rest/activity
rhythms might be of more interest to studies of patients early in the course of disease.
Cortisol rhythms could be of interest to studies aiming to develop better medical
intervention such as chronomodulated chemotherapy or medications addressing cortisol
irregularities associated with cancer.
In speculating that psychosocial variables are more strongly related with
rest/activity rhythms and cortisol rhythms are more strongly related to biological
outcomes, a larger model can also be conceived. The disruption of circadian cortisol
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rhythms by psychosocial variables may be mediated by rest/activity rhythm disruption.
The results from the current study are consistent with this conceptualization, as intrusions
were related to disrupted rest/activity rhythms, but few relationships with disrupted
cortisol rhythms were observed. As this study included only women who had been
recently diagnosed with breast cancer, perhaps disruption of the cortisol rhythm would be
present only after prolonged exposure to abnormal rest/activity patterns.
The reason rest/activity rhythms might influence subsequent disruption of
circadian cortisol rhythms is not known, but several possibilities exist. One possibility is
that the body might adjust to disrupted rest/activity rhythms with less pronounced
physiological rhythms as a means of adaptation to environmental demands. Strong
circadian cortisol rhythms are less useful if physiological resources are not reliably
needed at specific times of the day, but are rather needed sporadically throughout the day
and night. Another possibility is suggested by epidemiological studies of cancer
incidence in people working third shifts. Decreased melatonin secretion has often been
proposed as a mechanism for this effect because melatonin suppresses estrogen and
increased exposure to estrogen is a risk factor for breast cancer. People who work third
shift are exposed to light at night more often than people who sleep at night, and this light
inhibits secretion of melatonin. Similarly, people with disrupted rest/activity rhythms
would not be expected to be inactive or sleep at night as regularly as most people and
could have increased exposure to light. Disruption of melatonin secretion rhythms likely
alters other biological circadian rhythms, including cortisol. These relationships are
worthy of further study. It would be interesting to follow patients longitudinally to
determine whether the initial disruption of activity rhythms is related to subsequent
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disruption of circadian cortisol rhythms that were not observed in the period immediately
after diagnosis. Such a study would extend the findings of the current study and inform a
more complete model of relationships between psychosocial variables and circadian
disruption.
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Contributors
A number of people contributed to this study. Contributors are listed in Table 17
below, with their roles briefly described. Patients were enrolled in this study by Eric
Dedert (17), Elizabeth Lush (15), Meagan Martin (11), and Patrick Rhodes (2). Numbers
in parentheses indicate the number of patients included in some primary analyse who
were enrolled by each researcher.

Table 16. Study personnel and roles on the current project.

Study Personnel:
Name
Sandra Sephton,
Ph.D.
Anees Chagpar,
M.D., M.Sc.

Title
Associate Professor

Paul Salmon,
Ph.D.
Jamie Studts,
Ph.D.
Eric Dedert, M.A.

Associate Professor

Graduate Student

Psychological &
Brain Sciences

Elizabeth Lush

Graduate Student

Project Director

Kelly McMasters,
M.D., Ph.D.
Meagan Martin

Professor and Chair

Psychological &
Brain Sciences
Surgery

Graduate Student

Assistant

Patrick Rhodes

Graduate Student

Robyn McLean,
M.S.

Laboratory
Technologist

Psychological &
Brain Sciences
Psychological &
Brain Sciences
Psychological &
Brain Sciences

Assistant Professor

Associate Professor
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Department
Psychological &
Brain Sciences
Medicine, Surgery

Psychological &
Brain Sciences
Behavioral Science

Role on Project
Principal Investigator
Co-Principal
Investigator,
Referring Physician
Co-Principal
Investigator
Co-Principal
Investigator
Project Director

Referring Physician

Assistant
Saliva Assays

Name
Ehab Dayyat,
M.D.
Andrea Floyd,
M.A.
Jesse Thornton

Title
Postdoctoral
Fellow
Graduate Student
Graduate Student

Amanda Mattingly Honors Student
Jennifer Wrubel

Honors Student

Steven Kniffley

Honors Student
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Department
Pediatrics

Role on Project
Actigraphy
Consultant
Psychological & Brain Assistant
Sciences
Spalding University
Assistant
Psychology
Department
Psychological & Brain Assistant
Sciences
Psychological & Brain Assistant
Sciences
Psychological & Brain Assistant
Sciences
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Instructions
Please read this the evening before you begin data collection
Thank you for providing saliva samples and activity data for three full days. We
appreciate your careful attention to the details necessary for good data collection in this
study! This set of instructions will guide you through each part of the study over the next
three days. If you have any questions or difficulties, please call the study Project Director
Elizabeth Lush: (502) 298-4561.
NOTE: If you have any bleeding in your mouth you should wait until after it heals to
complete the study. Even a tiny amount of blood in the saliva will interfere with cortisol
measurement.
I. You received a black plastic box to store saliva samples after you complete each
collection. Please place the empty box in your refrigerator.
II. Please assemble the following items, and place them at your bedside:
♦
♦

♦

♦

This instruction packet
The white “trackcap” bottle containing cotton swabs for saliva collection.
The purpose of the trackcap is to record the exact time you collect saliva
samples. This information is needed to study your cortisol rhythm. Never
open the trackcap before you are ready to take a sample!
The small black case containing “salivettes” (tubes for holding saliva
samples)
The black “Sharpie” pen provided in the case (for you to write on the tubes).

III. During the next three days you will collect four saliva samples at set times during the
day. You will also complete questionnaires each morning just after you provide your
first saliva sample in the morning. Open the black case and take out the salivettes
labeled “day 1.” Note the labels are color coded by collection time as follows:
TIME of SAMPLE

LABEL COLOR

IMMEDIATELY after you wake up in the morning

YELLOW

EXACTLY 30 minutes after you wake up

GREEN

4 PM

GRAY

Just before going to bed

PINK

IV. Prepare to provide saliva samples for early tomorrow morning:
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♦

From the black case, take out two tubes and put them where you can easily reach
them from your bed when you first wake up in the morning:
Day 1: WAKING (yellow)
Day 1: 30 minutes after awakening (green)

♦

Set out the white “trackcap” bottle containing cotton swabs for saliva collection.

♦

Take out the marking pen and set it next to the tubes.

V. Please wear the actiwatch all the time during the next three days and nights---except
when showering, bathing, swimming, or doing anything else that would immerse the
watch in water (it is NOT waterproof!). Please note the time you remove the watch
and the time you put it back on. The watch will continuously record your level of
physical activity, providing data used to measure your sleep-wake rhythms.
If you are not wearing the actiwatch, please put it on your
non-dominant wrist now

COLLECTING SALIVA SAMPLES
VI. How to collect saliva samples:
♦

Open the “trackcap” bottle. Remove one cotton swab. Close the cap again, tightly.

♦

Place swab in your mouth and gently move it around with your tongue to soak up
saliva. Keep the cotton in your mouth until it feels full like a wet sponge. This
usually takes a minute or two, but can take longer. If you have trouble getting
enough saliva, try imagining the smell of a lemon.

♦

While the cotton is in your mouth, use the black “Sharpie” pen to write the date,
your ID number and the exact time on the correct salivette tube. Please record the
time to the minute (e.g., 5:06). Circle “AM” or “PM” accordingly.

♦

When the cotton swab feels full of saliva, open the salivette. Spit the cotton swab
into the small plastic holder that rests inside the tube, and cap the tube very tightly
again.

♦

Place the salivette in the black plastic box in your refrigerator. Sometimes it may be
inconvenient to immediately refrigerate your sample. For example, if you are away
from home when you take the 4 pm sample you may refrigerate it later that evening.
Samples should not be left out for more than a day.

VII.

When to collect saliva samples:
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Waking sample. For the next three mornings, the moment you wake up in the morning—
when you are ready to arise for the day—provide the “WAKING (yellow) sample. After
you collect this sample you may get out of bed and continue your usual routine for the
next 30 minutes.
NOTE: Please do not eat, drink, brush teeth, use mouthwash, chew gum, or smoke for
30 minutes before providing any saliva sample. These things can interfere with the
measurement. Please do not put anything in your mouth until after you have completed
the waking sample, the short questionnaire, and the 30 minutes post-waking sample.
30 Minutes after Waking. Exactly 30 minutes after waking—please provide the 30
minute (green) sample each morning.
4 p.m. At 4p.m. each day, please provide the (gray) sample.
Bedtime. Just before going to bed each night, please provide the (pink) sample. You
should give your first bedtime sample tomorrow evening.

Are you ready to begin?

♦

Plan to note the exact times you remove and the activity watch to shower or bathe as
well as the exact times you get into bed and begin trying to fall asleep. We’ll need to
know both the time you take it off and the time you put it back on, to the minute.
Please record this information, along with any problems during saliva collection, in
the Saliva and Activity Watch Log (located at the end of this packet).

♦

Plan on completing the Daily Questionnaires and Cortisol Questionnaire just after
you provide your first saliva sample in the morning.
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If you have any questions please do not hesitate to call us:
Study Telephone Number: 852-5562

Elizabeth Lush Telephone Number: 298-4561
If we are not available, please leave a message and we will call you back as soon as
possible.
Thank you very much!
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YOUR SALIVA AND ACTIVITY WATCH DATA
SALIVA SAMPLES
Please provide saliva samples when you wake in the morning (#1 in
the figure below), 30 minutes after waking (#2), at 4 pm (#3), and at
bedtime (#4) on three consecutive days. We will measure the levels of
the stress hormone, cortisol, in these samples. The graph below shows
the usual daily rhythm of cortisol, which may be disrupted by stress,
illness, sleep disruption, diet and exercise.
ACTIVITY WATCH
Please wear the “actigraph” on your wrist during the three day period
that you provide saliva samples. This device records physical
movement to characterize your sleep-wake rhythm. The black and
green graph below shows a "normal" rest-activity pattern over a 24
hour period.
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ID _____

DATE ___/___/___

Daily Data Collection Schedule
DAY ONE
Sample 1: Awakening
___
Take your waking saliva sample immediately. Refer to Saliva Collection
Instructions.
___ Label the correct tube and place it in the plastic box in your refrigerator.
___ Your Activity Watch should still be on your wrist since it is on for 3 days,
24 hours per day. Only take the Activity Watch off during activities in which
it may be immersed in water. Record the time duration in which you take
the Activity Watch off on the Saliva and Activity Watch Log (one log for
all days located at the end of the packet).
___ Fill out the Day One Daily Questionnaires.
Sample 2: 30 minutes post-waking
___ Take your 30-minute post-waking saliva sample at EXACTLY 30 minutes
after your wake time.
___ Place the salivette fully labeled in the plastic box in your refrigerator.
Sample 3: 4:00pm
___
Take your 4:00pm saliva sample.
___
Place the salivette fully labeled in the plastic box in your refrigerator.
Sample 4: Bedtime
___
Take your Bedtime saliva sample immediately before you go to sleep.
___
Place the salivette fully labeled in the plastic box in your refrigerator.
___ Plan to note the exact times you get into bed and begin trying to fall
asleep.

IMPORTANT:
Don’t forget to let us know of any comments about saliva samples, as well as
exact times you take off your Activity Watch (temporarily) during the day on
the Saliva and Activity Watch Log sheet.
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ID _____
DATE ___/___/___
Daily Questionnaire for DAY ONE
(to be completed immediately after awakening)

Rarely

Sometimes

Often

I thought about it when I didn't mean to.
I had trouble falling asleep or staying asleep, because of pictures
of thoughts about it that came into my mind.
I had waves of strong feelings about it.
I had dreams about it.
Pictures about it popped into my mind
Other things kept making me think about it.
Any reminder brought back feelings about it.

Not at all

Below is a list of comments made by people after stressful life events. Please fill in each
item, indicating how frequently the comments were true for you YESTERDAY regarding your
diagnosis and treatment of BREAST CANCER. If they did not occur, please mark the "Not at All"
column.

0
O

1
O

2
O

3
O

O
O
O
O
O
O

O
O
O
O
O
O

O
O
O
O
O
O

O
O
O
O
O
O

I've been turning to work or other activities to take my mind off
things.
I've been saying to myself "this isn't real".
I've been giving up trying to deal with it.
I've been refusing to believe that it has happened.
I've been giving up the attempt to cope.
I've been doing something to think about it less, such as going to
movies, watching TV, reading, daydreaming, sleeping, or
shopping.
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I did this
a lot

I did this a
medium
amount

I did this
a little bit

I didn’t do
this at all

We are interested in how people respond when they confront the experience of having
breast cancer in their lives. There are lots of ways to try to deal with having breast cancer. This
questionnaire asks you to indicate what you did and felt yesterday, when you experienced
stressful events related to having breast cancer. Obviously, different events bring out somewhat
different responses, but think about what you usually did yesterday when you were under a lot of
stress related to having breast cancer.
Then respond to each of the following items by filling in one number for each, using the
response choices listed just below. Please try to respond to each item separately in your mind
from each other item. Choose your answers thoughtfully, and make your answers as true FOR
YOU as you can. Please answer every item. There are no "right" or "wrong" answers, so choose
the most accurate answer for YOU-- not what you think "most people" would say or do. Indicate
what YOU did yesterday when YOU experienced a stressful event related to having breast
cancer.

1
O

2
O

3
O

4
O

O
O
O
O

O
O
O
O

O
O
O
O

O
O
O
O

O

O

O

O

ID _____

DATE ___/___/___

ACTIVITY WATCH LOG - DAY ONE

UPON AWAKENING (Please complete as soon as possible after waking)
1. Time you got into bed last night: ___:___ am/pm (circle one)
2. Time you began trying to fall asleep: ___:___ am/pm (circle one)
3. Time you woke up for the last time this morning: ___:___ am/pm (circle
one)
4. Time you got out of bed this morning: ___:___ am/pm (circle one)

For the question below, please fill one bubble on the scale from 0 – 100
that best describes your answer. For example, if you slept just as well as you
have usually slept in the past few months, you would fill in the bubble = 50. If
worse, you would fill in 60, 70, or 80, etc.
5. How well did you sleep last night?
much better
than usual

O
0

O
10

O
20

O
30

O
40

O
50

O
60

O
70

O
80

O
90

O
100

much
worse
than usual
6. Do you have any other comments regarding last night’s sleep?
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________

Remember to take saliva samples 30 minutes after you awoke and
at 4pm this afternoon.
Please note any times you remove the activity watch.
The questionnaire continues tomorrow morning.
Have a good day!
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Daily Data Collection Schedule
DAY TWO
Sample 1: Awakening
___ Take your waking saliva sample immediately. Refer to Saliva Collection
Instructions.
___ Label the correct tube and place in the plastic box in your refrigerator.
___ Your Activity Watch should still be on your wrist since it is on for 3 days 24
hours per day. Only take the Activity Watch off during activities in which it
may be immersed in water. Record the time duration in which you take the
Activity Watch off on the Saliva and Activity Watch Log (one log for all
days located at the end of the packet).
___ Fill out the Day Two Daily Questionnaires and Cortisol Questionnaire.
Sample 2: 30 minutes post-waking
___ Take your 30-minute post-waking saliva sample at EXACTLY 30 minutes
after your wake time.
___ Place the salivette fully labeled in the plastic box in your refrigerator.
Sample 3: 4:00pm
___ Take your 4:00pm saliva sample.
___ Place the salivette fully labeled in the plastic box in your refrigerator.
Sample 4: Bedtime
___ Take your Bedtime saliva sample immediately before you go to sleep.
___ Place the salivette fully labeled in the plastic box in your refrigerator.
___ Plan to note the exact times you get into bed and begin trying to fall
asleep.

IMPORTANT:
Don’t forget to let us know of any comments about saliva samples, as well as
exact times you take off your Activity Watch (temporarily) during the day on
the Saliva and Activity Watch Log sheet.
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ID _____
DATE ___/___/___
Daily Questionnaire for DAY TWO
(to be completed immediately after awakening)

Rarely

Sometimes

Often

I thought about it when I didn't mean to.
I had trouble falling asleep or staying asleep, because of pictures
of thoughts about it that came into my mind.
I had waves of strong feelings about it.
I had dreams about it.
Pictures about it popped into my mind
Other things kept making me think about it.
Any reminder brought back feelings about it.

Not at all

Below is a list of comments made by people after stressful life events. Please fill in each
item, indicating how frequently the comments were true for you YESTERDAY regarding your
diagnosis and treatment of BREAST CANCER. If they did not occur, please mark the "Not at All"
column.

0
O

1
O

2
O

3
O

O
O
O
O
O
O

O
O
O
O
O
O

O
O
O
O
O
O

O
O
O
O
O
O
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I did this
a little bit

I did this
a medium
amount

I did this
a lot

I've been turning to work or other activities to take my
mind off things.
I've been saying to myself "this isn't real".
I've been giving up trying to deal with it.
I've been refusing to believe that it has happened.
I've been giving up the attempt to cope.
I've been doing something to think about it less, such as
going to movies, watching TV, reading, daydreaming,
sleeping, or shopping.

I didn’t do
this at all

We are interested in how people respond when they confront the experience of having
breast cancer in their lives. There are lots of ways to try to deal with having breast cancer. This
questionnaire asks you to indicate what you did and felt yesterday, when you experienced
stressful events related to having breast cancer. Obviously, different events bring out somewhat
different responses, but think about what you did yesterday when you were under a lot of stress
related to having breast cancer.
Then respond to each of the following items by filling in one number for each, using the
response choices listed just below. Please try to respond to each item separately in your mind
from each other item. Choose your answers thoughtfully, and make your answers as true FOR
YOU as you can. Please answer every item. There are no "right" or "wrong" answers, so choose
the most accurate answer for YOU-- not what you think "most people" would say or do. Indicate
what YOU did yesterday when YOU experienced a stressful event related to having breast
cancer.

1
O

2
O

3
O

4
O

O
O
O
O

O
O
O
O

O
O
O
O

O
O
O
O

O

O

O

O

ID _____

DATE ___/___/___

ACTIVITY WATCH LOG - DAY TWO

UPON AWAKENING (Please complete as soon as possible after waking)
1. Time you got into bed last night: ___:___ am/pm (circle one)
2. Time you began trying to fall asleep: ___:___ am/pm (circle one)
3. Time you woke up for the last time this morning: ___:___ am/pm (circle
one)
4. Time you got out of bed this morning: ___:___ am/pm (circle one)
For the question below, please fill one bubble on the scale from 0 – 100
that best describes your answer. For example, if you slept just as well as you
have usually slept in the past few months, you would fill in the bubble = 50. If
worse, you would fill in 60, 70, or 80, etc.
5. How well did you sleep last night?
much O O
better 0 10
than
usual

O
20

O
30

O
40

O
50

O
60

O
70

O
80

O
90

O
100

much
worse
than
usual

6. Do you have any other comments regarding last night’s sleep?
______________________________________________________________
______________________________________________________________
______________________________________________________________

Please continue to the next page
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ID _____

DATE ___/___/___

Cortisol Questionnaire for DAY TWO
(to be completed immediately after awakening)
Please choose the number that best describes your experience or
activities yesterday. Please answer by comparing yesterday with “your average
day” over the last few months. Rate your experience yesterday by filling in a
bubble from 0 – 100 on the scale below each statement. For example, for
question 1 if you were just about as physically active yesterday as you have
usually been in the past few months, you would fill in the bubble = 50. If you
exercised more than usual, you would fill in 60, 70, or 80, etc.
1. How much physical activity or exercise did you have yesterday?
O
O
O
O
O
O
O
O
O
O
much less O
physically 0
10 20 30 40 50 60 70 80 90 100
active than
usual
2. If you exercised yesterday, please fill in the following:
a) Exercise activity (e.g., walking, running, etc.) ____________________
b) Duration ___________ minutes
c) Level of exertion (darken one):
O HIGH
O MEDIUM
O LOW
d) Time you began to exercise (hour:minutes) _____:_____
3. How would you rate your health yesterday (how generally well you felt).
much better
than usual

O
0

O
10

O
20

O
30

O
40

O
50

O
60

O
70

O
80

O
90

O
100

O
50

O
60

O
70

O
80

O
90

O
100

4. How stressful was your day yesterday?
much less
stressful
than usual

O
0

O
10

O
20

O
30

O
40

5. If yesterday was MORE stressful than usual, what events during the day, and/or
what times of day were particularly stressful?
Event: _____________________________________________________________
Time it began to be stressful: ____:____ (hour:minutes)
Event: _____________________________________________________________
Time it began to be stressful: ____:____ (hour:minutes)

6. How much pain did you experience yesterday?
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much less
pain than
usual

O
0

O
10

O
20

O
30

O
40

O
50

O
60

O
70

O
80

O
90

O
100

O
70

O
80

O
90

O
100

7. How well did you sleep the night before last night?
much better
than usual

O
0

O
10

O
20

O
30

O
40

O
50

O
60

8. If you smoke, how many cigarettes (cigars, or pipes) did you smoke yesterday?
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T SMOKE
much less O
O
O
O
O
O
O
O
O
O
than usual 0
10 20 30 40 50 60 70 80 90

O
100

9. If you drink alcoholic beverages, how many drinks did you have yesterday?
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T DRINK ALCOHOL
much less O
O
O
O
O
O
O
O
O
O
O
than usual 0
10 20 30 40 50 60 70 80 90 100
10. If you drink caffeinated beverages, how many did you have yesterday?
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T USE CAFFEINATED
DRINKS
much less O
O
O
O
O
O
O
O
O
O
O
than usual 0
10 20 30 40 50 60 70 80 90 100
Remember to take saliva samples 30 minutes after you awoke and
at 4pm this afternoon.
Please note any times you remove the activity watch.
The questionnaire continues tomorrow morning.
Have a good day!
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Daily Data Collection Schedule
DAY THREE
Sample 1: Awakening
___
Take your waking saliva sample immediately. Refer to Saliva Collection
Instructions.
___ Label the correct tube and place it in the plastic box in your refrigerator.
___ Your Activity Watch should still be on your wrist since it is on for 3 days 24
hours per day. Only take the Activity Watch off during activities in which it
may be immersed in water. Record the time duration in which you take the
Activity Watch off on the Saliva and Activity Watch Log (one log for all
days at the end of the packet).
___ Fill out the Day Three Daily Questionnaires.
Sample 2: 30 minutes post-waking
___ Take your 30-minute post-waking saliva sample at EXACTLY 30 minutes
after your wake time.
___
Place the salivette fully labeled in the plastic box in your refrigerator.
Sample 3: 4:00pm
___
Take your 4:00pm saliva sample.
___
Place the salivette fully labeled in the plastic box in your refrigerator.
Sample 4: Bedtime
___
Take your Bedtime saliva sample immediately before you go to sleep.
___
Place the salivette fully labeled in the plastic box in your refrigerator.
___ Plan to note the exact times you get into bed and begin trying to fall
asleep.

IMPORTANT:
Don’t forget to let us know of any comments about saliva samples, as well as
exact times you take off your Activity Watch (temporarily) during the day on
the Saliva and Activity Watch Log sheet.
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ID _____
DATE ___/___/___
Daily Questionnaire for DAY THREE
(to be completed immediately after awakening)

Rarely

Sometimes

Often

I thought about it when I didn't mean to.
I had trouble falling asleep or staying asleep, because of
pictures of thoughts about it that came into my mind.
I had waves of strong feelings about it.
I had dreams about it.
Pictures about it popped into my mind
Other things kept making me think about it.
Any reminder brought back feelings about it.

Not at all

Below is a list of comments made by people after stressful life events. Please fill in each
item, indicating how frequently the comments were true for you YESTERDAY regarding your
diagnosis and treatment of BREAST CANCER. If they did not occur, please mark the "Not at All"
column.

0
O

1
O

2
O

3
O

O
O
O
O
O
O

O
O
O
O
O
O

O
O
O
O
O
O

O
O
O
O
O
O

I didn’t do
this at all

I did this
a little bit

I did this a
medium
amount

I did this
a lot

We are interested in how people respond when they confront the experience of having
breast cancer in their lives. There are lots of ways to try to deal with having breast cancer. This
questionnaire asks you to indicate what you did and felt yesterday, when you experienced
stressful events related to having breast cancer. Obviously, different events bring out somewhat
different responses, but think about what you did yesterday when you were under a lot of stress
related to having breast cancer.
Then respond to each of the following items by filling in one number for each, using the
response choices listed just below. Please try to respond to each item separately in your mind
from each other item. Choose your answers thoughtfully, and make your answers as true FOR
YOU as you can. Please answer every item. There are no "right" or "wrong" answers, so choose
the most accurate answer for YOU-- not what you think "most people" would say or do. Indicate
what YOU did yesterday when YOU experienced a stressful event related to having breast
cancer.

1

2

3

4

O

O

O

O

O

O

O

O

O
,
O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

I've been turning to work or other activities to take my mind off things.
I've been saying to myself "this isn't real".
I've been giving up trying to deal with it.
I've been refusing to believe that it has happened.
I've been giving up the attempt to cope.
I've been doing something to think about it less, such as going to movies,
watching TV, reading, daydreaming, sleeping, or shopping.
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,
ID _____

DATE ___/___/___

ACTIVITY WATCH LOG - DAY THREE
UPON AWAKENING (Please complete as soon as possible after waking)
1. Time you got into bed last night: ___:___ am/pm (circle one)
2. Time you began trying to fall asleep: ___:___ am/pm (circle one)
3. Time you woke up for the last time this morning: ___:___ am/pm (circle
one)
4. Time you got out of bed this morning: ___:___ am/pm (circle one)

For the question below, please fill one bubble on the scale from 0 – 100 that best
describes your answer. For example, if you slept just as well as you have usually
slept in the past few months, you would fill in the bubble = 50. If worse, you
would fill in 60, 70, or 80, etc.
5. How well did you sleep last night?
much better
than usual

O
0

O
10

O
20

O
30

O
40

O
50

O
60

O
70

O
80

O
90

O
100

6. Do you have any other comments regarding last night’s sleep?
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________

Please continue to the next page
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ID _____

DATE ___/___/___

Cortisol Questionnaire for DAY THREE
(to be completed immediately after awakening)
Please choose the number that best describes your experience or
activities yesterday. Please answer by comparing yesterday with “your average
day” over the last few months. Rate your experience yesterday by filling in a
bubble from 0 – 100 on the scale below each statement. For example, for
question 1 if you were just about as physically active yesterday as you have
usually been in the past few months, you would fill in the bubble = 50. If you
exercised more than usual, you would fill in 60, 70, or 80, etc.
1. How much physical activity or exercise did you have yesterday?
O
O
O
O
O
O
O
O
O
O
much less O
physically 0
10 20 30 40 50 60 70 80 90 100
active than
usual
2. If you exercised yesterday, please fill in the following:
a) Exercise activity (e.g., walking, running, etc.) _______________________
b) Duration ___________ minutes
c) Level of exertion (darken one):
O HIGH
O MEDIUM
O LOW
d) Time you began to exercise (hour:minutes) _____:_____
3. How would you rate your health yesterday (how generally well you felt).
much better
than usual

O
0

O
10

O
20

O
30

O
40

O
50

O
60

O
70

O
80

O
90

O
100

O
50

O
60

O
70

O
80

O
90

O
100

4. How stressful was your day yesterday?
much less
stressful
than usual

O
0

O
10

O
20

O
30

O
40

5. If yesterday was MORE stressful than usual, what events during the day, and/or
what times of day were particularly stressful?
Event: _____________________________________________________________
Time it began to be stressful: ____:____ (hour:minutes)
Event: _____________________________________________________________
Time it began to be stressful: ____:____ (hour:minutes)

6. How much pain did you experience yesterday?
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much less
pain than
usual

O
0

O
10

O
20

O
30

O
40

O
50

O
60

O
70

O
80

O
90

O
100

O
70

O
80

O
90

O
100

7. How well did you sleep the night before last night?
much better
than usual

O
0

O
10

O
20

O
30

O
40

O
50

O
60

8. If you smoke, how many cigarettes (cigars, or pipes) did you smoke yesterday?
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T SMOKE
much less O
O
O
O
O
O
O
O
O
O
than usual 0
10 20 30 40 50 60 70 80 90

O
100

9. If you drink alcoholic beverages, how many drinks did you have yesterday?
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T DRINK ALCOHOL
much less O
O
O
O
O
O
O
O
O
O
O
than usual 0
10 20 30 40 50 60 70 80 90 100
10. If you drink caffeinated beverages, how many did you have yesterday?
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T USE CAFFEINATED
DRINKS
much less O
O
O
O
O
O
O
O
O
O
O
than usual 0
10 20 30 40 50 60 70 80 90 100

Remember to take saliva samples 30 minutes after you awoke and
at 4pm this afternoon.
Please note any times you remove the activity watch.
The questionnaire continues tomorrow morning.
Have a good day!

226

Daily Data Collection Schedule
DAY FOUR
Awakening
___ Fill out the Day Four Daily Questionnaires, Activity Watch
Questionnaire, and
Cortisol Questionnaire.
___
You may take off the Activity watch. Keep them with the supplies (but not in
the plastic box with the saliva samples) to return to the research staff.
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ID _____
DATE ___/___/___
Daily Questionnaire for DAY FOUR
(to be completed immediately after awakening)

Rarely

Sometimes

Often

I thought about it when I didn't mean to.
I had trouble falling asleep or staying asleep, because of
pictures of thoughts about it that came into my mind.
I had waves of strong feelings about it.
I had dreams about it.
Pictures about it popped into my mind
Other things kept making me think about it.
Any reminder brought back feelings about it.

Not at all

Below is a list of comments made by people after stressful life events. Please fill
in each item, indicating how frequently the comments were true for you YESTERDAY
regarding your diagnosis and treatment of BREAST CANCER. If they did not occur,
please mark the "Not at ALL" column.

0
O

1
O

2
O

3
O

O
O
O
O
O
O

O
O
O
O
O
O

O
O
O
O
O
O

O
O
O
O
O
O
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I did this
a little bit

1
O

2
O

3
O

4
O

O
O
O
O

O
O
O
O

O
O
O
O

O
O
O
O

O

O

O

O

I did this
a lot

I didn’t do
this at all

I've been turning to work or other activities to take
my mind off things.
I've been saying to myself "this isn't real".
I've been giving up trying to deal with it.
I've been refusing to believe that it has happened.
I've been giving up the attempt to cope.
I've been doing something to think about it less, such
as going to movies, watching TV, reading,
daydreaming, sleeping, or shopping.

I did this a
medium
amount

We are interested in how people respond when they confront the experience of having
breast cancer in their lives. There are lots of ways to try to deal with having breast cancer. This
questionnaire asks you to indicate what you did and felt yesterday, when you experienced
stressful events related to having breast cancer. Obviously, different events bring out somewhat
different responses, but think about what you did yesterday when you were under a lot of stress
related to having breast cancer.
Then respond to each of the following items by filling in one number for each, using the
response choices listed just below. Please try to respond to each item separately in your mind
from each other item. Choose your answers thoughtfully, and make your answers as true FOR
YOU as you can. Please answer every item. There are no "right" or "wrong" answers, so choose
the most accurate answer for YOU-- not what you think "most people" would say or do. Indicate
what YOU did yesterday when YOU experienced a stressful event related to having breast
cancer.

ID _____

DATE ___/___/___

ACTIVITY WATCH LOG - DAY FOUR
UPON AWAKENING
1. Time you got into bed last night: ___:___ am/pm (circle one)
2. Time you began trying to fall asleep: ___:___ am/pm (circle one)
3. Time you woke up for the last time this morning: ___:___ am/pm (circle
one)
4. Time you got out of bed this morning: ___:___ am/pm (circle one)
For the question below, please fill one bubble on the scale from 0 – 100 that best
describes your answer. For example, if you slept just as well as you have usually
slept in the past few months, you would fill in the bubble = 50. If worse, you
would fill in 60, 70, or 80, etc.

5. How well did you sleep last night?
much better
than usual

O
0

O
10

O
20

O
30

O
40

O
50

O
60

O
70

O
80

O
90

O
100

6. Do you have any other comments regarding last night’s sleep?
______________________________________________________________
______________________________________________________________
______________________________________________________________
______________________________________________________________

Please continue to the next page
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ID _____

DATE ___/___/___

Cortisol Questionnaire for DAY FOUR
(to be completed immediately after awakening)
Please choose the number that best describes your experience or
activities yesterday. Please answer by comparing yesterday with “your average
day” over the last few months. Rate your experience yesterday by filling in a
bubble from 0 – 100 on the scale below each statement. For example, for
question 1 if you were just about as physically active yesterday as you have
usually been in the past few months, you would fill in the bubble = 50. If you
exercised more than usual, you would fill in 60, 70, or 80, etc.

1. How much physical activity or exercise did you have yesterday?
O
O
O
O
O
O
O
O
O
O
much less O
physically 0
10 20 30 40 50 60 70 80 90 100
active than
usual
2. If you exercised yesterday, please fill in the following:
a) Exercise activity (e.g., walking, running, etc.) _______________________
b) Duration ___________ minutes
c) Level of exertion (darken one):
O HIGH
O MEDIUM
O LOW
d) Time you began to exercise (hour:minutes) _____:_____
3. How would you rate your health yesterday (how generally well you felt).
much better
than usual

O
0

O
10

O
20

O
30

O
40

O
50

O
60

O
70

O
80

O
90

O
100

O
50

O
60

O
70

O
80

O
90

O
100

4. How stressful was your day yesterday?
much less
stressful
than usual

O
0

O
10

O
20

O
30

O
40

5. If yesterday was MORE stressful than usual, what events during the day, and/or
what times of day were particularly stressful?
Event: _____________________________________________________________
Time it began to be stressful: ____:____ (hour:minutes)
Event: _____________________________________________________________
Time it began to be stressful: ____:____ (hour:minutes)

6. How much pain did you experience yesterday?
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much less
pain than
usual

O
0

O
10

O
20

O
30

O
40

O
50

O
60

O
70

O
80

O
90

O
100

O
70

O
80

O
90

O
100

7. How well did you sleep the night before last night?
much better
than usual

O
0

O
10

O
20

O
30

O
40

O
50

O
60

8. If you smoke, how many cigarettes (cigars, or pipes) did you smoke yesterday?
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T SMOKE
much less O
O
O
O
O
O
O
O
O
O
than usual 0
10 20 30 40 50 60 70 80 90

O
100

9. If you drink alcoholic beverages, how many drinks did you have yesterday?
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T DRINK ALCOHOL
much less O
O
O
O
O
O
O
O
O
O
O
than usual 0
10 20 30 40 50 60 70 80 90 100
10. If you drink caffeinated beverages, how many did you have yesterday?
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T USE CAFFEINATED
DRINKS
much less O
O
O
O
O
O
O
O
O
O
O
than usual 0
10 20 30 40 50 60 70 80 90 100
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Saliva and Activity Watch Log Sheet

Example

Saliva

Watch

Please write about any
problems with saliva
collection
Date/Time
Comments
Late taking
1/1/06
4 p.m.
4:12 p.m.
sample

Please write down any
times the Actiwatch is
removed
Date/Time
Comments

DAY 0

DAY 1

DAY 2
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1/1/06
6:37 - 7:12 p.m.

Washed
dishes

Saliva and Activity Watch Log Sheet

Example

Saliva

Watch

Please write about any
problems with saliva
collection
Date/Time
Comments
Late taking
1/1/06
4 p.m.
4:12 p.m.
sample

Please write down any
times the Actiwatch is
removed
Date/Time
Comments
1/1/06
6:37 - 7:12 Washed
p.m.
dishes

DAY 3

DAY 4
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You Are Finished!
Thank You So Much For Your Time and Patience!
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Stress, Coping, and Sleep in Breast
Cancer
Questionnaire Packet

Sandra Sephton, Ph.D., Director
Biobehavioral Research Laboratory
University of Louisville
2301 S. Third Street, 427 Lutz Hall
Louisville, KY 40208
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Stress, Coping, and Sleep in Breast Cancer

Questionnaire Packet
Instructions:

Dear Research Participant.
We greatly appreciate your willingness to take part in this study of the effects of
stress, coping, and sleep in women with breast cancer. It may take you about one hour
to complete this packet. Please complete it in a quiet place, alone, at a time when you
can be free from interruption.
•
•
•

•
•

Please be sure to write the date that you answer each questionnaire at the top
of the page on which it begins.
Please fill in the bubbles so that the entire circle is blackened (do NOT make
check marks)
Do not skip any items
Please use a dark pen and write clearly DO NOT USE PENCIL
If you make any mistakes, please put an “X” through the incorrect answer and
fill in the correct answer.

By completing this questionnaire, you will help us understand much about stress
in cancer. We hope this will be a valuable experience for you as well as for us. We are
very grateful to you for making the commitment to participate. Your role in this research
is vital. You may feel as though you are answering the same question more than once;
however, your answer on each item is needed.
The timing of your menstrual cycle, your physical condition, and some of the
medications you may be taking are likely to influence the stress hormones we will be
measuring in your blood, urine and saliva samples. Thus, please be as accurate as
possible when recording your medical information. To maintain the confidentiality of the
information you provide, all data will be secured in locked files and will be accessed only
by research staff. In some of the enclosed questionnaires you will be asked to answer
questions about past stressful experiences. This may bring up painful feelings or
memories. If you experience so much distress that you would benefit from personal
counseling, the investigators can refer you to the Behavioral Medicine Clinic at Norton
Hospital, although the study cannot provide payment for such treatment. If you have
concerns or questions that come up in the process of completing these questionnaires,
you may contact Sandra Sephton.
With our sincere thanks,

Sandra Sephton, Ph.D. (502-852-1166)
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The packet contains the following questionnaires:

Page

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.

4
8
8
9
9
11
13
15
17
19

Background
Medications
KAR
IES
COP
QOL
ISEL
POM
PFS
MSA

Thank you very much for participating in this
study!
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Please answer the following questions about your background and medical history.
1. Name:______________________________________________________________
2. Nickname:___________________________________________________________
3. Age:__________
4. Gender: Male O Female O
5. Date of Birth:

Month: _______

Day: _______

Year: _______

6. Address:
Street ______________________________ Apt. # ___________
City _______________________ State_________ Zip _________
Phone Number:_________________________________

O Yes

7. Family/Friend Caregiver Support?

O

No

Name ______________________________
Phone Number _______________________
. Diagnosing physician:
Name:_____________________________ Phone
number:__________________
Location (practice, clinic or hospital,
city):________________________________

9. Date of first breast cancer diagnosis (mm/dd/yy):
__________________________________
10. On which side was your cancer? _____________________________________
11. Stage at diagnosis: : _____________________________________
12. Have you EVER had radiation therapy?

O

Yes

O No

13. Are you currently receiving radiation therapy?

O

Yes

O

DATE STARTED?
Month______ Year_______ DATE
ENDED?_________________
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14. When was the last date of your radiation therapy? (mm/dd/yy):
_______________________
15. Have you EVER had chemotherapy treatment?
DATE STARTED?

O

Yes

No

(mm/dd/yy): _______________________

16. Are you currently receiving chemotherapy treatment? O
DATE STARTED?

O

Yes

O

No

(mm/dd/yy): _______________________

17. When was the last date of your chemotherapy treatment? (mm/dd/yy):

_____________________
18. Have you had a breast or part of a breast removed surgically? (mm/dd/yy):

_________________
Which breast or part of your breast?________________________________
19. Have you been diagnosed with any other type of cancer?:
When? (mm/dd/yy):

_______________________________________________
What kind of cancer?____________________________________________
Treatment?____________________________________________________
20. Have you been diagnosed with other ongoing medical conditions (diabetes,
cardiovascular disease, high blood pressure, renal disease, etc.)?

O
Yes
21. Do you have children?
If so, how many children have you had?
Number of children you have had: _____
Number of children living with you: _____
Number of elderly parents living with you: _____
Number of other people living with you: _____
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O

No
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O
O
O
O
O
O
O
O
O

22. What is your marital status?

Single, never married
Single, divorced
Single, living with partner
Married
Divorced and remarried
Widowed
Widowed and remarried
Separated
Other

23. If you are separated, divorced, or widowed, when did this occur? Month _______
Year _______

24. What is your racial-ethnic background?

O
O
O
O
O
O

Asian
Black
Hispanic
Native American
White/Caucasian
Other

25. How many years of education have you completed?
Use the following numbers as a guide to your answer:

26. Are you currently employed?

O
O
O
O
O
O
O

Grade School = K-6
Middle School = 7-8
High School = 12
AA/Technical = 14
BA/BS = 16
MA = 18
PhD, MD, JD = 20

O

Yes

O

No

27. If currently employed: Hours per week? (enter 0 if not applicable) :
Occupation: _____________________________________________
28. If not currently employed, which of the following best describes your situation?

O
O
O
O
O
O
O

Not looking for work
Looking for work
Leave of Absence
Retired
Medical leave or temporary disability
Permanently disabled
Not applicable
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29. If not currently employed, what was your previous occupation, if any?
___________________
30. What is your total annual household income before taxes?

O
O
O
O
O
O

Less than $20,000
$20,000 - $39,999
$40,000 - $59,999
$60,000 - $79,999
$80,000 - $99,999
$100,000 and above

31. What is your current living situation?
(Do not include temporary visitors.) O

O
O
O
O
O
O

Live alone
Live with spouse/partner only
Live with spouse/partner and child only
Live with child or children only
Live with other relatives
Live with other non-relatives
Other

32. Do you own or rent your place of residence?

O

Own O

Rent

33. What is the total number of people living in your household, including yourself?
_______

O
Protestant
O
Jewish
O
Catholic
O
None
O Other____________(please specify)

34. What is your religious affiliation?
(darken one)

35. Insurance:

Private
Public
Other
None

O
O
O
O

36. Do you consider yourself to be?
O
pre-menopause (you have a menstrual period on a regular cycle)
O
peri-menopause (you have begun to experience symptoms of
menopause, but have not completed this transition)
O
post-menopause (you no longer menstruate, and have completed the
transition into menopause)
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37. If you currently experience a regular menstrual period, what was the first day of your
last menstrual period?

(mm/dd/yy): _____________________
38. If you currently experience a regular menstrual period, how many days is your usual
cycle (days from the beginning of one period to the beginning of the next one, for
example, 28 days, 31 days, etc.).
_______ # days
39. Do you currently use oral contraceptive pills?

O

Yes

40. Are you currently taking estrogen replacement therapy? O Yes
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O

No

O

No

MEDS

Please list all medications you have taken in the past month. Please include prescription
medications and non-prescription (over-the-counter) medications, as well as any herbal
supplements. You may find it helpful to have your medications at hand while completing this form.
Please use the back of this page if you need additional room.
Medication

Dosage

Number of

Number of days per

times per day

week
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Reason taken

KAR
100

Normal, no complaints, no evidence of disease

90

Able to carry on normal activity: minor symptom of disease

80

Normal activity with effort: some symptoms of disease

70

Cares for self: unable to carry on normal activity or active work

60

Requires occasional assistance but is able to care for needs

50

Requires considerable assistance and frequent medical care

40

Disabled: requires special care and assistance

30

Severely disabled: hospitalization is indicated, death not imminent

20

Very sick, hospitalization necessary; active treatment necessary

10

Moribund, fatal processes progressing rapidly

0

Death
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IES

13.
14.
15.

Never

5.
6.
7.
8.
9.
10.
11.
12.

Sometimes

3.
4.

I thought about it when I didn't mean to.
I avoided letting myself get upset when I thought about it or
was reminded of it.
I tried to remove it from memory.
I had trouble falling asleep or staying asleep, because of
pictures of thoughts about it that came into my mind.
I had waves of strong feelings about it.
I had dreams about it.
I stayed away from reminders of it.
I felt as if it hadn't happened or it wasn't real.
I tried not to talk about it.
Pictures about it popped into my mind.
Other things kept making me think about it.
I was aware that I still had a lot of feelings about it, but I didn't
deal with them.
I tried not to think about it.
Any reminder brought back feelings about it.
My feelings about it were kind of numb.

Rarely

1.
2.

Not at all

Below is a list of comments made by people after stressful life events. Please fill in each
item, indicating how frequently the comments were true for you DURING THE CURRENT DAY
regarding your diagnosis and treatment of BREAST CANCER. If they did not occur, please mark
the "Not at All" column.

0
O

1
O

2
O

3
O

O

O

O

O

O

O

O

O

O

O

O

O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O

O

O

O

O
O
O

O
O
O

O
O
O

O
O
O
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I usually
do this a
little bit

I usually
do this a
medium
amount

I usually
do this a
lot

1. I've been concentrating my efforts on
doing something about the situation I'm
in.
2. I've been trying to come up with a
strategy about what to do.

I usually
don’t do
this at all

We are interested in how people respond when they confront difficult or stressful events
in their lives that are related to the experience of having breast cancer. There are lots of ways to
try to deal with this stress. This questionnaire asks you to indicate what you generally do and feel,
when you experience stressful events related to breast cancer. Obviously, different events bring
out somewhat different responses, but think about what you usually do when you are under a lot
of stress related to breast cancer.
Then respond to each of the following items by filling in one number for each, using the
response choices listed just below. Please try to respond to each item separately in your mind
from each other item. Choose your answers thoughtfully, and make your answers as true FOR
YOU as you can. Please answer every item. There are no "right" or "wrong" answers, so choose
the most accurate answer for YOU-- not what you think "most people" would say or do. Indicate
what YOU usually do when YOU experience a stressful event related to breast cancer.

O

O

O

O

O

O

O

O
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I usually
do this a
medium
amount

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O
O
O

O
O
O

O
O
O

O
O
O

O

O

O

O

O

O

O

O

O

O

O

O

O
O

O
O

O
O

O
O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

I usually
do this a
lot

I usually
do this a
little bit

to make it seem more positive.
4. I've been accepting the reality of the fact
that it has happened.
5. I've been making jokes about it.
6. I've been trying to find comfort in my religion
or spiritual beliefs.
7. I've been getting emotional support from
others.
8. I've been trying to get advice or help from
other people about what to do.
9. I've been turning to work or other activities
to take my mind off things.
10. I've been saying to myself "this isn't real."
11. I've been saying things to let my unpleasant
feelings escape.
12. I've been using alcohol or other drugs to
make myself feel better.
13. I've been giving up trying to deal with it.
14. I've been criticizing myself.
15. I've been learning to live with it.
16. I've been taking action to try to make the
situation better.
17. I've been thinking hard about what steps to
take.
18. I've been looking for something good in
what is happening.
19. I've been making fun of the situation.
20. I've been praying or meditating.
21. I've been getting comfort and understanding
from someone.
22. I've been getting help and advice from other
people.
23. I've been doing something to think about it
less, such as going to movies, watching TV,
reading, daydreaming, sleeping, or
shopping.
24. I've been refusing to believe that it has
happened.
25. I've been expressing my negative feelings.
26. I've been using alcohol or other drugs to
help me get through it.
27. I've been giving up the attempt to cope.
28. I've been blaming myself for things that
happened.

I usually
don’t do
this at all
3. I've been trying to see it in a different light,

QOL

Somewhat

Quite a bit

Very much

1. I have a lack of energy.
2. I have nausea.
3. Because of my physical condition, I have trouble meeting
the needs of my family.
4. I have pain.
5. I am bothered by side effects of treatment.
6. I feel ill.
7. I am forced to spend time in bed.

A little bit

PHYSICAL WELL-BEING

Not at all

Below is a list of statements that other people with your illness have said are
important. By circling one number per line, please indicate how true each statement has
been for you during the past 7 days.

0

1

2

3

4

O
O

O
O

O
O

O
O

O
O

O

O

O

O

O

O
O
O
O

O
O
O
O

O
O
O
O

O
O
O
O

O
O
O
O

Not at all

9. I feel distant from my friends.
10. I get emotional support from my family.
11. I get support from my friends and neighbors.
12. My family has accepted my illness.
13. Family communication about my illness is poor.
14. I feel close to my partner (or the person who is my
main support).

4
O

5
O

6
O

7
O

8
O

0
O
O
O
O
O
O

1
O
O
O
O
O
O

2
O
O
O
O
O
O

3
O
O
O
O
O
O

4
O
O
O
O
O
O

Regardless of your current level of sexual activity, please answer the following
questions:
No
Yes
15a. Have you been sexually active during the past year?
O
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9 10
O O

Very much

SOCIAL/FAMILY WELL-BEING

3
O

Quite a bit

2
O

Somewhat

1
O

A little bit

0
O

Not at all

Very much so
8. Looking at the above 7 questions,
how much would you say your
PHYSICAL WELL-BEING affects
your quality of life?

O

Not at all

A little bit

Somewhat

Quite a bit

Very much

0
O

1
O

2
O

3
O

4
O

15b. If yes: I am satisfied with my sex life.
Not at all

4
O

5
O

6
O

7
O

8
O

9 10
O O

RELATIONSHIP WITH DOCTOR

Very much

3
O

Quite a bit

2
O

Somewhat

1
O

A little bit

0
O

Not at all

Very much so
16. Looking at the above 7 questions,
how much would you say your
SOCIAL/FAMILY WELL-BEING
affects your quality of life?
QOL

17. I have confidence in my doctor(s).
18. My doctor is available to answer my questions.

0
O
O

1
O
O

2
O
O

3
O
O

4
O
O

Not at all

4
O

5
O

6
O

7
O

8
O

9 10
O O

EMOTIONAL WELL-BEING

Very much

3
O

Quite a bit

2
O

Somewhat

1
O

A little bit

0
O

Not at all

Very much so
19. Looking at the above 7 questions,
how much would you say your
RELATIONSHIP WITH THE
DOCTOR affects your quality of life?

20. I feel sad.
21. I am proud of how I'm coping with my illness.
22. I am losing hope in the fight against my illness.
23. I feel nervous.
24. I worry about dying.
25. I worry that my condition will get worse.

0
O
O
O
O
O
O

1
O
O
O
O
O
O

2
O
O
O
O
O
O

3
O
O
O
O
O
O

4
O
O
O
O
O
O

Not at all
Very much so
26. Looking at the above 6 questions,
how much would you say your
EMOTIONAL WELL-BEING affects
your quality of life?

0
O
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1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9 10
O O

FUNCTIONAL WELL-BEING

Not at all

A little bit

Somewhat

Quite a bit

Very much

27. I am able to work (include work in home).
28. My work (include work in home) is fulfilling.
29. I am able to enjoy life.
30. I have accepted my illness.
31. I am sleeping well.
32. I am enjoying the things I usually do for fun.
33. I am content with the quality of my life right now.

0
O
O
O
O
O
O
O

1
O
O
O
O
O
O
O

2
O
O
O
O
O
O
O

3
O
O
O
O
O
O
O

4
O
O
O
O
O
O
O

Not at all

4
O

ADDITIONAL CONCERNS

35. I have been short of breath.
36. I am self-conscious about the way I dress.
37. One or both of my arms are swollen or tender.
38. I feel sexually attractive.
39. I am bothered by hair loss.
40. I worry about the risk of cancer in other family
members.
41. I worry about the effect of stress on my illness.
42. I am bothered by a change in weight.
43. I am able to feel like a woman.

5
O

6
O

7
O

8
O

9 10
O O

Very much

3
O

Quite a bit

2
O

Somewhat

1
O

A little bit

0
O

Not at all

Very much so
34. Looking at the above 7 questions,
how much would you say your
FUNCTIONAL WELL-BEING affects
your quality of life?
QOL

0
O
O
O
O
O
O

1
O
O
O
O
O
O

2
O
O
O
O
O
O

3
O
O
O
O
O
O

4
O
O
O
O
O
O

O
O
O

O
O
O

O
O
O

O
O
O

O
O
O

Not at all
Very much so
44. Looking at the above 9 questions,
how much would you say these
ADDITIONAL CONCERNS affect
your quality of life?

0
O
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1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9 10
O O

ISEL

Definitely
False
Probably
False
Probably
True
Definitely
True

This scale is made up of a list of statements each of which may or may not be
true about you. Choose “definitely true” if you are sure it is true about you and “probably
true” if you think it is true but are not absolutely certain. Similarly, you should choose
“definitely false” if you are sure the statement is false and “probably false” if you think it
is false but are not absolutely certain.

1. There are several people that I trust to help solve my
problems.
2. If I needed help fixing an appliance or repairing my car,
there is someone who would help me.
3. Most of my friends are more interesting than I am.
4. There is someone who takes pride in my
accomplishments.
5. When I feel lonely, there are several people I can talk to.
6. There is no one that I feel comfortable to talking about
intimate personal problems.
7. I often meet or talk with family or friends.
8. Most people I know think highly of me.
9. If I needed a ride to the airport very early in the morning,
I would have a hard time finding someone to take me.
10. I feel like I’m not always included by my circle of friends.
11. There really is no one who can give me an objective
view of how I’m handling my problems.
12. There are several different people I enjoy spending time
with.
13. I think that my friends feel that I’m not very good at
helping them solve their problems.
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O

O
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Probably
False

Probably
True

Definitely
True

14. If I were sick and needed someone (friend, family member,
or acquaintance) to take me to the doctor, I would have
trouble finding someone.
15. If I wanted to go on a trip for a day (e.g., to the mountains,
beach, or country), I would have a hard time finding
someone to go with me.
16. If I needed a place to stay for a week because of an
emergency (for example, water or electricity out in my
apartment or house), I could easily find someone who
would put me up.
17. I feel that there is no one I can share my most private
worries and fears with.
18. If I were sick, I could easily find someone to help me with
my daily chores.
19. There is someone I can turn to for advice about handling
problems with my family.
20. I am as good at doing things as most other people are.
21. If I decide one afternoon that I would like to go to a movie
that evening, I could easily find someone to go with me.
22. When I need suggestions on how to deal with a personal
problem, I know someone I can turn to.
23. If I needed an emergency loan of $100, there is someone
(friend, relative, or acquaintance) I could get it from.
24. In general, people do not have much confidence in me.
25. Most people I know do not enjoy the same things that I do.
26. There is someone I could turn to for advice about making
career plans or changing my job.
27. I don’t often get invited to do things with others.
28. Most of my friends are more successful at making changes
in their lives than I am.
29. If I had to go out of town for a few weeks, it would be
difficult to find someone who would look after my house or
apartment (the plants, pets, garden, etc.).
30. There really is no one I can trust to give me good financial
advice.
31. If I wanted to have lunch with someone, I could easily find
someone to join me.
32. I am more satisfied with my life than most people are with
theirs.
33. If I was stranded 10 miles from home, there is someone I
could call who would come and get me.
34. No one I know would throw a birthday party for me.
35. It would me difficult to find someone who would lend me
their car for a few hours.
36. If a family crisis arose, it would be difficult to find someone
who could give me good advice about how to handle it.
37. I am closer to my friends than most other people are to
theirs.
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Probably
True

Definitely
True

Probably
False

38. There is at least one person I know whose advice I
really trust.
39. . If I needed some help in moving to a new house or
apartment, I would have a hard time finding someone
to help me.
40. I have a hard time keeping pace with my friends.

Definitely
False

ISEL
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POM

253

A little

Moderately

Quite a bit

Extremely

1. Friendly
2. Tense
3. Angry
4. Worn out
5. Unhappy
6. Clear-headed
7. Lively
8. Confused
9. Sorry for things done
10. Shaky
11. Listless
12. Peeved
13. Considerate
14. Sad
15. Active
16. On edge
17. Grouchy
18. Blue
19. Energetic
20. Panicky
21. Hopeless
22. Relaxed
23. Unworthy
24. Spiteful
25. Sympathetic

Not at all

Below is a list of words that describe feelings people have. Please read each one
carefully. Then circle ONE number under the answer to the right which best describes
HOW YOU HAVE BEEN FEELING DURING THE PAST WEEK INCLUDING TODAY.
The numbers refer to these phrases:

0
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O

1
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O

2
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O

3
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O

4
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O

26. Uneasy
27. Restless
28. Unable to concentrate
29. Fatigued
30. Helpful
31. Annoyed
32. Discouraged
33. Resentful
34. Nervous
35. Lonely
36. Miserable
37. Muddled
38. Cheerful
39. Bitter
40. Excited
41. Anxious
42. Ready to fight
43. Good-natured
44. Gloomy
45. Desperate
46. Sluggish
47. Rebellious
48. Helpless
49. Weary
50. Bewildered
51. Alert
52. Deceived
53. Furious
54. Efficient
55. Trusting
56. Full of pep
57. Bad-tempered
58. Worthless
59. Forgetful
60. Carefree
61. Terrified
62. Guilty
63. Vigorous
64. Uncertain about things
65. Bushed
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Extremely

Quite a bit

Moderately

A little

Not at all

POM
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PFS
For each of the following questions, circle the number that best describes the fatigue you are
experiencing now. Please make every effort to answer each question to the best of your ability. Thank you
very much.
1. How long have you been feeling fatigued? (fill one circle only)
O
Minutes
O
Hours
O
Days
O
Weeks
O
Months
O
Other (please describe): ___________________
2. To what degree is the fatigue
you are feeling now causing you
distress?

None

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

A great deal

3. To what degree is the fatigue
you are feeling now interfering
with your ability to complete
your work or school activities?

None

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

A great deal

None

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

A great deal

None

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

A great deal

None

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

A great deal

Mild

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Severe

4. To what degree is the fatigue
you are feeling now interfering
with your ability to visit or
socialize with your friends?
5. To what degree is the fatigue
you are feeling now interfering
with your ability to engage in
sexual activity?
6. Overall how much is the
fatigue, which you are
experiencing now, interfering
with your ability to engage in the
kind of activities you enjoy
doing?
7. How would you describe the
degree of intensity or severity of
the fatigue which you are
experiencing now?
8. To what degree would you
describe the fatigue which you
are experiencing now as being:

Pleasant

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Unpleasant

9. To what degree would you
describe the fatigue which you
are experiencing now as being:

Agreeae

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Disagreeable

10. To what degree would you
describe the fatigue which you
are experiencing now as being:

Protective

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Destructive

11. To what degree would you
describe the fatigue which you
are experiencing now as being:

Positive

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Negative

12. To what degree would you
describe the fatigue which you
are experiencing now as being:

Normal

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Abnormal

13. To what degree are you now
feeling:

Strong

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Weak
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14. To what degree are you now
feeling:

0
O

Awake

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Listless

Sleepy

Lively

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

16. To what degree are you
now feeling:

Refreshe
d

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Tired

17. To what degree are you
now feeling:

Energetic

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Unenergetic

18. To what degree are you
now feeling:

Patient

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Impatient

19. To what degree are you
now feeling:

Relaxed

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Tense

20. To what degree are you
now feeling:

Exhilarated

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Depressed

21. To what degree are
you now feeling:

Able to
concentrate

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Unable to
concentrate

22. To what degree are
you now feeling:

Able to
remember

0
O

1
O

2
O

3
O

4
O

5
O

6
O

7
O

8
O

9
O

10
O

Unable to
remember

23. To what degree are
you now feeling:

Able to
think clearly

0

1

2

3

4

5

6

7

8

9

10

Unable to
think clearly

15. To what degree are you now
feeling:

O O O O O O O O O O

O

24. Overall, what do you believe is most directly contributing to or causing your fatigue?
_________________________________________________________________________
______
25. Overall, the best thing you have found to relieve your fatigue is:
__________________________
_________________________________________________________________________
_______
26. Is there anything else you would like to add that would describe your fatigue better to
us?
_________________________________________________________________________
_______
27. Are you experiencing any other symptoms right now?

O No
O Yes (please describe)______________________
______________
If you need more space, please continue below and include the item number:
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MSA
We have listed 24 symptoms below. Please read each one carefully. If you had the
symptom during the past week, let us know how OFTEN you had it, how SEVERE it was usually
and how much it DISTRESSED OR BOTHERED you by circling the appropriate number. If you
DID NOT HAVE the symptom, make an X in the box marked "DID NOT HAVE".

Almost
Constantly
Slight

Moderate

Severe

Very Severe

Not at all

A Little Bit

Somewhat

Quite a Bit

Very Much

IF YES
How much did it
DISTRESS or
BOTHER you?

Frequently

Difficulty
concentrating
Pain
Lack of energy
Cough
Feeling nervous
Dry mouth
Nausea
Feeling drowsy
Numbness/tingling
in hands/feet
Difficulty sleeping
Feeling bloated
Problems with
urination
Vomiting
Shortness of
breath
Diarrhea
Feeling sad
Sweats
Worrying
Problems with
sexual interest or
activity
Itching
Lack of appetite
Dizziness
Difficulty
Swallowing
Feeling irritable

N
O
T

IF YES
How SEVERE
was it usually?

Occasionally

Did you have any
of the following
symptoms?

IF YES
How OFTEN did
you have it?

Rarely

DURING THE
PAST WEEK

D
I
D

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O
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O
O
O
O
O

O
O
O
O
O
O
O

O
O
O
O
O
O
O

O
O
O
O
O
O
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O
O
O
O
O
O
O

O

O

O

O

O

O

O

O

O
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O
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O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

O

H
A
V
E
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MSA
We have listed 8 symptoms below. Read each one carefully. If you have had the
symptom during this past week, let us know how SEVERE it was usually and how much
it DISTRESSED or BOTHERED you by circling the appropriate number. If you DID NOT
HAVE the symptom, make an "X" in the box marked "DID NOT HAVE."
DURING THE PAST
WEEK

IF YES
How SEVERE was it
usually?

Moderate

Severe

Very Severe

Not at all

A Little Bit

Somewhat

Quite a Bit

Very Much

N
O
T

IF YES
How much did it DISTRESS or
BOTHER you?

Slight

Did you have any of the
following symptoms?

D
I
D

Mouth sores
Change in the way food
tastes
Weight loss

O

O

O

O

O

O

O

O

O

O

O
O

O
O

O
O

O
O

O
O

O
O

O
O

O
O

O
O

O
O

Hair loss

O

O

O

O

O

O

O

O

O

O

Constipation

O

O

O

O

O

O

O

O

O

O

Swelling of arms or legs

O

O

O

O

O

O

O

O

O

O

H
A
V
E

"I don't look like myself"

O

O

O

O

O

O

O

O

O

O

Changes in skin

O

O

O

O

O

O

O

O

O

O

Very Much

Not at all

A Little Bit

Quite a Bit

Somewhat

IF YOU HAD ANY OTHER SYMPTOMS DURING THE PAST WEEK, PLEASE LIST BELOW
AND INDICATE HOW MUCH THE SYMPTOM HAS DISTRESSED OR BOTHERED YOU.

Other:

O

O

O

O

O

Other:

O

O

O

O

O

Other:

O

O

O

O

O
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traumatic brain injury.
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I am a postdoctoral research fellow at Duke University. My doctoral degree will be
conferred from the University of Louisville in December of 2007. My clinical training
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am currently an active researcher with the Nicotine Research Lab at Duke University and
the Durham, NC VA and the Biobehavioral Research Lab at the University of Louisville.

264

